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ABSTRACT 




Janet Lynn Anderson 
University of New Hampshire, May, 2008 
Representational Difference Analysis (RDA) was used to identify genes 
that were differentially expressed between White Carneau (WC) and Show 
Racer (SR) pigeon aortic smooth muscle cells. The gene(s) responsible for 
atherosclerotic resistance in cultured SR smooth muscle cells (SMC) were 
hypothesized to be silent or down regulated in the WC. In the reciprocal 
experiments, it was hypothesized that the gene(s) contributing to the 
spontaneous atherosclerotic phenotype in cultured WC SMC would not be 
expressed in the SR. 
Total RNA was extracted from primary cultured cells of each breed, 
converted to cDNA, and compared in four reciprocal RDA experiments. 
Seventy-four transcripts were identified exclusively in the WC cells, and 63 
were unique to the SR. Genes representing several biochemical pathways were 
xu 
distinctly different between aortic cells from susceptible (WC) and resistant (SR) 
pigeons. 
The most striking genetic differences were observed in energy 
metabolism and smooth muscle contractility. The WC cells derived their energy 
from glycolysis, while the SR cells utilized oxidative phosphorylation to produce 
energy. Myosin light chain kinase and alpha actin were exclusively expressed 
by the SR SMC, whereas beta actin and collagen were dominant in the WC. 
Because of the compressed in vitro time frame compared with in vivo 
development, it was not obvious whether insufficient ATP synthesis is 
preventing the WC aortic cells from performing their contractile function or if the 
lack of functional contractile elements in the WC causes the mitochondrial ATP 
synthesis to down regulate. Either way, energy production was successfully 
coupled to muscle contraction in the SR, but not in the WC. This difference was 
observed prior to lipid accumulation in the WC cells, and appears to be a major 
contributing factor in pigeon atherogenesis. 
One hundred forty five pigeon transcripts were homologous to the 
chicken. However, the mitochondrial genes expressed in the pigeon were more 
closely related to non-domestic birds such as the turkey vulture and oriental 
stork. Despite this categorical exception, the recently published chicken 
genome was an ideal resource for identifying differentially expressed genes in 
the pigeon. The results were interpreted in the context of current hypotheses of 
human atherogenesis. The pigeon transcripts can also be used in comparative 
studies of avian genomics. 
xiii 
INTRODUCTION 
Atherosclerotic cardiovascular disease is the leading cause of death in 
the United States and other economically developed countries. One of the 
earliest manifestations of this disease is the formation of lesions, known as 
plaques, in the arterial wall. These plaques accumulate lipid, proteoglycans, 
and fibrous material which can lead to a restriction in blood flow, increasing the 
likelihood of a heart attack or stroke. Many environmental factors such as diet, 
lack of exercise, stress, and smoking habits are known to contribute to the 
severity of the lesion once it is formed. However, the mechanism(s) that initiate 
lesion development is unknown, and quantifiable risk factors such as elevated 
blood cholesterol, triglycerides, and blood pressure fail to predict over fifty 
percent of heart disease mortality. 
Despite the prominent role of heritability in the "pathophysiology of 
atherosclerosis, clinical risk assessment and therapeutic decision making are 
still based on classical risk factprs."1 Until the genetic basis for susceptibility to 
atherosclerosis is understood, correlation of various risk factors with specific 
metabolic or pathological features will be difficult to assess, and efforts for 
prevention will remain equivocal. The individual and synergistic effects of 
multiple genes, various linkages, and gene-environment interactions that 
contribute to the atherosclerotic phenotype are difficult to separate. Work 
reported to date has looked at gene expression in human atherosclerotic 
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plaques compared to non-involved arterial segments, or at the identification of 
genes and loci correlating with lesion severity in knockout mice. In both cases, 
the research focus has been on end point gene expression, rather than initiation 
of the disease itself. This is problematic because it is only when the genetic 
contributions to lesion initiation and progression are understood that the true 
impact of dietary and lifestyle choices can be determined. Clinical trials have 
demonstrated that the "efficacy of dietary factors to prevent cancer is probably 
stage dependent"2, and it is reasonable to expect that this will also be the case 
for heart disease. 
An animal model that could facilitate characterization of the initiating 
mechanisms of atherosclerosis without the complications of environmental or 
genetic modifications would allow the systematic analysis of lesion 
pathogenesis under a wide variety of conditions. The domestic pigeon 
(Columba livia) is an appropriate model of human atherosclerosis for several 
reasons. The foremost reason is susceptible and resistant breeds exist within 
the same species, eliminating the need to create an artificial atherosclerotic 
phenotype in the laboratory. In addition, susceptibility to spontaneous (non-
induced) atherosclerosis in the pigeon is inherited as an autosomal recessive 
trait. Susceptibility resides at the level of the arterial wall and is manifested as 
lesions at the celiac bifurcation of the descending aorta. These lesions are 
pathologically and biochemically similar to the human lesion, yet occur in the 
absence of elevated blood cholesterol and other traditional risk factors. 
Comparisons of genetic and metabolic differences between the susceptible and 
2 
resistant pigeon breeds are further facilitated because preliminary cellular 
features of atherogenesis are also seen in pigeon aortic cell cultures. 
Representational Difference Analysis (RDA) is a positive selection 
technique to determine differential gene expression between two closely related 
species. RDA will be used to characterize the genetic contribution to 
spontaneous atherosclerosis in the pigeon by comparing the gene expression 
between susceptible and resistant pigeon aortic cells. Once a panel of 
differentially expressed genes has been identified, it will become feasible to 
monitor atherogenesis and disease progression in response to diet, stress, and 
other environmental factors. Since gene structure, function, and pattern of 
expression is extensively conserved across living organisms, candidate genes 
isolated from the pigeon can be screened against the human genome and 





Introduction to Human Atherosclerosis 
Atherosclerosis is the most common form of heart disease, a general 
term encompassing a variety of pathologies affecting the heart and circulatory 
system. More specifically, atherosclerosis is a disease of the arteries, and is 
most likely to develop at branch points and other regions of low shear stress 
along the arterial tree, such as the celiac bifurcation of the aorta, and in 
coronary and carotid arteries3,4. 
Atherosclerotic lesions begin to develop during childhood as lipid-filled 
foam cells making up "fatty streaks"5,6, and slowly progress through fibrous 
lesions into complex plaques consisting of multiple cell types, intra- and 
extracellular cholesterol esters, calcium deposits, proteoglycans, and extensive 
connective tissue. The final and terminating event of atherosclerosis is blood 
vessel occlusion, often caused by plaque rupture, which can lead to a heart 
attack, stroke, or embolism, depending on the location of the affected artery. 
However, not all fatty streaks progress to the stage of an advanced lesion7, and 
the rate of progression/regression, although well correlated with classical risk 
factors, is unique to each individual. 
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Clinical symptoms of atherosclerosis do not usually appear until later in 
life5,8. Therefore, research and intervention strategies have focused on delaying 
the progression of plaque formation rather than preventing the appearance of 
foam cells or fatty streaks in the first place. There is a strong familial component 
to all forms of heart disease, and many genetic disorders have been identified 
that contribute to lesion progression and the probability of plaque rupture in the 
general population. However, little is known about the specific genes that 
determine disease predisposition or how these genes interact with each other 
and the environment to initiate atherosclerotic foam cell formation in any one 
individual. 
Human Atherogenesis 
The Observed Beginning: Foam Cells and Lesion Development. In 
human lesions, early foam cells originate primarily from vascular smooth 
muscle cells (VSMC)9. They are the first cell type to appear in susceptible 
regions of the aorta10,11, and the most abundant cell type in the developing fatty 
streak9,12"15. As early as 1964, using electron microscopy, Balis et al. noted that 
VSMC were often filled with lipid when there was no lipid in either existing 
macrophage cells or in the extracellular space, but the reverse was never 
observed. Therefore, the following series of events was proposed10: 
1. VSMC accumulate lipid 
2. Sloughing of endothelial cells, compromising VSMC membranes 
3. Lipid released from VSMC and enters extracellular space 
4. Macrophage cells arrive and phagocytose the lipid 
5. Lipid accumulates in the macrophage cells 
5 
There has been little reason to reconsider this sequence of events except for 
two additional observations. First, multiple investigators have since reported 
that abnormal accumulation of VSMC in susceptible regions of the aorta 
precedes the actual lipid accumulation11,12. Second, atherosclerotic foam cells 
can be derived from both VSMC and macrophage cells916, depending on the 
physical location17 and the cause of initiation. 
Plaques that develop along the descending thoracic aorta tend to have 
more macrophage cells than VSMC, whereas plaques along the abdominal 
aorta and coronary arteries are comprised mostly of VSMC, with very few 
macrophage cells present in early stages9. Thoracic plaques are very rare in 
humans, and those that do progress are usually secondary to other chronic 
conditions such as hypertension and hyperlipidemia9. 
It is interesting that although VSMC are the first cell type to accumulate 
lipid and initiate the fatty streak, a new researcher to the field of atherogenesis 
would not be aware of this key event. Most of the current literature describes 
only the mechanisms of macrophage foam cell development. For example, 
using the key words "macrophage foam cells" and "myogenic foam cells" to 
search the PubMed Database (NCBI: September 2007) results in 2048 hits, and 
7 hits, respectively. In December 2006 the same search resulted in 1957 hits 
and 7 hits, further revealing the research trend. This emphasis on macrophage 
foam cells rather than myogenic foam cells could be for many reasons. 
Macrophage cells are the predominant cell type in common animal models of 
human atherosclerosis, especially transgenic mice. In these animals, 
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macrophage-derived foam cells are quick to develop into lesions and are easy 
to induce with a high-fat and/or high-cholesterol diet18"20. Also, unlike VSMG, 
which can alternate between two phenotypes, contractile and synthetic, 
macrophage cells do not change during the progression of the disease, and so 
are easier to identify in the laboratory under controlled conditions. 
This research bias towards macrophage-derived foam cells is 
problematic because the pathogenic mechanism of lipid accumulation appears 
to be different for the two cell types5'10. Unfortunately, much of the clinical and 
genetic work on atherogenesis has focused exclusively on the macrophage cell 
and the immune response as the primary event. However, preliminary lesions 
observed in the aortas of humans aged 15-34 consist almost entirely of VSMC, 
with macrophages rarely present at this stage of the disease9. Therefore, rather 
than being an initiative mechanism in humans, the arrival of macrophage cells 
appears to be a secondary response, as they are far more common in 
advanced plaques than in early lesions5,9,21,22. In order to develop a more 
complete picture of atherogenesis relevant to humans, further investigation into 
the mechanisms of VSMC proliferation and foam cell development independent 
from the influence of macrophages is warranted. 
Risk Factors and Atherogenesis. There are several physiological 
conditions and lifestyle patterns, which, if present, can increase an individual's 
risk of developing atherosclerosis. Major factors such as high blood cholesterol 
(high LDL/low HDL), high blood pressure, and diabetes are not just "used to 
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diagnose or monitor the disease but are used to estimate risk of developing 
heart disease and to estimate the risk of death (American Heart Association 
Website, January 2007)". Collectively, these risk factors, along with physical 
inactivity, maleness, smoking, obesity, stress, heredity, and advanced age have 
been extensively researched and statistically correlated to specific stages of 
lesion development, plaque stability, and overall disease outcome in the 
general population. 
In spite of genetic influences on traits such as LDL/HDL levels, blood 
pressure, and adiposity23, progress has been made on minimizing the effects of 
the controllable risk factors in order to disrupt, delay, reverse, or otherwise 
interrupt plaque rupture and aortic occlusion in "high risk" individuals. This has 
been possible largely because of the interrelationship of many of the individual 
risk factors, resulting in a synergistic effect. For example, controlling weight 
(obesity) can reduce the impact of diabetes and hypertension. Physical activity 
can in turn decrease weight and stress, and increase HDL levels. Despite 
moderate success, especially in the realm of cholesterol-lowering drugs, 
unknown genetic factors continue to influence both the age of onset and the 
frequency/severity of clinical symptoms1. Unfortunately, by the time most 
people manifest clinical symptoms, the lesions have become complex plaques, 
and it is too late to implement preventative measures. Therefore, the sooner 
susceptible individuals can be identified; the earlier treatment can begin. 
However, less than 50% of the mortality from coronary heart disease can be 
predicted by currently recognized risk factors24. 
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In order to understand what is happening in the at-risk population that 
remains unidentified under current screening methods, it is necessary to 
determine the specific contributions of heredity, diet, and lifestyle influences on 
atherogenesis and its progression. Towards this end, research emphasis has 
recently shifted towards identifying markers of cardiovascular disease that may 
be detectable prior to the manifestation of most of the classical risk factors. 
Markers are simply allelic variations that are known to associate with a specific 
disease phenotype. Markers do not necessarily cause the disease, but can be 
used to improve diagnosis and risk assessment23. Inflammatory markers such 
as C-reactive protein (CRP)24,25 and markers of oxidative damage such as 
myeloperoxidase26 and paraoxanase27 have already increased the predictive 
power of clinicians. As more markers of atherosclerosis are identified and 
correlated with disease progression and outcome, the genetic variation 
contributing to predisposition and initial manifestation will become clear. 
Until the genetic basis for susceptibility to atherosclerosis is understood, 
correlation of various risk factors with specific metabolic or pathological features 
will be difficult to assess, and prevention efforts will remain equivocal. 
Understanding the mechanisms of inheritance in atherosclerosis is an important 
step towards reducing the morbidity and mortality from the disease by 
customizing intervention strategies for individuals based upon unique 
genotypes and environmental risk exposures. 
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Hypotheses of Human Atherogenesis. A variety of hypotheses have 
been proposed in an attempt to explain how an atherosclerotic lesion is initiated 
in the human aorta. Although there are model-specific differences in the order 
of events, the pathological steps common to all theories of atherogenesis 
are5,8,9,12,28,29. 
1. Site specific proliferation of intimal smooth muscle cells 
2. Elaboration of excessive and/or abnormal extracellular components 
3. Accumulation of lipids within and around cells 
4. Entry of monocytes/macrophages into area of proliferation 
The abnormal accumulation of lipid within smooth muscle and macrophage 
cells could arise from increased infiltration (influx), increased retention, 
decreased efflux, and/or increased lipid biosynthesis by the cells themselves. 
The Lipid Infiltration Hypothesis states that cells in the arterial wall will 
accumulate lipid if there is a high concentration of circulating blood lipids, or a 
consistently elevated amount of low-density lipoproteins (LDL). In the healthy 
human aorta, circulating LDL particles are incorporated into SMC by receptor-
mediated endocytosis. In atherosclerosis, the rate of LDL influx could 
overwhelm these receptors, causing the excess lipid to be taken up by 
scavenger receptors. Modified lipoproteins such as oxidized30, acetylated31, or 
particularly small (<70nm)32 LDL are thought to slip through the loose junctions 
between endothelial cells and accumulate in the intima intact. In these cases, 
because of their altered conformation, it is hypothesized that the modified LDL 
molecules are readily incorporated into SMC by uncharacterized scavenger 
receptors. As foam cells develop and burst, macrophage cells are recruited to 
the region. The precise mechanism of how cholesterol from circulating LDL 
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enters the intima to be incorporated in the developing foam cell is not clear. In 
addition, the Lipid Infiltration Hypothesis does not, on its own, account for the 
observed proliferation of SMC prior to lipid accretion. 
If lipid infiltration of any type is coupled with decreased HDL levels, there 
will be reduced cholesterol clearance (efflux) from the cells, and the sterol will 
remain trapped. In addition, the innermost arterial cells are in a state of chronic 
hypoxia33. If the fatty acids released by neutral cholesterol ester hydrolase 
(NCEH) are not completely oxidized, the metabolites will accumulate at an 
accelerated rate34, and can potentially serve as substrate for endogenous 
cholesterol and/or triacylglycerol (TAG) synthesis. There is compelling evidence 
indicating that the increase of intracellular cholesterol is at least partly the result 
of biosynthesis, and not uptake of circulating lipoproteins35. However, this 
mechanism is not explained by any of the current hypotheses of atherogenesis, 
which are mainly focused on the infiltration and retention of plasma lipids and 
their subsequent inflammatory effects. 
One mechanism proposed to explain the increased retention of 
circulating blood lipids is the Response to Retention Hypothesis36. According to 
this idea, as proteoglycans (PG), especially versican32,37, accumulate in the 
extracellular matrix (ECM) of the proliferating smooth muscle and recruited 
macrophage cells, they bind to incoming LDL particles. The electrostatic 
interaction between the apoB component of LDL and the sulfated chains on the 
core PG protein binds the LDL to the cell surface38 where its solubility is 
decreased39. PG-bound LDL is also more likely to become oxidized, and in 
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either case, the trapped lipoprotein is incorporated into the developing foam 
cell. Presumably the lipid enters the individual cells by the action of scavenger 
receptors, but proponents do not directly address this component. Despite this 
omission, the Response to Retention Hypothesis does provide a concrete 
mechanism for the adherence of circulating lipoproteins to the arterial intima. 
Therefore, advocates of this hypothesis claim that "essentially all later advances 
can be traced to36" the initial attraction of circulating LDL to ECM proteoglycans. 
Although the aforementioned explanations of lipid infiltration and 
retention provide mechanistic evidence of how lipoproteins can accumulate in 
the arterial intima, there are key steps of atherogenesis that are not addressed. 
Neither hypothesis offers direct evidence for how cholesterol esters form within 
early foam cells, nor do they explain the initial cellular proliferation of SMC prior 
to lipid accumulation. Neither hypothesis explains the subsequent entry of 
monocytes and macrophages to the region of infiltration, nor do they explain the 
predictable locations of lesion development along the arterial tree. 
The observation that both smooth muscle and macrophage cell types 
were actively recruited to the site of balloon catheterization led to the 
"Response to Injury" hypothesis11. According to this idea, the arterial 
endothelium is compromised by various perturbations such as environmental 
chemicals, high concentrations of blood lipids, certain types of bacteria and 
viruses, autoimmunity, and/or hemodynamic stress40. In response, the 
endothelial cells can either slough off or become porous, allowing the 
subsequent influx of lipoproteins and macrophages into the arterial intima. 
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Once initial damage has occurred, the exposed intimal cells are increasingly 
vulnerable to additional hemodynamic and environmental aggravation, thus 
perpetuating the original injury and eliciting a multi-pronged immune response. 
Although endothelial denudation or injury is not necessary for foam cell 
formation, there is an obvious and observable inflammatory response that 
seems to exacerbate the developing plaque. 
Atherosclerosis is now considered to be a chronic inflammatory 
disease24, largely because in a variety of animal models, signs of inflammation 
occur hand in hand with hypercholesterolemia41"44. This hypothesis proposes 
that the immune system is activated as a direct result of lipid infiltration45,46 and 
so readily explains the presence of monocytes and macrophages in the fatty 
streak. These cells express scavenger receptors that not only ingest lipid, 
especially oxidized LDL; they actively secrete cytokines and recruit adhesion 
molecules to the region. These actions are thought to be directly responsible for 
the increase in extracellular components observed during later stages of 
atherogenesis47. As the matrix between cells becomes more complex, there are 
more opportunities for proteoglycans to bind and transform lipid molecules, and 
so perpetuate the entire process of macrophage recruitment and cytokine 
signaling. In addition to macrophage cells, endothelial cells, SMC, and platelets 
in the developing lesion are all capable of synthesizing and/or releasing 
chemoattractants and growth factors9. These cellular interactions work together 
to expand the initial fatty streak to a more advanced fibrous plaque. The 
inflammatory response is well correlated with plaque stability, and there are 
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already blood tests available that will assess the risk of thrombosis based on 
the levels of inflammatory markers23. However, as with other hypotheses of 
atherogenesis, the inflammatory response does not seem to account for the 
initial proliferation of SMC prior to lipid accumulation and macrophage 
recruitment. Nor does the inflammatory response explain that, in humans, early 
foam cells are primarily myogenic. For these reasons, the inflammatory 
hypothesis explains the mechanisms of plaque progression and the likelihood of 
disease endpoint better than it explains atherogenesis itself. 
A fourth hypothesis of atherogenesis is that the smooth muscle cells that 
abnormally proliferate and accumulate lipid are transformed and of monoclonal 
origin48,49. The SMC which develop into foam cells are phenotypically different 
from their counterparts in the normal media14,50 in that they actively secrete 
ECM components such as proteoglycans and collagen51. Healthy, fully 
differentiated SMC are slow to proliferate and do not synthesize an extensive 
ECM52. Loss of cell cycle control and the ability to regulate cholesterol 
metabolism are early hallmarks of cancerous cells, and it is interesting that both 
of these pathological phenotypes are seen in atherogenesis. The idea of 
monoclonal SMC has not been well accepted by the field. However, 
technological advances in DNA sequence analyses have confirmed that 
although SMC in general are largely heterogenic, subsets of cells involved in 
atherogenic events are derived from specific clones53,54 that seem to proliferate 
in patches55. A second observation that lends support to this controversial 
hypothesis is the recent observation that the DNA in atherosclerotic lesions is 
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hypo-methylated56. Decreased methylation is significantly correlated with 
increases in transcriptional activity. During the development of cancer, normally 
silent oncogenes can be turned on (expressed) because of under methylation57. 
More research is needed to determine the role of hypo-methylated DNA and 
clonal SMC cells in atherogenesis. 
Although the monoclonal origin hypothesis explains the proliferation of 
an altered population of lipid-accumulating, ECM-producing SMC in the arterial 
intima, no specific transformation event or set of pathological conditions have 
been proposed that would account for the initial change in differentiation state, 
methylation status, and/or the increased rate of mitosis of a specific 
subpopulation of SMC. In addition, it is difficult to explain the reversibility of 
lesions with the Monoclonal Hypothesis, and there are examples in both 
animals and humans where atherosclerotic lesions appear to regress58"60. 
Smooth muscle cell differentiation is a complex process that requires 
more than just a few transcription factors to be successful61. In the developing 
embryo, SMC are in the "synthetic" state as they are actively proliferating and 
synthesizing their contractile elements, myofilaments, and ECM to form the 
arterial intima51,62. Once the blood vessels are fully formed, the SMC reach the 
"contractile" state where they stop proliferating and function to facilitate muscle 
contraction in response to stimuli. A healthy vessel wall is able to maintain both 
contractility and the quiescent state50,63. 
It has been observed that during atherogenesis, SMC seem to revert 
back to the synthetic state where they abnormally produce an extensive ECM64. 
15 
This phenotypic modulation is believed to occur before the cells begin to 
replicate and migrate to the arterial intima, but the stimulus for this change is 
unknown. An alternative explanation is that in individuals predisposed to 
atherosclerosis, the SMC never fully differentiate in certain arterial regions. In 
either case, modified SMC are characterized by a decrease in the alpha/beta 
actin isoform ratio14,50,65 and the loss of the intermediate filament proteins such 
as vinculin and desmin50,65,66. Research in this area has focused on identifying 
more SMC phenotypic markers52,61,67 in order to both clearly define the state of 
differentiation, and to articulate what is driving the change in differentiation 
state68,69. Although this idea is narrowly focused on the role of SMC, and does 
not address macrophage recruitment, it is a valid attempt to describe what is 
happening in the earliest stages of atherogenesis at the cellular level. 
Hemodynamic stress is a pervasive factor in all hypotheses of 
atherogenesis, because lesions typically develop at aortic regions of bi-
directional flow. However, if it were simply a matter of arterial architecture, all 
humans would develop atherosclerosis. Indeed, any organism with a branching 
aorta would spontaneously develop foam cells and initiate the atherosclerotic 
pathology. Because this is not the case, there must be some as yet unidentified 
factor intrinsic to the vessel wall of resistant individuals that can withstand the 
effects of low shear stress and maintain the cells in a contractile phenotype. 
It is clear that all of the current hypotheses have gaps. None of them 
provide a causative explanation that includes all features and is both necessary 
and sufficient to invoke the full atherosclerotic cascade. Many of them explain 
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lipid accumulation in the arterial wall, some of them describe the preferred site 
of fatty streak formation and the appearance of macrophage cells, but none of 
them completely describe the entire series of events that occurs in human 
atherogenesis. Genetic factors clearly influence cholesterol metabolism70, 
replication rates71, the immune response22,43, and the oxidative capacity of the 
mitochondria for cellular lipids72, thereby manifesting an underlying influence on 
all aspects of atherogenesis that warrants further discussion. 
Genetic Defects in Human Atherogenesis. There is clearly a higher 
relative risk for atherosclerotic incidents in individuals with a familial history, 
than there is for those with a susceptible lipid profile1'70,73. Many studies have 
been conducted to explore and quantify the relationship, or concordance, 
between heredity and atherosclerosis. Heritability has been found to have an 
overall concordance rate with early-onset coronary heart disease of 0.6374. The 
relationship becomes even clearer after analyzing concordance in monozygotic 
and dizygotic twins. Twins fertilized from one egg (monozygotic) have a 
concordance rate of 0.83, whereas twins that arose from two separate 
fertilizations (dizygotic) demonstrate a concordance rate of 0.2274. These 
concordance values suggest a tight correlation between the genotype of an 
individual and the incidence of heart disease. 
The fact that the concordance rate in monozygotic twins is not 1.0 
(indicating 100% correlation) most likely reflects the attenuating effects of 
environmental risk factors on atherosclerosis initiation and progression. This 
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gap in causality underscores the importance of understanding the genetic 
profile of a client before attempting intervention, because even among those 
sharing the same set of alleles, the phenotype of atherosclerosis will vary 
depending on individual exposures. 
Genetic research on human atherosclerosis has focused primarily on the 
role of cholesterol metabolism. It is estimated that several hundred genes70 are 
involved in the absorption, conversion, transport, deposition, excretion, and 
biosynthesis, of cholesterol and other lipid substrates in the body19,75, and very 
few have been characterized. A defect in any of these pathways may 
contribute to atherosclerotic susceptibility, because the net result can be a 
significant increase in plasma lipoprotein concentration, especially LDL, and/or 
the inappropriate deposition of cholesterol in peripheral tissues such as skin, 
tendons, and arteries76. 
Blood lipid homeostasis and cellular cholesterol metabolism are known 
to be highly regulated77, and genetic defects have been found to impact overall 
cholesterol metabolism at many locations. In humans, most plasma cholesterol 
is in the form of LDL, and the half-life of circulating LDL is believed to be about 
2.5 days78. Some of the cholesterol component of LDL is transferred to HDL via 
the action of cholesterol ester transfer protein (CETP). However, as much as 
70% of LDL is removed from the blood by LDL receptors (LDLR) in the liver76. 
A variety of single gene defects have been identified that increase the incidence 
of atherosclerosis by influencing the activity of the LDLR1. 
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Probably the most studied of these LDLR defects is familial 
hypercholesterolemia (FH). FH is an autosomal dominant Mendelian disorder 
that is caused by a mutation in the LDLR gene1,78,79. This mutation renders the 
hepatic receptors nonfunctional, so that they are unable to clear circulating LDL 
from the blood. A second type of hypercholesterolemia, Autosomal Recessive 
Hypercholesterolemia (ARH), results from an LDLR mutation inherited as an 
autosomal recessive trait76,78. ARH is similar to FH, in that both of these 
hereditary defects result in chronically elevated blood cholesterol. However, 
unlike FH, it is believed that in ARH, the LDLR are functional, but their altered 
location in the liver makes them inaccessible to circulating LDL76,78. 
Brown and Goldstein have also identified a single gene defect known as 
familial ligand defective apoB-100. ApoB-100 is the primary apoprotein in 
human LDL80 , and this inherited disorder results in a decreased ability of the 
LDL to be picked up by the LDLR78,81. In this situation, the hepatic receptors 
are in the correct location, and they are functioning properly. The defect lies in 
the composition and binding capacity of the apoB-100 to the LDLR. There are 
also apoB-100 binding sites on the ECM components versican and biglycan82. 
These proteoglycans have a lower affinity for the apoB-100 portion of LDL than 
the LDLR, but have a much higher capacity78. Therefore, genetic mutations in 
the apoB-100 could impact both cholesterol clearance rates (directly) and levels 
of lipoprotein retention in the arterial wall (indirectly). 
In the healthy human aorta, LDL particles are thought to be incorporated 
into SMC by receptor mediator endocytosis. Chemically modified or oxidized 
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LDL enters via scavenger receptors. Once inside the cell, the cholesterol 
esters (CE) in LDL are transported to the lysosomes where they are hydrolyzed 
by lysosomal acid lipase (LAL), also known as acid cholesterol ester hydrolase 
(ACEH). This enzyme breaks each CE into its free fatty acid (usually linoleate), 
and free cholesterol. There are several known genetic mutations to the LAL 
gene that result in the abnormal accumulation of cholesterol esters in the 
lysosome. 
Two of the more common lysosomal storage disease phenotypes of a 
congenital LAL defect are Wolman's Disease83,84 and cholesterol ester storage 
disease (CESD). Both are inherited as an autosomal recessive trait, although 
Wolman's disease is usually fatal within the first year of life, and so not directly 
related to atherogenesis in the general population. However, individuals with 
CESD do demonstrate premature atherosclerosis, although they also 
accumulate CE and triglycerides (TG) in the liver, adrenal glands and 
intestines85. Niemann-Pick Type C is a third form of lysosomal storage disease 
that directly impacts cholesterol metabolism at the cellular level85. In this 
scenario, the CE is successfully hydrolyzed by ACEH, but the released 
cholesterol component is unable to leave the lysosome to travel to the 
endoplasmic reticulum, causing the accumulation of free cholesterol in the 
lysosome. 
Lysosomes are also responsible for the degradation of 
glycosaminoglycan (GAG) chains after the core proteoglycan has been broken 
down by extracellular proteases such as matrix metallopeptidases (MMP) and 
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disintigrins (ADAM) • . There is an extensive repertoire of catalytic lysosomal 
enzymes, and their functions have been revealed mostly by observing the 
consequences of their absence89. Defective enzymes lead to a wide variety of 
diseased phenotypes known as mucopolysaccharidoses (MP) ranging from the 
mild Schie Disease to the severe Hurler Disease, which results in childhood 
mortality. In these two examples, GAGs are not properly degraded, and so will 
accumulate in the lysosomes and in the extracellular space. GAGs in the ECM 
will attract LDL that has entered the intima by binding to apoB-100 as previously 
described, and the cholesterol is most likely endocytosed by macrophage and 
SM cells within the developing plaque. 
Once in the cytoplasm, cholesterol that is not needed for routine cellular 
functions is esterified by acyl CoA: cholesterol acyltransferase (ACAT) and 
stored in vacuoles. Intracellular CE remain trapped in the cytoplasm until 
hydrolyzed by NCEH. This enzyme releases the free cholesterol so it can be 
removed by HDL and taken to the liver for excretion. A pair of ATP binding 
cassette proteins has been identified that are believed to control this efflux of 
cellular cholesterol. One of these, ABCP-1 is defective in Tangier Disease90, 
an inherited condition where cholesterol is unable to exit the cell via reverse 
cholesterol transport. There is a moderate risk of atherogenesis associated 
with Tangier Disease, and this risk is increased in the presence of additional 
risk factors91. 
Research is also being directed towards a range of apoproteins 
associated with HDL. It has been suggested that approximately 50% of the 
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variance of HDL composition and plasma concentration in the general 
population is due to genetic factors91. The primary apoprotein in HDL is apoA1, 
followed by apoA2, apoC, and apoE80. ApoE is an important ligand for receptor 
mediated clearance of HDL from arterial cells75,92. The role of apoE is of great 
interest to investigators of atherosclerotic resistance because most patients with 
familial dysbetalipoproteinemia (FD) are homozygous for the E2 isoform of 
apoE93. Although this defect has been shown to be relevant in some animal 
models, especially apoE null mice20'94, only 1-4% of humans with the E2/E2 
apoE phenotype actually develop FD93. The pathological influence of apoE 
dysfunction is important in these genetically susceptible individuals, but may not 
be relevant to the more common forms of atherosclerosis in the overall 
population. 
Any of the currently identified monogenic defects that directly or indirectly 
influence cholesterol metabolism and/or the inflammatory response will 
increase the likelihood of atherosclerotic events. However, individual genes do 
not always act alone, and additional genetic and/or environmental factors may 
be required to determine the overall susceptibility or resistance. Nuclear 
hormone receptors and other types of transcription factors are under 
investigation to determine how they exert their regulatory effects95,96. For 
example, although the binding capacity of apoB-100 is genetically determined78, 
the specific number of hepatic LDLR being expressed at any given time is 
dependent on dietary and hormonal factors81. In a hypothetical situation, the 
apoB domain of LDL may be functional (non-mutated), but without the adequate 
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expression of the LDLR to bind circulating LDL, the end result could still be high 
blood cholesterol. 
Clinical studies have demonstrated that not all individuals afflicted with 
FH will develop early onset atherosclerosis. Of those manifesting the 
heterozygous form of the disease, where circulating LDL levels tend to range 
between 300-400 mg/dL, only 50% will actually develop cardiovascular 
disease75. This is because there are both hyper- and hypo- responders to the 
effects of dietary cholesterol on serum levels, and some individuals 
demonstrate relative resistance to atherogenesis, even in the face of 
hypercholesterolemia75. In addition to looking for genetic defects that contribute 
to individual predisposition and susceptibility, the goal should also be to identify 
protective factors that denote resistance. 
The ultimate sequel of atherosclerotic events is a result of the combined 
effects of many genes, regulatory factors, and environmental exposures97. This 
synergistic influence on phenotype may give the appearance of a polygenic or 
multifactorial effect1,78, even when a monogenic abnormality has been dearly 
implicated. These interactions have made it difficult to establish a universally 
accepted mechanism of atherogenesis98, because the sample sizes needed to 
test these gene-gene and gene-environment interactions are much larger than 
those needed for simpler genotype-phenotype associations70. There have not 
been enough human population studies that allow a true "estimate of the 
percentage of genes where a single mutation has a contribution to the 
phenotype large enough to be detectable1." It is often difficult to determine 
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whether a polymorphism is THE initiating factor, or if the mutation has simply 
associated with the susceptible or resistant phenotype under study by chance". 
For these reasons, "although there has been considerable success in 
identifying genes for the rare disorders associated with atherosclerosis, the 
understanding of genes involved in the more common forms is largely 
incomplete100". 
Pathways that trigger atherosclerosis in the general population have yet 
to be elucidated27. Most genomic scale experiments have compared either full-
blown plaques against non-affected aortic segments101"104, or they have 
analyzed differences between plaques that have ruptured and those that have 
not105"107. In both types of comparisons, differentially expressed genes have 
been identified that shed light on plaque development and mortality risk. 
However, genes responsible for initiating foam cell formation could not be 
discriminated from those involved in later events. This gap is not an oversight 
by the investigators, but rather reflects the limited availability of human tissue 
samples at early stages of atherosclerosis for relevant comparative studies. 
One of the major limitations of elucidating the sequence of events that occur 
during atherogenesis is that an investigator can "observe and study a single site 
in the arterial vasculature" only once11. For this and other reasons, most 
atherogenic research requires animal and in-vitro models of the human disease. 
Models of Human Atherogenesis. No animal model of human disease 
can fully encompass the unique complexity of molecular machinery and the 
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wide range of expressed clinical phenotypes. However, many important 
metabolic pathways have been explained by the judicious use of animal 
models97. Therefore, the selection of a disease model for genetic inquiry 
becomes important, and the most appropriate choice will ultimately depend on 
the specific hypothesis or research question being investigated. 
There are some general guidelines to follow when choosing an animal 
model of human disease. The phenotype should resemble the physiological 
condition of humans as closely as possible in both the normal and diseased 
state92. In the specific case of circulating cholesterol, genetics, and 
atherosclerosis, it is essential that the lipoprotein profile is comparable to 
humans, and the familial lineage is clearly defined99. In addition, there are 
practical issues to consider such as the size of the animal and housing 
requirements, generation times, and the specific cost of overall maintenance, 
including food, daily care, and experimental treatment92,108. These concerns 
become especially important with the development of transgenic models, in that 
the associated investment costs are much higher than with traditional animal 
studies. 
There are currently several animal models being used to investigate 
various clinical manifestations and genetic mechanisms of human 
atherosclerosis. Although mice (regular laboratory and transgenic) are the most 
commonly used, rabbits, hamsters, miniature swine, primates, rats, dogs, and 
pigeons are also used. The primary contribution of these animal models has 
been to elucidate the role of specific molecules in atherogenesis, lesion 
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progression, thrombosis, and plaque rupture by direct hypothesis testing. 
Selected characteristics of atherosclerosis in animal models and their 
relationship to the human disease are presented in Table 1 (page 27). 
One of the difficulties encountered when studying lipid metabolism in 
animals is that most species circulate the majority of cholesterol in HDL108, 
whereas most human cholesterol is in the form of LDL76. For example, a 
decrease in plasma HDL has been associated with a reduced risk of 
atherosclerosis in mice109. It does make sense that relatively low levels of HDL 
decreased the clinical incidence of atherosclerosis because 70% of the total 
cholesterol in mice is in the form of HDL92. 
However, in humans, decreased HDL levels are associated with an 
increased risk of atherosclerosis. Despite this marked inconsistency, the 
successful extrapolation of animal studies to human atherosclerosis is 
exemplified by the fact that Goldstein and Brown found that it was impossible to 
raise levels of circulating LDL, and thus increase the risk of atherosclerosis in 
experimental models, unless the LDLR were somehow compromised, either 
genetically or in response to dietary overload78'79. Subsequently, over 600 
mutations in the human LDLR gene have been identified that result in varying 
degrees of hypercholesterolemia78 similar to FH. In addition, it has been 
repeatedly demonstrated in hamsters, rabbits and primates, that the functional 
capacity of hepatic receptors is decreased in response to a diet high in fat108. It 
has also been demonstrated that there are individual variations in LDLR activity 































































































































































































































































































































































































































































and rabbits, like humans, have been shown to be hypo- or hyper- responsive to 
diet75,78,92,no w j t h s o m e i n d i v i d u a | s demonstrating unique resistance. 
In newborn humans and many animal species, hepatic LDLR have been 
shown to have a maximum operative capacity when circulating LDL levels are 
approximately 0.25 mg/dL111. Approximately 60% of plasma LDL in hamsters is 
removed by hepatic receptors. The hamster clearance rate for the LDLR is 3.1 
mg/hr whereas the companion human LDLR only removes 0.6 mg/hour108. 
However, the fact that hamsters and humans share a common mechanism of 
LDL clearance makes the hamster a suitable model for this aspect of 
cholesterol metabolism. Hamsters also share the CETP with humans108. This 
molecule transfers the cholesterol component of LDL to HDL, a key step in 
reverse cholesterol transport. These homologous features are in direct contrast 
to the mpuse, which, despite being fed a high-fat high-cholesterol diet112 and its 
evolutionary relationship to the hamster, does not develop advanced 
atherosclerotic plaques resembling those found in humans unless mice with 
"sensitized genetic backgrounds18" are studied113. 
The mouse is technically advantageous because of its small size, short 
generation time, large litters, and the availability of many inbred strains109. 
However, laboratory mice fed on a chow diet do not develop spontaneous 
atherosclerotic lesions. Atherosclerosis must be experimentally induced by 
feeding a diet containing 15% fat, 1.25% cholesterol, and 0.5% cholic acid. 
These non-physiological conditions create serious limitations for comparison 
with human studies. The most important factor may be the presence of cholate 
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in the diet. Cholate is enough, in and of itself, to put mice in a chronic 
inflammatory state109,114 confounding the true role of inflammation in 
atherogenesis. This is further exacerbated by the fact that some mice are more 
sensitive to inflammatory cues115 so that "although the inflammation correlates 
with atherosclerosis... it is possible that some of the genetic differences 
between susceptible and resistant mouse strains pertain to the diet used, rather 
than the atherogenic process as it is observed on Western diets109." 
These and other genetic differences that exist between mouse strains 
can cause significant problems when interpreting and comparing the results of 
gene expression studies116. For example, just because a specific inflammatory 
marker was identified in an atherosclerotic plaque and not in a healthy aorta 
does not mean that inflammation is causing the disease. Indeed, the molecule 
could be there to accelerate the cascade; but it could also be there in an 
attempt to reverse the pathology, or may even be responding to a cellular signal 
not specific to plaque progression19 such as cholate. This is true even with 
transgenic mice because the foundation stock may be different. Also, as gene 
insertion is random, knock-in models do not by definition contain the gene of 
interest at the same locus. Therefore, simple transgenics may not be sufficient 
to prove the role of any given trait because of positional insertion effects on 
both absolute gene expression and copy number variation99. Delineating the 
specific function of a candidate gene is difficult, if not impossible, without being 
able to precisely correlate the phenotype back to the initiating mechanism of 
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foam cell formation; and, the heterogenic background of the mice combined 
with the variable responses to the atherogenic diet confound the interpretation. 
Despite these often overlooked limitations of extrapolating mouse studies 
to the human disease, research using transgenic mice further developed the 
concept that atherosclerosis is not a simple lipid disorder. New hypotheses of 
atherogenesis must be explored in order to explain the occurrence of 
atherosclerotic heart disease in individuals displaying no dyslipidemia. Over 
twenty unique quantitative trait loci (QTL) have been identified in mice94, and 
most of them do not influence plasma lipid levels or blood pressure100,117. This 
finding has been especially interesting because these QTL were identified in 
hypothesis-driven experiments to look specifically at cholesterol metabolism in 
LDLR and/or apoE knockout mice. Many of these studies have demonstrated 
the strong influence of genetic factors in the arterial wall on the susceptible and 
resistant phenotypic differences between mouse strains118. 
Knockout models theoretically mirror homozygous recessive forms of 
inherited disease because of a loss of gene function19. As in Familial 
Hypercholesterolemia (FH), LDLR null mice experience a 2X increase in 
plasma cholesterol levels, even on a regular diet, and the effect is exacerbated 
on the high-fat, high-cholesterol atherogenic diet19. The same is true for apoE 
null mice, although the impact of this mutation has a greater effect on plasma 
cholesterol compared with LDLR negative mice, with 4-5 times the normal 
amount of circulating lipoproteins19,20. However, preliminary studies revealed no 
relationship between tfe^s,e elevatf^ lipid levels and lesion size in apoE null 
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mice119. In fact, only 2% of the homozygous apoE2 null mice developed aortic 
lesions at all, and the contribution of this mutation to the overall human disease 
burden has been questioned27,74. Subsequent studies have shown contradictory 
results, as the nature of the lesion appears to be dependent on the parental 
strain used in the experiment rather than the particular knockout gene7,94,100 116. 
The largest effect noticed to date in these hypercholesterolemic models is that 
of Macrophage Colony Stimulation Factor (MCSF) on lesion progression19. 
MCSF has been reported in advanced human atheromas, and this finding in 
mice lends experimental support to the role of the inflammatory response in 
atherosclerosis. However, the role of this molecule in atherogenesis per se is 
difficult to elucidate in the mouse, because of its chronically inflamed state. 
Although not yet yielding consistent results applicable to human 
therapeutics120, transgenic mouse research has reinforced how important the 
genetic background is in determining atherosclerotic susceptibility and 
resistance in an individual. These studies have also suggested that the 
mechanism of foam cell formation is different in different individuals under 
different experimental and/or environmental stimuli. The importance of the 
specific initiating mechanisms on the developing phenotype has been further 
demonstrated in rabbit models of atherosclerosis. 
Rabbits, like hamsters, have CETP and do develop atherosclerotic foam 
cells when induced by an unnatural diet108. Unlike the other animal models 
described in Table 1, rabbits are vegetarian, and so cholesterol is not a normal 
component of their wild-type diet. The Watanabee Heritable Hyperlipidemic 
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(WHHL) rabbit was developed through selective breeding, and does not have 
LDLR121. WHHL rabbits get lesions within six months along the aortic arch, but 
do not experience thrombosis or myocardial infarction. However, these 
advanced atherosclerotic phenomena are observed in a sub-strain, the 
WHHLMI rabbit. This rabbit does get a heart attack similar to one of the 
endpoints of human atherosclerosis122. 
One of the important contributions of the rabbit model to understanding 
human disease was the observation that foam cells in rabbits can be derived 
from smooth muscle cells (SMC) or macrophage cells (M0), depending on the 
specific dietary perturbation123. This finding is in direct contrast to the mouse, 
where the predominant cell type in early lesions is always the macrophage cell, 
regardless of diet and genetic strain124. Myogenic foam cells in the rabbit are 
biochemically and morphologically distinct from macrophage derived foam cells, 
and both types of early lesions are structurally different from those produced by 
catheter injury123. Recognizing that different types of foam cells develop in 
response to different initiating mechanisms should help unravel the controversy 
of foam cell origin. In all probability, the predominant cell type in early 
atherogenesis is dependent on the pathological stimulus, and the specific 
model under study. 
A second revelation from rabbit research has been that both M0 and 
SMC express receptors for the MCSF protein125. The proto oncogene c-fms3 
induces SMC migration and proliferation, as well as M0 recruitment to the 
atherosclerosis-prone regions of the aorta126. This is important for the 
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investigation of atherogenesis because both SMC and M0 are found in human 
lesions and the ratio of these cells change as the disease progresses. The fact 
that both cell types share an activation mechanism means that the presence of 
MCSF in an experimental sample does not by definition mean that only M0 will 
be recruited. This simple fact is not evident from the plethora of mouse studies, 
and is further evidence that multiple models are needed to grasp the complexity 
of human atherosclerosis, especially at the initiation stage. 
Swine are unique among the other mammals depicted in Table 1 
because, although they are LDL carriers like the hamster127, and most lesions 
develop in the aortic arch, they also develop spontaneous lesions in the 
abdominal aorta128. The initial foam cells are derived from intimal SMC128, and 
appear similar to those found in early stages of the human disease. 
Unfortunately, these lesions do not progress to advanced atheromas without 
being induced by a 4% (w/w) cholesterol diet92. Interestingly, even after 90 days 
on a hyperlipidemic diet, less than 5% of the cells are monocytes128. For this 
reason, it would appear that the pig could adequately model the gradual 
transition from a myogenic fatty streak to an advanced lesion with activated 
macrophage cells, mirroring the inflammatory response in humans over time. 
Avian models of human atherosclerosis such as the chicken, turkey, 
quail, and pigeon are not currently in widespread use, but have a longer and 
richer history than most mammalian models of cardiovascular disease. The first 
angioplasty surgery of the aortic wall was performed in birds in 1874129. 
Spontaneous (non-induced) atherosclerosis in the chicken was first described in 
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1914130, and it has been repeatedly observed that avian lesions bear close 
resemblance to their human counterparts131"134. The pigeon (Columba livia) is 
especially suited for genetic studies of atherosclerosis because susceptible and 
resistant strains exist in the natural population132,135, eliminating the need to 
construct an artificial phenotype through genetic or dietary manipulation. In fact, 
it has been suggested that the White Carneau (WC) pigeon may be one of the 
most appropriate models of early human lesions92'133'136. 
The WC pigeon is unique among non-primate models in that it develops 
naturally occurring (spontaneous) atherosclerosis at both the celiac bifurcation 
of the aorta and in the coronary arteries131,137. Foam cells develop into fatty 
streaks which progress into mature plaques in the absence of elevated plasma 
cholesterol and other traditional risk factors138,139. These non-induced 
atherosclerotic lesions are morphologically and ultrastructurally similar to those 
seen in humans4,140 and occur at parallel anatomical sites along the arterial 
tree4,133,141. A variety of studies have clearly demonstrated that susceptibility in 
the WC resides at the level of the arterial wall138,142,143, and the lesion site 
specificity, severity, and disease progression as a function of age are highly 
predictable144,145. 
Show Racer pigeons (SR) are resistant to atherosclerosis, while 
consuming the same cholesterol-free diet. This difference occurs despite the 
fact that both WC and SR have similar plasma cholesterol and lipoprotein 
concentrations146. WC pigeons are one of the few animal models to develop 
severe atherosclerosis while consuming a cholesterol free diet, and using the 
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SR as an experimental control enables pathological changes associated with 
the disease to be distinguished from changes due to the natural aging process 
in the pigeon. Virtually all differences between the WC and SR are at the level 
of arterial tissue as there are few system level differences147. 
In the wild, both breeds of pigeons are hypercholesterolemic compared 
to humans, and, like mice and rabbits, they are primarily HDL carriers. 
However, pigeons are unique in that for the first three days of life, cholesterol is 
circulated in the form of LDL, after which time the lipoprotein profile switches to 
HDL148 for the remainder of the pigeon's life. Neither breed has apoE149 or. 
LDLR143,150, so the effect of these variables in other models of the human 
disease is not a factor in the pigeon pathology. Combined data gathered on 
several hundred birds aged 6 months to 3 years over a twenty-year period 
shows that the average plasma cholesterol concentration in pigeons ranges 
from 201 mg/dL in the SR to 242 mg/dL in the WC (+/-16 in both groups)151. 
Although these values are significantly different (p<0.05), they do not change 
during the progression of the disease, and it appears blood cholesterol does not 
induce foam cell development in the WC. This fact is further supported in wild 
mourning doves, a close relative of the pigeon. These birds have average 
plasma cholesterol levels of 258 mg/dL, and they do not get atherosclerosis152. 
Sterol balance studies have revealed that the WC excretes less neutral sterols 
than the SR breed153,154, but this seems to impact the differences observed in 
the diet-induced form of atherosclerosis to a much greater degree than it does 
35 
the susceptible phenotype of the WC to the naturally occurring form of the 
disease155. 
The most widely studied spontaneous atherosclerotic lesion in 
susceptible pigeons occurs at the celiac bifurcation of the aorta, and by three 
years of age reaches a size to be easily visible on gross examination144,156. 
Early pathological and metabolic changes are apparent microscopically in this 
site by six months of age145. In contrast, diet-induced lesions in the WC aorta 
occur at various and unpredictable sites along the descending138,157,158 and 
abdominal aortas, and are pathologically very different from non-induced 
lesions. Foam cells in spontaneous lesions consist primarily of modified 
SMC135,145 while cholesterol-induced foam cells are mostly composed of 
macrophage cells135,158-160. 
As with mice, diet-induced lesions develop more rapidly in the pigeon 
than their spontaneous counterparts18,160, but different mechanisms of 
atherogenesis appear to be involved135,144. One of the primary effects of diet 
induction is to shift the physiological HDL lipoprotein profile to that of primarily 
I_pj_i6i,i62 | n fa£^ ^jgj SUpp|ementat ion with 1 % cholesterol causes such a 
rapid onset of atherosclerotic foam cells in both breeds that it becomes virtually 
impossible to detect the influence of intrinsic factors163 contributing to either 
susceptibility in the WC or resistance in the SR. Therefore, in order to identify 
candidate genes that predispose the WC to atherosclerosis, it is necessary to 
use the spontaneous pigeon model, as the introduction of an artificial diet 
confounds the interpretation of the earliest events occurring in atherogenesis. 
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Although this may seem like a novel idea in this era of cholesterol-mania, 
Kauniz warned thirty years ago that "the preoccupation with studying the 
cholesterol induced lesion may be retarding progress in the search for the true 
initiating factor in atherosclerosis"164. 
Since 1959, many studies have been performed to systematically 
characterize the initiating factor in lesion development in the susceptible WC 
pigeon. However, the mechanism(s) leading to foam cell development in the 
WC is not known, and no studies have been conducted in the spontaneous 
model to identify the gene(s) or gene product(s) that are specific to initiation. 
Clarkson and Prichard observed that age and heredity were the biggest factors 
in atherosclerotic susceptibility131. Diet, exercise, and gender were not primary 
factors in the WC pathology. The effects of age and heredity were further 
distinguished in 1963, when Goodman and Herndon demonstrated that 
genetics play a larger role in lesion development than the normal aging 
process165. The authors hypothesized that inheritance was a polygenic trait. In 
1973, Wagner et al. compared susceptibility to lesion development between the 
WC and SR celiac bifurcation of the aorta142. The authors found a greater 
number of advanced lesions in the WC than in the SR, and concluded that the 
genetic control conferring susceptibility or resistance in the pigeon appeared to 
be at the level of the artery. Further experiments by the Wagner group showed 
that blood cholesterol, triacylglycerol, and glucose levels were not different 
between the two breeds138, and that blood pressure is actually a consequence 
of pigeon atherosclerosis, rather than being an initiating factor139. The latter 
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study provided one of the first indications that although diet is not the primary 
factor contributing to atherosclerotic susceptibility in the pigeon, it can impact 
the severity of a lesion once formed; thus indicating a role in progression. 
In addition to investigating the effect of risk factors on lesion 
development, various studies have identified metabolic differences between the 
arterial wall of WC and SR pigeons. In vivo, differences in the WC susceptible 
foci include increased glycosaminoglycans, especially chondroitin-6-sulfate166, 
greater lipid content, predominantly in the form of cholesterol esters156,167, lower 
oxidative metabolism166,169, relative hypoxia170, decreased acid cholesterol ester 
hydrolase171 and neutral cholesterol ester hydrolase172 activities, increased 
glycolysis173, decreased tricarboxylic acid cycle activity173, and the increased 
synthesis of prostaglandin E2, which also decreased cholesterol ester 
hydrolase activity174. Although these studies did not distinguish the primary or 
underlying problem from those that are secondary effects, increases in non-
esterified fatty acids (NEFA) and in chondroitin-6-sulfate (C6S) seem to 
precede many of the other observed differences. 
The role of excess NEFA and C6S in pigeon atherogenesis is not yet 
clear, although the presence of C6S in the susceptible pigeon by six weeks of 
age does lend support to the response to retention hypothesis. Both human and 
pigeon smooth muscle cells synthesize C6S as part of the ECM175'176, where it 
has been observed to form complexes with plasma LDL entering the vascular 
wal|2i,177-179 T n e q U e s t i o n remains as to why there is more C6S in the WC aorta 
than in the SR aorta in the first place. The same question can be asked 
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regarding the presence of more NEFA. Although the excess NEFA could be a 
result of deficient mitochondrial oxidation, the influence of NEFA on lesion 
development is not understood. Clearly, more studies are needed determine 
what is happening at the earliest stages of pathology in the WC pigeon. 
In humans, atherosclerosis is considered to be a multifactorial disease, 
with many genes and environmental factors contributing to the specific 
phenotype and ultimate endpoint. In pigeons, where individual lifestyle choices 
and environments are not factors, the numbers and types of genes contributing 
to baseline susceptibility and resistance may be easier to elucidate. Preliminary 
crossbreeding studies indicated a polygenic mechanism of inheritance165 with 
resistance being the dominant trait. However, the authors noted that each breed 
responded differently to the effects of dietary manipulation132, so it is possible 
that the number of genetic differences observed may have reflected the 
confounding influence of diet, rather than the spontaneous expression profile. 
Pigeons are not as well suited for traditional inheritance studies as 
hamsters, mice, and rabbits because the birds mate for life, and do not reach 
sexual maturity until seven months of age180. Although excess cholesterol 
esters can be detected biochemically at 12 weeks, three years are required in 
order to definitively characterize the complete atherosclerotic phenotype. 
However, the pigeon genome is approximately half the size of its counterpart in 
mammalian models, and comparative genomic studies are facilitated by the 
recent publication of the chicken (Gallus gallus) genome, which is similar in 
size181 to that of the pigeon. 
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In 2001, Smith, Smith, and Taylor completed a 15-year cross breeding 
study at the University of New Hampshire. From the examination of grossly 
visible lesions (or lack thereof) at three years of age in the celiac foci of 
susceptible WC, resistant SR, and in Fi, F2, and backcross progeny, the 
authors determined that susceptibility to spontaneous atherosclerosis in the 
pigeon was inherited as a single gene autosomal recessive trait182. This finding 
is in direct contrast to earlier results indicating a polygenic mechanism, but the 
researchers at UNH carried the experiments all the way through the backcross 
generation, where Herndon et al. only investigated the F1 progeny. In addition, 
and probably of greater importance to the experimental results, all of the 
pigeons consumed the same cholesterol-free diet. Parallel investigation of the 
smooth muscle cells cultured from several tissues of the WC, SR, and F-\ 
pigeons demonstrated that lipid accumulation observed at the celiac bifurcation 
is a constitutive property of WC182. 
The finding that spontaneous atherosclerosis in the susceptible WC 
appears to be the result of a single gene, and not the net result of many 
interacting genes, as is thought to be the case in humans, makes the pigeon 
model a simplest case system. Identification of the gene responsible for 
predisposition, and an understanding of how this gene influences the described 
metabolic and morphological changes could reveal an initiating mechanistic 
pathway that remains undetected in more confounded models of atherogenesis. 
It has been demonstrated that the SMC in monolayers grown in vitro 







, but at an accelerated rate. A comparison of the 
maturation and degeneration of pigeon aortic cells in vivo and in vitro is 
presented in Figure 1 (p.42). In culture, foam cell development is evident in WC 
SMC by 8-10 days, where several weeks are needed in order to observe the 
same phenomena in-vivo. Other differences in the WC SMC include more 
esterified cholesterol present in lipid vacuoles, less arachidonate, and 
decreased mitochondrial metabolism. Although the act of culturing aortic cells 
can change the SMC phenotype from contractile to synthetic65, this has not 
been observed in primary cultures, where the lack of sub-culture minimizes 
these and other types of potential genetic alterations. In addition, WC aortic 
cells obtained in vitro demonstrate a similar degenerative progression as those 
cells observed from the celiac bifurcation145,184, further evidence that the gene 
expression profile is comparable between the two model systems. 
In vitro, there is no signal communication between SMC and endothelial 
cells, monocytes, hormones, neurotransmitters, other humoral factors, and 
whole body feedback systems51,67. The only sources of interaction are between 
the SMCs and SMC with the media components, resulting in cell growth and the 
synthesis of the ECM. This makes it possible to observe the intrinsic 
characteristics of WC and SR aortic cell development in a controlled, time-
compressed setting, while limiting the number of genes under investigation to 
those specific to aortic SMC. Interestingly, although only the SMC of the WC 
celiac and coronary bifurcations are susceptible to atherogenesis in vivo, SMC 
taken from other WC tissue such as the gizzard or small intestine will exhibit 
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Figure 1: Maturation and Degeneration of Pigeon Aortic Cells 
Approximate Age 
(in vivo) 










formation of myofibrils 
dilation of GER 
1-2 days 
2-4 days 
1 day - 6 months SHOW RACER WHITE CARNEAU 4-6 days 
myofibrils enlarge extension & dilation of GER 
modified SMC 




pinched off cisternae of GER 
loss of ribosomes 
mitochondrial abnormalities 
lipid inclusions, vacuoles 
rounding of cell 
6-8 days 
MATURE SMC FOAM CELL 8-10 days 
42 
features similar to atherogenesis in aortic cells in vitro. This is not the case in 
the SR, where neither SMC from the celiac foci, nor SMC from any other tissue 
undergo phenotype modification when cultured under identical conditions. 
The aforementioned experiments provide additional evidence that the 
genetic defect predisposing the WC to atherosclerosis is conditionally 
expressed in SMC. Factors that stimulate the expression of atherogenic genes 
at the celiac bifurcation in vivo appear to be present in vitro, as the cultured WC 
cells undergo degeneration parallel to their counterparts in aortic tissue145,184. In 
addition, the genetic factors denoting resistance in the SR remain expressed in 
both experimental environments. Therefore, comparing gene expression 
between the two breeds in vitro may identify the single gene responsible for 
atherogenesis in the WC. Future experiments to directly test the response of 
the causative gene to extrinsic (dietary manipulations) and intrinsic (whole 
body) stimuli in terms of spontaneous atherogenesis in the pigeon could then 
be designed. 
Themes, Gaps, & Inconsistencies in Current Knowledge of Human 
Atherogenesis. Phenomena that occur during the progression of 
atherosclerosis cannot by default be used to deduce the initiating mechanism. 
Many studies reporting metabolic or genetic differences in atherogenesis in 
humans and animal models are actually reporting the occurrences of 
progression. The merging of progressive and initiative factors in the literature is 
partly because it is more convenient to study pathological changes as they 
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occur, but also because of the broad and varied definitions of atherogenesis. 
The medical field works directly with the prevention and treatment of myocardial 
infarction and stroke, and, therefore, tends to view atherogenesis as anything 
that is observed prior to a clinical event. However, multiple mechanisms can 
cause varied paths to a similar phenotype1,23, and each may warrant a unique 
treatment strategy. In order to sort out the chronology of events in different 
individuals, a more precise definition of atherogenesis is needed. 
Foam cell development is the earliest common event across all animal 
models and in humans, and it would be helpful if atherogenesis referred only to 
the specific mechanisms leading up to and including this event. Once a fatty 
streak has formed, whether myogenic or macrophage based, all subsequent 
events, whether progression, regression, or inert, should be characterized and 
reported in terms that are specific to the type and location of the initial foam cell. 
Smooth muscle and macrophage cells appear to play different pathogenic roles 
in different animal models, and in different forms of the human disease. SMC 
are more prevalent in the abdominal aortic branches of spontaneous models, 
and in the abdominal and coronary atheromas found in humans. Macrophage 
cells predominate in animal models where foam cell development is induced by 
an artificial diet and/or genetic manipulation. In the human, this type of foam cell 
is also associated with extreme hypercholesterolemia, often in the thoracic 
aorta, and tends to be secondary to other pathological conditions. Macrophage 
cells appear in the progressive stages of atherosclerosis in all models, which 
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further underscores the need to clearly articulate the precise pathological step 
understudy. 
The confusion between types of cells involved in early atherosclerotic events 
may be explained by the fact that a non-specific antibody was often used to 
positively distinguish a macrophage cell from a SMC45,61,185,186. Alpha actin is 
the major actin isoform in a differentiated SMC, and the lopsided emphasis of 
monocytes in foam cell development may be because any cell that did not stain 
for this marker was considered to be of non-SMC origin187,188. The predominant 
actin isoform in the SMC switches from alpha to beta/gamma (BG) as part of 
the phenotypic modulation observed during the initial stages of 
atherosclerosis14'45'61,67,188'189. The alpha/BG actin ratio in a contractile SMC is 
2:1 whereas after the cell becomes synthetic, the alpha/BG ratio is 2:714. 
Because alpha actin is not expressed in a phenotypically modified SMC, it is not 
a reliable marker to use in distinguishing SM from macrophage cells. 
Therefore, many researchers may have falsely concluded that SMC were not a 
major cell type in the development of atherosclerosis in their model. 
The literature is also confounded in terms of spontaneous and diet-
induced atherosclerosis. Many authors are beginning to report spontaneous 
atherosclerosis in transgenic models20,40,190 which calls the true meaning of 
spontaneous into question. Any type of experimental manipulation required to 
induce the desired phenotype cannot be considered spontaneous. This is 
because additive effects are complicating the true role of both 
hypercholesterolemia and inflammation in atherogenesis, and are preventing 
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the identification of intrinsic factors within a given individual model. Induced 
models (transgenic or diet) can be used to look at the interactions of genes 
known to be involved with atherosclerosis, and to investigate the synergistic 
effects of these genes with identified risk factors in a hypothesis driven fashion. 
However, in order to describe unknown facets of the disease, spontaneous, 
non-induced models are needed. Genetic factors influencing susceptibility and 
resistance in the absence of confounding factors remain to be identified in order 
to explain the prevalence of atherosclerosis in individuals that remain at risk 
under current screening methods. 
Investigating the Genetic Differences between Two Similar Populations 
There are many strategies and techniques available to investigate the 
differences in genetic expression between susceptible and resistant individuals 
within a defined population. It is important to appreciate that most of these 
methods are not competitive, in that one is any better than another. Rather, the 
varied approaches provide complementary information that can be utilized in 
assembling the bigger picture of human atherogenesis. Experimental design 
must consider not only the specifics of the research question being asked, but 
also what resources exist for the selected organism. 
If the genome has been published and well annotated, more options are 
available. The orthologous relationship between highly conserved functional 
proteins among species allows the identification of an unknown nucleotide 
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sequence based on its similarity to something that has already been 
characterized. However, if the genome of interest has not been characterized, a 
method must be selected that that does not depend on prior knowledge of the 
nucleotide sequence or karyotype. An experimental technique that requires a 
priori knowledge is considered to be a closed system, and is well suited for 
hypothesis driven experiments when the gene of interest has been 
characterized191. In contrast, open systems are those that do not depend on 
previous knowledge, and so allow for the discovery of novel genes and 
expression events62. 
Traditionally, molecular biologists have focused on open systems such 
as subtractive hybridization (SH) and differential display (DD) in order to identify 
restriction fragment length polymorphisms (RFLP)192. With advances in the 
polymerase chain reaction (PCR), sequencing and microarray technology, 
many eukaryotic genomes have been characterized, and there are valuable 
closed systems in which to test a multitude of hypotheses. When information 
about an organism is complete, a closed system is preferable to an open 
system because all of the potential interactions are traceable. However, there 
is still a lot that is not known, and an over emphasis on closed systems can 
actually prevent the discovery of new knowledge. In fact, most of the gene 
expression studies described to date have "merely validated differential 
expression of genes and pathways known to be involved in atherosclerosis, and 
have yet to fully exploit the power and possibility of identifying novel players 
(and eventually novel pathways) underlying atherosclerosis"193. 
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New genes are identified by either one of two ways: computer prediction 
based on the identification of open reading frames (ORF) or the isolation and 
functional analysis of expressed sequence tags (EST) in a traditional wet lab194. 
Despite the fact that the human genome was published in 2001195,196, and the 
mouse and rat genomes soon followed197,198, researchers are still finding 
transcripts that have not been predicted by current computer models. A number 
of Serial Analysis of Gene Expression (SAGE) experiments continue to isolate 
genuine transcripts that are not in the EST databases194. The fact that new 
genes are still being discovered provides strong rationale for employing 
discovery-based experiments in order to identify novel candidate genes 
involved in the pathogenesis of atherosclerosis. 
The most common source of genetic variation between individuals is 
single nucleotide polymorphisms (SNP). Any given mutation will only be present 
in a small percentage of the population, and the associated risk will be clinically 
important only in some subjects199. However, the effect of the nucleotide 
sequence may be quite large in those populations that are susceptible, and it is 
imperative that large genetic screenings are conducted along with precise 
phenotype descriptions in order to determine the true impact of a polymorphic 
allele in the general population27,99,200. Even when the allele frequency is known 
for a sample population, it still may not correlate with disease. Many times a 
polymorphism will randomly associate with susceptible and resistant strains, 
and these events can be hard to distinguish from those that are actually 
causative99,201"203. The definitive assignment of a SNP to a phenotype is 
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complicated by the fact that even when carrying the deleterious allele, some 
individuals will only develop the associated disease in conjunction with an 
environmental trigger27. 
In addition to using SNPs to correlate genotype and phenotype within a 
defined population, another source of genetic variation is that of copy number 
(CNV)204. CNV are structural variations at the chromosome level that can be 
quantified by measuring their effects. CNV affect both the allele dosage and the 
transcript copy number and they are widely prevalent throughout the genome. 
Distinct genomic regions have particular copy number variations and these 
could be a source of variation between species as well as between susceptible 
and resistant individuals within a single species204. The mechanism and 
purpose of CNV are not yet understood in healthy individuals, so it is too early 
to use them to predict disease. However, it is expected that CNV will help to 
explain how similar genes come to develop new or altered functions, and they 
will be used in conjunction with SNP to generate novel phenotypic markers 
throughout the genome. 
Alternative splicing is an important posttranscriptional mechanism that is 
known to generate diverse proteins from a single transcript205. It is now 
believed that a substantial fraction of human genes (35-60%) produce 
transcripts that are differentially spliced206, to provide a third source of genetic 
variation between individuals. Furthermore, 70-90% of these alternative-splicing 
events alter the resulting protein product206. Almost all ion-channel and 
neurotransmitter receptor pre-mRNA undergo extensive alternative splicing to 
49 
generate several protein isoforms. Differential splicing may account for the 
localization of gene expression to a particular tissue and /or developmental 
stage191, but has also been implicated in some types of genetic diseases98,207. 
Sometimes mutations in regulatory regions of the genome can cause the 
altered expression of many genes, thus appearing to be a multifactorial trait, yet 
still inherited in a classic Mendelian fashion208,209. Alternative splicing is one 
example of this type of regulation, as is chromatin remodeling, transcription 
initiation, RNA elongation and editing, and instructions for protein 
degradation191,209. Each level is composed of a "dynamic system of self-
organizing proteins, the output of which is governed by laws that are still poorly 
understood"210. Careful analysis of many nucleotide sequences in many 
organisms has revealed that the distribution of exons, promoters, gene start 
sites, and other genomic features is highly variable, and functions to regulate 
overall genetic expression211. 
Many genes may be common between organisms, especially those of 
the same breed. Sequence and functional similarity is what gives comparative 
genomics its strength212. However, when trying to isolate differentially 
expressed genes from closely related species, it may be more efficient to look 
at those genes expressed only in the tissue of interest rather than the overall 
genomic content. Genomic DNA is more stable than messenger RNA (mRNA); 
however, it is not expressed at all times in all cells. In contrast, mRNA provides 
a snapshot of transcriptional activities at the moment of cell lysis213. Therefore, 
RNA expression profiling has the potential to "identify genes involved in disease 
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pathogenesis resulting from both environmental and genetic factors, along with 
associated interactions."214. 
It is important to keep in mind that the amount of mRNA present does not 
necessarily correlate with the amount of protein made215 for many reasons. 
There are varying degrees of translation efficiency, and different messages 
have different half-lives. For example, the mRNA for c-fos has a half-life of just 
a few minutes, whereas beta actin mRNA is stable for several hours191. The 
specifics of mRNA degradation are considered to be an important aspect of 
genetic regulation, but many of the details of this pathway have not yet been 
elucidated. Once the primary protein sequence is translated, there are a 
multitude of post-translational modifications (PTM). Sulfation, phosphorylation, 
glycosylation and proteolytic cleavage are just a few directed changes that 
provide the cell with flexibility, and guide the peptide to its functional form. Most 
proteins that will be secreted from the cell or embedded in the plasma 
membrane will be glycosylated191. The genetic signals for specific PTM events 
are not known and it is not always possible to predict how each protein will be 
modified after it is translated based on the nucleic acid or amino acid sequence. 
Therefore, although general transcription rates do correspond to general rates 
of protein synthesis, it is important not to make quantitative comparisons 
between the two types of molecules unless they are being analyzed in parallel. 
Although targeting the transcriptome will not necessarily identify the 
regulatory regions in non-coding DNA208, this strategy significantly decreases 
the complexity of the starting material, as only around 2% of the genome 
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actively codes for protein . The specific profile of these mRNA transcripts 
constitutes a fingerprint, or signature of the phenotype. Theoretically, after the 
genes composing that fingerprint are characterized, the upstream regulatory 
events can be deduced from the unique signature. 
As the genes involved in atherogenesis are presumed to be different 
than those genes responsible for progression, changes in gene expression will 
occur as the pathological events progress and as a consequence of normal 
development and cellular differentiation of the vasculature217. The interpretive 
challenge is not to confuse the genes that caused the foam cell to appear at 
discrete loci in the first place, with those being expressed as a secondary or 
downstream effect. It is therefore necessary to look at entire pathways instead 
of just the individual players218 as investigating the effects of only one gene at a 
time can provide fragmented knowledge219 that is potentially misleading200. The 
goal of cardiovascular genomics is to establish the genetic baseline of 
susceptible and resistant phenotypes. By interrogating the system as a whole, 
as is possible with a discovery based approach, gene-gene interactions and 
overall profile patterns that are consistent with either a susceptible or resistant 
phenotype can be detected99,220. Subsequent perturbations can then be 
imposed in order to observe the influence of genotypic variation on initiation, 
progression, and regression of human atherosclerosis in a hypothesis-directed 
approach. 
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There are basically three types of biochemical approaches to investigate 
the expression levels of differential transcripts221. (1) Hybridization experiments 
take advantage of the chemistry of Watson-Crick base pairing in order to isolate 
transcripts of both known and unknown (random primers) nucleotide 
sequences. (2) PCR methods depend on the controlled and exponential 
amplification of the target transcript to generate enough product to be analyzed, 
and (3) sequence based methods use capillary gel electrophoresis to determine 
the identity and order of the nucleotides in a sample based on their 
densitometric difference, although novel sequencing methods are being 
developed as the race for the $1000 genome continues222. Newer techniques 
are able to employ a combination of these three primary approaches to 
maximize the output from the varying amounts provided by biological samples. 
The primary methods used to investigate the transcriptome are 
presented in Table 2 (p.54). Eight methods are presented, and categorized in 
terms of the following criteria: open or closed system; hybridization (H), PCR 
(P), or sequence (S) based technique; the ability to detect alternative splicing; 
the possibility of absolute quantification; and throughput capacity191,221,223. 
Sample throughput refers to the number of different biological samples that can 
be analyzed in one experiment, whereas transcript throughput represents the 
number of differentially expressed transcripts that can be analyzed after 
completing one experiment221. The classification of high, medium, and low 
throughput is not quantitative, as they are simply generalizations of the relative 
amounts of information when compared to the other methods. 
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Legend: SAGE = Serial Analysis of Gene Expression; CHIP=Microarray Analysis; qPCR=Quantitative 
Polymerase Chain Reaction; RNAi=RNA Interference; DD=Differential Display; SH=Subtractive 
Hybridization; RDA=Representational Difference Analysis; NOR=Northern Blot Analysis 
*Microarray technology is only as specific as its composition. If Individual exons are plated on the slide, 
alternative splicing can be detected224. 
Representational Difference Analysis (RDA) is a positive selection 
technique that couples the specificity of subtractive hybridization with the 
sensitivity and amplification power of PCR to isolate differentially expressed 
transcripts. RDA draws from the strengths of all three primary methods of 
investigating the transcriptome, and as an open system, provides the 
opportunity for discovering genes not previously implicated in atherosclerosis. It 
is considered to be a positive enrichment strategy because is selects for what is 
different between two samples, rather than degrades what is the same, as is 
the case with negative enrichment designs. 
RDA was originally developed to find subtle differences between whole 
genomes225, and has successfully identified disease markers in pedigree 
dogs226 and strain differences between palm trees227. The technique has been 
modified to use cDNA as a starting template228, and as such, is capable of 
picking up variations in gene expression between tissues or individuals. RDA 
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provides an advantage over SH and SAGE by reducing the bias of abundant 
transcripts217. It allows more opportunities to capture rarely expressed 
transcripts229,230, and variations in copy number, as well as the 
presence/absence of a message from a candidate gene. RDA can detect 
differences in less than one copy per cell223,231, which is important considering 
that anywhere from 80-95% of transcripts are present in less than 5 copies per 
cell191'223'232. 
There have been many modifications to the original cDNA RDA protocol in 
order to minimize the isolation of false positives and accommodate smaller 
amounts of clinical tissue233"235. In general, there are three steps common to all 
RDA protocols: representation; PCR coupled subtractive hybridization; and 
screening of the difference products. Methods used to verify and characterize 
transcripts vary by researcher, including northern blots, virtual southern blots, 
microarrays and
 qPCR62,234,236,237. Northern blots and microarray analysis are 
not always sensitive enough to detect rarely expressed messages that are 
captured during the enrichment process of RDA62'223 so preliminary sequence 
analysis can be performed in order to identify the top candidate among the 
difference products238,239. Although the copy number variation detected in RDA 
cannot be considered absolute because of the multiple PCR steps and the 
variable number of clones actually picked and analyzed, general trends in 
regulation have been consistently confirmed using qPCR. Upregulated 
transcripts identified in an open system such RDA can then be plated on a 
microarray chip240,241 to monitor changes in gene expression under varying 
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environmental conditions, and/or used to design fluorescent probes and primers 
in order to provide absolute quantitative results with qPCR. 
Research Objectives 
1. To isolate genes that are differentially expressed between cultured aortic 
smooth muscle cells (SMC) from White Carneau (WC) and Show Racer 
(SR) pigeons by Representational Difference Analysis (RDA). 
2. To identify the differentially expressed genes by comparative genomics 
(Bioinformatics). 
3. To correlate the function of differentially expressed genes with mechanisms 
for initiation of spontaneous atherosclerosis in the susceptible WC pigeon. 
Hypotheses 
1. The gene(s) responsible for atherosclerotic resistance in cultured SR SMC 
are silent or down regulated in the WC SMC. 
2. The gene(s) contributing to the spontaneous atherosclerotic phenotype in 
cultured WC SMC are not expressed in SR SMC. 
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Experimental Design 
1. Representational Difference Analyses (RDA) was performed to compare 
gene expression in SMC cultured from susceptible WC and resistant SR 
aortas. 
2. The reciprocal RDA experiment (diagrammed in Figure 2) was done in 
quadruplicate on several pools of WC and SR cells.A list of candidate 
genes for susceptibility/resistance to pigeon atherogenesis was 
compiled. 
3. The functional role of genes that are differentially expressed between the 
two breeds was deduced. 
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CHAPTER II 
METHODS AND MATERIALS 
Pigeon Colonies 
White Carneau (WC) and Show Racer (SR) pigeons were obtained from 
the UNH colonies, which are housed in fly coops at ambient temperature and 
allowed free access to water, Purina Pigeon Chow Checkers, and Kaytee Red 
Grit. The colonies were established in 1962 with birds obtained from the 
Palmetto Pigeon Plant in Sumter, South Carolina and have remained closed 
flocks. The colonies are maintained under the supervision of the UNH Animal 
Care and Use Committee (Approval #050601). 
Ceil Culture System 
One to three day-old WC and SR pigeons were used to prepare primary 
cultures of aortic smooth muscle cells according to the method developed in 
this laboratory183. One culture preparation of 18-25 flasks requires 3-5 pigeon 
aortas. Thirty-two explants were planted in each 24cm2 flask and grown for 7 
days at which time flasks that exhibited confluent monolayers were washed 
three times with Hanks Balanced Salt Solution (HBSS) to remove the growth 
media. Cells were serially harvested in 1 ml Trizol™ (Invitrogen) for RNA 
extraction. Briefly, cells from the first flask were scraped into Trizol™ and 
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poured into the second flask. This process was continued until all of the cells 
from 8-10 flasks were concentrated into one 1.7mL microcentrifuge tube. A 
second 1mL Trizol™ was used to serially harvest the remaining flasks, and the 
extractions were not pooled until total RNA was assessed. 
Preparation of Total RN A 
An RNA extraction procedure must allow for complete cellular disruption 
while effectively inhibiting the ribonucleases (RNAses) that are released upon 
membrane lysis242. Trizol™ is an effective acid-phenol-guanidium-thiocyanate 
(APGT) RNA extraction reagent237. Guanidium thiocyanate is a chaotropic salt 
that denatures protein:nucleic acid complexes while simultaneously distorting 
the tertiary structure of RNAses, rendering them inactive242,243. Once the cellular 
RNA is exposed and protected from endonuclease degradation, the acid-phenol 
component of Trizol™ reacts with chloroform (0.2mL per 1.0 ml_ Trizol™) and 
partitions the DNA, protein, and RNA according to density gradient and pH. The 
RNA partitions in the aqueous phase with the guanidium thiocyanate and is 
recovered by precipitating overnight with isopropanol. There are many versions 
of APGT lysis buffers commercially available, and Trizol™ is routinely used in 
this laboratory to extract total RNA from both aortic tissue (1mL: 70 mg) and 
cultured aortic cells (1 ml_: 8-10 flasks/50-65mg). 
Following the overnight incubation in isopropanol, total RNA was 
sedimented by centrifugation at 16,000xg for 18 minutes (Eppendorf Model 
#5415D), and the resultant "pellet" was washed in 70% ethanol to remove the 
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guanidium thiocyanate. Each pellet was dissolved in 125ul_ of molecular grade 
water (18.2 megOhm), and mixed with 12.5uL 3M sodium acetate (pH 5.3) and 
313uL of ice-cold 100% ethanol to initiate a second purification step. The 
sample was vortexed for 10 seconds, incubated at 4°C for 30 minutes, 
centrifuged for 18 minutes as before, and the pellet was washed in 70% 
ethanol. The supernatant was removed using a vacuum with a 20ul_-filtered 
pipet tip, and the rim of each tube was wicked dry against a clean paper towel. 
The purified pellets of total RNA were dissolved in 20uL water. 
The concentration of total RNA was estimated using the optical density 
(OD) of the sample at the wavelength of 260nm (A260) in a 3mM sodium 
phosphate buffer, pH 7.5244,245. Absorbance values must be within the range of 
0.1-1.0 in order to provide accurate information about the amount of RNA in 
solution. The OD was also measured in 10nm intervals from 220-320nm to 
determine the presence of contaminants that interfere with the absorbance of 
light by the sample at 260nm. Sources of these contaminants include 
components of the biological starting material that were not completely removed 
from the RNA extract such as protein (280nm) and polysaccharide (230nm) in 
addition to residuals from the extraction process itself including phenol (270nm) 
and salts (240nm)213'245'246. 
Although spectrophotometric quantitation is not absolute, checking the 
relative absorbance of these common contaminants can increase the reliability 
and, thus, usability of the A260 reading for calculating the yield of RNA. In 
addition, impurities in the RNA preparation can inhibit many of the downstream 
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manipulations required for RDA such as reverse transcription and the 
polymerase chain reaction. Polysaccharides are a significant component of 
pigeon aortic tissue, and are routinely detected in RNA extracts prior to the 
second purification step247. The 230/260 ratio should be < 0.5248, and, in 
general, the ratio of "good" absorbance values at 230:260:280 approximate 
1:2:1246. Although a 260/280 ratio of 2.0 +/- 0.15213 is often used to assign 
quality to an RNA sample, it is at best a gross estimate of protein 
contamination249 and was reported, but not used as the primary indicator of 
RNA purity. 
Spectrophotometry provides an estimate of the amount of nucleic acid 
extracted, but because all nucleic acids absorb light at 260nm, further analysis 
is required to determine whether the sample is in fact RNA, and not genomic 
DNA, and to determine whether the product is intact or degraded. Therefore, 
both spectrophotometric and electrophoretic analyses of the sample were 
performed before the integrity of the RNA preparation was accepted. Since 
nucleic acids have a net negative charge, electrophoresis can separate the 
DNA and various forms of RNA on the bases of the density, mass, and shape of 
each molecule. These separations correspond to specific sedimentation rates 
in ultracentrifugation, which are expressed as Svedberg coefficients (S)213. 
An aliquot (0.5ug) of RNA was run on a 1.2% agarose gel at 85 volts for 
25 minutes and stained in an ethidium bromide solution (0.01mg/ml). The 
predominant 18S and 28S ribosomal RNA (rRNA) bands were visualized under 
ultraviolet light (302nm) for evidence of degradation and DNA contamination 
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using the MuitiDoc-lt Digital Imaging System (UVP Model M-20). For the RNA 
to be considered pure, the 28S band should be about twice the intensity of the 
18S band213, and both bands should be discrete with no sign of smearing. If the 
RNA is degraded (smeared), it must be discarded. Residual DNA in the sample 
can be observed at the origin of the well. Additional treatment with DNAse can 
be performed to remove the genomic DNA, but this was not necessary for any 
of the RNA preparations used for the RDA experiments. The amount of total 
RNA available for RDA decreases with each purification step, but potential yield 
must be sacrificed for a quality template, especially when working with the 
pigeon, whose genome has not been sequenced. RNA samples determined to 
be pure by both spectrophotometric and electrophoretic assessments were 
stored at -80°C until the next step in the RDA procedure. 
Preparation of Complementary DNA fcDNA) 
RNA was converted to double stranded (ds) cDNA using the BD 
SMART™ PCR cDNA Synthesis Kit (BD Biosciences Clontech Division 
#K1052-1). This kit utilizes a special primer set to capture both the 
polyadenylated tail at the 3' end of the mature transcript, and the guanidiated 
cap at the 5' end. The primer extension option allows the researcher to 
produce full-length cDNA250from as little as 50ng total RNA, thus eliminating the 
need to enrich for messenger RNA (mRNA). Because it can take from 100-
500ug total RNA to isolate 1ug mRNA213,234'251 depending on the method, the 
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SMART1 m technology employed during first strand synthesis significantly 
decreased the number of required ceil culture preparations, and, therefore, the 
number of pigeons, needed to complete the proposed RDA experiments. 
The SMART™ kit provides two options for generating cDNA, depending 
on the downstream applications of the product. The first protocol is specific for 
library construction, and the second protocol generates cDNA for other 
purposes. Although the second option was selected, both procedures depend 
on patented SMART™1 (Switching Mechanism At 5' end of RNA Transcript) 
oligonucleotides and a lock-docking primer to capture the polyadenylated tail 
from the 3'end of the RNA transcript and add a deoxycytidine "anchor" to the 5' 
end. This SMART™ anchor is then used as an extended template for 
PowerScript RT™, a modified Moloney murine leukemia virus (MMLV) reverse 
transcriptase. In theory, only full-length clones will be produced during the first 
strand synthesis reaction because transcripts lacking the 5' anchor will not 
serve as a template for the second strand. 
The SMART™ protocol was optimized to use 1 ug of total RNA to 
generate double-stranded cDNA for the proposed RDA experiments. The first 
strand reaction produces unstable RNA/cDNA hybrid molecules that can be 
stored up to three months. This template consistently yields 12-15ug double-
stranded cDNA, and the kit provides reagents for 25-second strand reactions. 
Second strand synthesis reactions were performed in the MasterCycler 
Gradient Thermal Cycler (Eppendorftt 5331; 115V) according the SMART™ 
PCR cDNA Synthesis Kit User Manual (Version No. PR3727&). The potential 
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for non-specific hybridization product is increased with every round of 
pCR2i3,249,252 y n e r e f o r e t n e number of PCR cycles was optimized at 23; the 
minimum number of amplification cycles before the amount of generated cDNA 
began to plateau. PCR products were extracted first with 100ul phenol-
chloroform-isoamyl alcohol (PCI), then with 100ul chloroform. The aqueous 
phase containing the cDNA was mixed with 0.1 volume (10ul) 3M sodium 
acetate (pH 5.3), 1ul glycogen (10mg/ml, Sigma #G1767), and 2.5 volumes 
(250ul) of 100% molecular grade ethanol, vortexed briefly, and placed at -20°C. 
Following overnight incubation cDNA was sedimented by centrifugation 
at 16,000xg for 18 minutes. The pellet was washed in 70% ethanol to remove 
the sodium acetate and spun for an additional 2 minutes. The supernatant was 
removed using a vacuum with a 20uL-filtered pipet tip, and the rim of each tube 
was wicked dry against a clean paper towel. The purified cDNA was dissolved 
in 25uL of 18.2 mgOhm water, and yield was determined using 
spectrophotometry (A260). An aliquot (0.5ug) of cDNA was separated on a 
1.2% surface tension agarose gel at 85V for 20 minutes and photographed 
under UV light using the MultiDoc-lt Digital Imaging System. Samples to be 
compared using RDA must demonstrate identical size distribution234, otherwise 
differential products will simply reflect variations in the molecular weight of 
converted RNA transcripts rather than their relative expression levels. Ethidium 
bromide staining (0.01mg/ml) should reveal a general smear from about 300bp-
7000bp, with specific intensity visible from 2000-3000bp234. Purified, analyzed 
cDNA was stored at -20°C until used for RDA. 
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Representational Difference Analysis (RDA) 
As described in the Literature Review, RDA is a multi-step positive 
enrichment technique that couples PCR with competitive hybridization to select 
and amplify the transcripts that are differentially expressed between two 
populations of RNA. A detailed protocol for RDA was generously provided to 
our laboratory by Pastorian et al234 and was systematically modified as needed 
to accommodate both the small amount of RNA produced by cultured aortic 
cells and the inevitable sample loss incurred during multiple chemical and 
physical manipulations235. Therefore, the procedural steps described in this 
section reflect the optimized protocol developed during the first successful RDA 
experiment and subsequently followed for all replicates. 
Amplicon Preparation 
Five micrograms of cDNA prepared from WC and SR cultured aortic cells 
were matched for RDA by size distribution and digested overnight at 37°C with 
44.4 units of Dpn II (10U/ul; New England Biolabs), a four-cutter restriction 
enzyme that generates cDNA fragments with a 5'GATC overhang, or "sticky 
end" on each strand. Following enzymatic restriction, the cDNA was extracted 
with PCI and chloroform as previously described, and the aqueous phase was 
run through Sephacryl® 300 HR Columns (GE Healthcare/Amersham #27-
5130-01) to remove both the restriction reagents and the cut fragments less 
than 100bp. The size-selected cDNA was precipitated for a minimum of three 
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hours (sometimes overnight) with glycogen, sodium acetate, and ethanol as 
described elsewhere and dissolved in 20ul Tris-EDTA (TE) buffer (pH 8.0). At 
this point, the cDNA population was an average size of 256bp, ranging from 
100-1000bp, and ready for adapter ligation and amplification. These cDNA 
"amplicons" were stored no longer than two days at -20°C. 
Primer Information 
The interchangeable primer sets required for adapter ligation and PCR 
amplification are presented in Table 3 and were purchased from Genosys, a 
subdivision of Sigma, as recommended by Pastorian234. 
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Lyophilized primers (12mers & 24mers) were dissolved in the appropriate 
amount of TE buffer as determined by nucleotide composition, optical density, 
and molecular weight provided by Genosys. The concentration of each re-
solubiliized primer was verified by spectrophotometric analysis (A260). Paired 
primer sets (A-F) consisting of 9ug of the 24mer and 4.5ug of the companion 
12mer were prepared and stored at-20°C in ready-to-use aliquots to prevent 
hydrolysis caused by repeated freeze-thaw steps. The primer sets were used 
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interchangeably throughout the RDA experiments, and care was taken to use a 
different 12/24mer set to prepare the Drivers and each round of Tester within a 
given experiment. 
Driver Preparation 
One of the prepared 12/24mer primer sets (Primer Set A) was thawed 
and mixed with 9ul 10X ligation buffer (New England Biolabs) in a total volume 
of 45ul. Twenty microliters were allocated to the entire volume (20ul) of the 
cDNA amplicons and subjected to the "SLOWCOOL" program (Appendix B, 
p.202) in the MasterCycler Thermal Cycler. Briefly, the cDNA was incubated at 
55°C for two minutes, allowing the primers to melt while the cDNA template 
remained intact. The temperature was slowly decreased to 8°C over a 45 
minute time period to allow the 12mer and 24mer to form hydrogen bonds with 
each other (anneal). At the same time, the GATC nucleotide sequence at the 5' 
end of the 12mer is annealed to the 5' "sticky" end (CTAG) of the Dpn II 
digested cDNA. 
Nine microliters of T4 DNA Ligase (400 Cohesive end units/ul; New 
England Biolabs #M02025) were mixed with 11ul 10X Ligation Buffer (included) 
and 90ul water. A fifty- microliter aliquot of this mixture was added to each tube 
containing the prepared cDNA and incubated at 15°C overnight. During this 
step, the 24mer ligates to the 5' overhang generated by Dpn II. Because ligation 
only occurs at the 5' ends of the molecule, the 12mer does not ligate at the 
67 
temporary bridge sites created at the 3' end of the cDNA in the previous step, 
and will separate from the cDNA molecule during subsequent manipulations. 
Following overnight ligation, the products were incubated at 65°C for 10 
minutes to inactivate the ligase and re-melt the unincorporated 12mers. The 
heated samples were immediately passed through HR S-300 columns as 
previously described to remove the ligase, buffer, and residual primers. The 
purified products were divided into six thin-walled tubes, for a total of 12 tubes 
per experiment. Taq Polymerase (5U/ul) was purchased from Promega 
(#M1861) and the Drivers were amplified exactly as described in the protocol 
obtained from Pastorian et al234. 
Briefly, a PCR master mix of 250ul 10X PCR Buffer, 400ul 25mM 
magnesium chloride, 62.5ul 10mM dNTPs (Promega # U151B), 1487.5ul water, 
and 18ug (50ul) of the same 24mer used to ligate the adapters to the cDNA 
was prepared. This mix was divided evenly among the12 PCR reactions and 
incubated at 72°C for 2 minutes to fully extend the cDNAs and create primer-
binding sites on the 3'ends. One microliter of Taq was added to each tube. The 
samples were then incubated for 5 more minutes at 72°C and cycled through 25 
rounds of PCR each for 45 seconds at 95°C followed by 4 minutes at 72°C 234. 
The PCR products were further extended for 10 min at 72°C, pooled, extracted 
with PCI and chloroform, precipitated as previously described, and dissolved in 
100ulTE buffer. 
The 24mers that were ligated to the cDNA template prior to PCR were 
removed by restriction digest by adding 4.5ul of Dpn II (10U/ul) and 10.5ul 10X 
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enzyme buffer to 87ul of each Driver and incubating the reactions overnight at 
37°C to regenerate the 5' sticky ends. The samples were again subjected to 
phase extraction with PCI and chloroform, spin column purification, and 
overnight precipitation. The pellets were dissolved in 50ul TE buffer, and 3ul 
were used to estimate the yield of amplified Drivers at A260. An additional 
aliquot (0.5ug) was run on a 2% agarose gel241 for 50 minutes at 75V. The gel 
was stained with ethidium bromide as previously described, and usually showed 
smearing from about 150bp -1000bp, with most of the intensity below 700bp. If 
any cDNA was visible above 1 Kb, the Drivers were not completely restricted 
and were not suitable for Tester preparation. Acceptable Drivers were stored at 
-20°C and thawed as needed. 
Initial attempts to generate Drivers yielded no more than eight 
micrograms of cDNA. Because a minimum of 50 micrograms are required to 
perform the subsequent subtractive hybridization steps234, four aspects of 
Driver preparation were optimized for pigeon aortic cells. 
Restriction Digest Parameters. The parameters suggested by Pastorian 
et al234 were insufficient to fully restrict the pigeon cDNA. The digestion time 
was therefore increased from four hours to overnight. In addition, the amount of 
Dpn II was increased from 30 to 44.4 units. 
Adapter Ligation Protocol. Prior to adaptor ligation, the RDA 12/24-mer 
primer sets were melted at 55°C and annealed to the restricted cDNA as the 
temperature was steadily decreased to 8°C during a "SLOWCOOL" step. 
During this time, the 12mers form a temporary bridge that allows the 24mers to 
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ligate to the 5' end of cDNA template when T4 DNA ligase is added. In the 
original protocol, "SLOWCOOL" was performed by heating an aluminum block 
containing the reactants to 55°C, and then moving the block to 4°C. Moving the 
entire reaction to a thermal cycler standardized the protocol. The ramp time is 
controllable in a thermal cycler, and is so quick that the length of time spent at 
55°C was increased from 1 minute to 2 minutes prior to cooling in order for 
primers to fully melt. The rate of cooling was controlled by reducing the 
temperature of the thermal cycler two degrees per minute until the reaction 
reached 8°C. 
Phase Extraction Parameters. According to Shanahan et al. 30-50% of 
the cDNA is lost at each phase extraction step235. RDA requires multiple phase 
extractions throughout the procedure, and in order to decrease the amount of 
sample lost during phenol and chloroform extraction steps, multiple optimization 
steps were performed. 
First, a "back extraction" step was performed in an attempt to maximize 
the recovery of the cDNA249. This was accomplished by adding TE buffer to 
dilute the extracted cDNA, and re-extracting the aqueous phase with an equal 
volume of chloroform. Although slightly increasing the yield, sample was still 
lost. Second, the overall reaction volumes were increased to dilute the cDNA, 
thus minimizing the amount lost per microliter sample at the interphase. Finally, 
Phase Lock Gel (PLG) tubes were employed (Eppendorf# 955154151). The 
PLG tubes include an inert gel that forms a protective barrier between the 
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aqueous and organic phases during the centrifugation step , allowing the 
cDNA to be recovered in total. 
Precipitation Parameters. The original protocol precipitated the extracted 
cDNA with ammonium acetate (4M). According to Farrell213, the types of salt 
and alcohol can be varied, as long as the correct ratios are used for a given 
pair. Sodium acetate (3M) was used successfully during the cDNA synthesis 
procedures, and the same protocol was applied to the RDA products. One 
microliter of glycogen (10mg/mL) was also added to the precipitation reaction to 
assist in visualizing the cDNA pellets. Once the four steps described above (1-
4) were optimized, there were no further problems with yield, and I was able to 
proceed with tester preparation. 
Tester Preparation 
One microgram of each Driver population was used to prepare Testers for 
the first round of subtractive hybridization. A second set of primers (Primer Set 
B) was used to perform the "SLOWCOOL" annealing step, and the 24mers 
were ligated to the 5'ends in a 60ul volume as described during the first step of 
Driver preparation. The only difference was the primer set selected. This is a 
small but important distinction because it ensures that that cDNAs with uncut 
adapters from Primer Set A will not be carried over to the hybridization step. 
Following overnight ligation at 15°C, the Testers were heated to 65°C for 10 
minutes and immediately used in the following procedural step. 
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Round One Hybridization 
Thirty microliters (0.5ug) WC Tester population was transferred to a new 
tube. Five micrograms of SR Driver was added, and the volume was adjusted to 
100ul with TE buffer. In the reciprocal experiment, 30ul (0.5ug) of SR Tester 
was combined with 5ug of WC Driver. Both samples were then extracted with 
100ul PCI, 100ul chloroform, and precipitated for a minimum of 4 hours 
(sometimes overnight) at -20°C. 
The cDNA pellets are very loose at this stage, and the supernatant was 
decanted very carefully. The pellets were washed in 70% ethanol, dried, and 
dissolved in 4ul of hybridization buffer234. For each hybridization reaction, 1ul of 
5M sodium chloride was added to a fresh thin walled tube and placed at 95°C. 
Each cDNA aliquot (4ul) was incubated at 95°C for 1 minute to denature the 
double stranded Tester and Driver populations. The cDNA was then added to 
the tubes containing sodium chloride, mixed well, covered with 20-25ul mineral 
oil (Sigma #M5904), and incubated for an additional 3 minutes at 95°C. Without 
removing the tubes from the thermal cycler, the temperature was decreased to 
67°C and the hybridization reactions continued for 24 hours at which time they 
were diluted with 45ul water and stored at -20°C. 
Amplification of Round One Hybridization Products 
Following hybridization, three types of double-stranded molecules are 
formed. Because the Driver is added in excess (10:1) of the Tester, most of the 
cDNA hybrids are Driver: Driver. During hybridization, some of the Tester 
sequences form hydrogen bonds with the excess Driver sequences, creating 
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Driver: Tester hybrids of transcripts common to both WC and SR populations. 
The smallest pool of molecules consist of Tester: Tester hybrids, which 
represent the target sequences present only in the Tester population. 
Background hybrids that do not represent differentially expressed transcripts 
will be effectively "drowned out" (subtracted) by the exponential amplification of 
Tester: Tester sequences during PCR. The PCR parameters used to amplify 
the subtracted differences are the same as used to generate the Drivers. 
Although all three types of cDNA hybrids are present at this point in the 
RDA procedure, they are each different at their 5' ends and so will react 
differently during the amplification step. The Drivers were generated with Primer 
Set A and subsequently digested with Dpn II to remove the adapters. Therefore, 
DrivenDriver hybrids have no priming site on either 5'overhang, and will not be 
amplified. The Testers were made with Primer set B, and the ligated adapter 
makes the tester template accessible for priming by 24mer B. Driver.Tester 
hybrids only have an adapter on one of the two strands, and will be amplified 
linearly. Only the Tester:Tester hybrids have a ligated primer site on the 5' end 
of each strand and so will be amplified exponentially. 
To further enrich the final PCR products for target hybrids, an aliquot 
(1/10 reaction volume, or 10ul) is transferred to four fresh PCR reactions after 
the first 7 cycles. This dilution step replaces the need to treat the samples with 
mung bean nuclease by reducing the background hybrids "to such an extent 
that only exponentially amplifiable cDNA hybrids (Tester:Tester) will contribute 
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significantly to the final product" after 20 additional rounds of PCR cycling in 
a total reaction volume of 210ul. 
Purification & Assessment of Round One Difference Products 
Following PCR, like samples were pooled and extracted with PCI and 
chloroform, and precipitated at -20°C with sodium acetate, glycogen, and 
ethanol as previously described for at least two hours. The samples were 
centrifuged at 16,000xg for 18 minutes, washed with 70% ethanol, spun for an 
additional two minutes, dried, and the purified Tester: Tester cDNA hybrid 
pellets were dissolved in 10Oul TE buffer. 
As with the final step in Driver preparation, the ligated 24mer adapters 
were removed by an overnight restriction digest with Dpn II to regenerate sticky 
ends. The samples were again extracted with PCI and chloroform, and the 
aqueous phase was run through the HR S-300 spin columns. The cDNAs were 
precipitated for at least two hours, centrifuged, washed, dried, dissolved in 50ul 
TE buffer, and labeled "Difference Product Round One" (DP1). 
The yield of the amplified difference products (testers) was determined 
by measuring the optical density of each DP1 at 260nm, and was usually 
between 10-20ug as suggested by Pastorian 234. An aliquot (0.5ug) was 
separated on a 2% agarose gel for 50 minutes at 75V and stained with ethidium 
bromide (0.01mg/ml). As with the Drivers, if smearing was visible above 1Kb, 
the cDNA restriction step was considered incomplete. A few differential bands 
were sometimes observed, but the real reason for electrophoretic analysis at 
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this point in the RDA protocol was to confirm the size distribution of the 
difference products from round one. 
Subsequent Rounds of RDA 
The amplified difference products from the first round of subtractive 
hybridization (DP1) were used to make the Testers for round two. Just as in the 
first round, 1ug DP1 was mixed with a brand new primer set (C), and the 
adapters were ligated onto the 5' ends of the subtracted cDNAs overnight at 
15°C. However, for each round of RDA the hybridization ratio is increased. 
Therefore, following a brief heating of the samples to 65°C for 10 minutes, only 
50ng of the ligated 24mer C WC Tester was mixed with 5ug of the original SR 
Driver and vice versa, for a Driver.Tester ratio of 100:1. The cDNA mixture was 
co-precipitated and hybridized as in round one, and the heterogeneous hybrids 
were subjected to PCR using 24mer C to prime the amplification. Following the 
first 7 rounds of PCR, the sample was again diluted in a fresh reaction mix for 
an additional 20 cycles. Following PCR, the TestenTester hybrids were purified 
and assessed exactly as described in RDA step 7. There were usually a few 
distinct bands visible at this point in the RDA procedure. Again, 1ug of the 
difference products from this round (DP2) was used to prepare the Testers for 
round 3. 
To prepare for the third round of subtractive hybridization, Primer Set D was 
used to ligate 1ng Tester, which was mixed with 5ug of Driver for a Driver: 
Tester ratio of 5000:1. To accommodate the small amount of Tester available to 
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form TestenTester hybrids, following the first 7 cycles of PCR the reactions 
were again diluted, but then subjected to 25 additional cycles rather than 20 as 
with the previous two rounds. The PCR products were purified, analyzed, and 
labeled "DP3". The difference products were stored at -20°C for no more than 
two weeks prior to cloning. 
Cloning the RDA Difference Products 
The pBlueScript II SK+ (pBS) Vector (Stratagene #212205) was selected for 
its flexibility because it contains multiple cloning sites as well as complementary 
binding sites for six different sequencing primers. The Dpn II generated 
difference products are easily cloned into the SamHI site of the
 P BS 6 2 ' 2 3 7 ' 2 4 1 2 5 4 
to be replicated as with a traditional plasmid vector. 
To prepare the vector to accept the cDNA inserts, 5ug of the circular 3.0Kb 
vector was digested with 5ul SamHI (5U/ul, Promega) for 1 hr at 37°C in a 
reaction volume of 50ul. The restricted vector was then dephosphorylated with 
20 units of calf intestine alkaline phosphatase (CIAP, Stratagene # 600015), 
increasing the total volume of the reaction to 100ul. The solution was incubated 
at 37°C for 30 minutes, followed by an additional 15 minutes at 68°C. The 
product was extracted with PCI and chloroform, precipitated for a minimum of 1 
hr at -20°C, centrifuged, washed, and dried as previously described, and 
subsequently dissolved in 5ul TE. One microliter was used to determine the 
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optical density at 260nm, and 0.5ug was run on a 1.2% surface tension gel at 
85V for 25 minutes. 
The digested, linearized vector was visible as a single band at 3.0Kb when 
compared against a 10kb DNA ladder (Fermentas #SM0311). The prepared 
vector was stored at -20°C and diluted to 0.1ug/ul immediately prior to the 
cloning step. The difference products were also diluted to 0.1ug/ul just prior to 
cloning, and if stored at -20°C for longer than two weeks, an additional 
restriction digest with Dpn II was performed to ensure the sticky ends were still 
available for vector insertion. 
Ligation parameters were adjusted and analyzed as suggested by the 
Stratagene protocol to verify the efficacy of the dephosphorylation step and to 
establish the optimal insert: vector ratio. It was determined that a 1:2 ratio 
resulted in the most efficient transformation; consequently, 0.5ul of cDNA insert 
(0.1ug/ul) was combined with 1.0ul (0.1ug/ul) prepared vector and ligated 
overnight at 4°C with 0.5ul T4 DNA Ligase (6U/ul) in a reaction volume of 10ul. 
The pBS vectors with the ligated cDNA inserts were then transformed 
into chemically competent XLI-blue MRF- cells (Stratagene #200230) exactly as 
instructed by the product manual. The advantage of using this particular host 
cell is that the F- episome allows for visual identification of the bacterial cells 
that contain the target insert. Cells that were successfully transformed will form 
white colonies, and those that were not transformed will be blue. Two 
microliters of the ligation reaction were added to 100ul of the thawed competent 
cells, gently stirred with the pipet tip, and incubated on ice for 30 minutes. The 
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samples were "heat-shocked" by placing them in a 42°C water bath for exactly 
45 seconds. This "transformation" was then diluted with 900ul of warm (42°C) 
SOC buffer249 and shaken at 230rpm for one hour at 37°C. 
An aliquot (40ul) of each transformation was diluted with 160ul warm 
SOC and plated on LB/agar bacterial growth plates containing 100ug/ml 
ampicillin (Teknova #A9510), 80ug/ml fresh 5-bromo-4-chloro-3-indoyl-B-D-
galactopyranoside (X-gal) (Promega, #V3941), and 30mM isopropyl- B-D-
thiogalactopyranasidase (IPTG) (Promega, #V3955). The dilution was allowed 
to seep into the agar for 15-20 minutes at room temperature at which time the 
plates were inverted and incubated for 18-19 hours at 37°C. To enhance the 
blue/white color selection, the plates then were cooled at 4°C for two hours. The 
remaining transformation was mixed with 333ul of 60% glycerol (Biochemika 
#49767) and stored at -80°C for subsequent plating if needed. 
One hundred ninety-two white colony-forming units (cfu) from each 
transformation were hand picked with sterile toothpicks into 1ml 96-well plates 
(VWR # 40002-011) containing 400ul yeast-tryptone bacterial growth media (2x 
YT249), and 0.4ul ampicillin (50mg/ml) per well. The plates were sealed with Air-
Pore tape (Rainin # 96-SP-STR) to allow respiration, and the clones were 
shaken at 180rpm for 18 hours at 37°C. The following morning, 133ul of 60% 
glycerol was added to each well, and the plates were sealed, vortexed, and 
stored at -80°C. 
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Sequencing of Cloned Difference Products 
Rolling Circle Amplification (RCA) was used to purify the pBlueScript SK+ 
vector from the XLI-blue MRF- host cells and to prepare the plasmids to be 
sequenced. The TempliPhi 500 Amplification Kit (GE Healthcare/Amersham 
Biosciences #25-6400-50) replaced the more traditional method of alkaline lysis 
to purify plasmids. In addition to requiring overnight growth of the bacterial 
hosts and many centrifugation steps, alkaline lysis does not produce a 
consistent concentration of purified plasmid across samples255. By normalizing 
the incubation time of the RCA reactions, sample concentrations are equivalent 
which is advantageous for obtaining reproducible sequence results by capillary 
electrophoresis255,256. 
RCA reactions were performed in 96-well PCR plates (Eppendorf 
# 951020303), and the protocol was modified to use half-reaction volumes, thus 
doubling the number of plasmids that can be purified using the RCA kit. Briefly, 
a 0.5ul aliquot from each well of the glycerol stock plates generated in step F 
was transferred to a clean PCR plate using a multi-channel pipet. This template 
was mixed with 2.5ul of sample buffer, covered with strip caps, and "pulse" 
spun for 20 seconds (0-3867rpm) in the Beckman Coulter Allegra 25R 
centrifuge to collect the reactions at the bottom of the plate. The samples were 
denatured at 95°C for 3 minutes to release the plasmids for subsequent 
amplification, and cooled to 4°C. A master mix of 250ul reaction buffer and 10ul 
TempliPhi enzyme mix was prepared, and 2.5ul of this was added to each 
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denatured sample. The plates were pulse spun to collect the total volume at the 
bottom of each well, and the entire plate was Incubated at 30°C for 16 hours. 
Following the overnight isothermal amplification of the plasmids, the plates 
were heated for 10 minutes at 65°C, cooled to 4°C, and pulse spun to collect 
the condensation. The samples were diluted with 10ul molecular biology grade 
water and stored at -20°C until restriction digest and sequencing were 
complete. Restriction analysis was performed on each prepared plasmid to 
determine whether the plasmid was indeed released from the bacterial host, 
and if the isolated plasmid contained the DP insert. Although blue/white 
selection increases the confidence that each clone contains an insert, it is 
important to verify this before investing time and money in the sequencing 
phase of analysis. A double restriction digest was performed using HindlW and 
Xbal. As described previously, the pBS vector contains multiple cloning sites, 
and the SamHI site was selected to clone the RDA fragments. There is a HindlW 
restriction site (TCTAGA) 24 bp upstream from the SamHI site, and an Xbal 
(AAGCTT) site just 8 bp downstream. Therefore, these two enzymes were 
selected to cut the insert out of the plasmid for electrophoretic assessment. A 
master mix was prepared containing 55ul HindlW (10U/ul), 55ul Xbal (10U/ul), 
11ul BSA (Promega), 110ul Multi Core Buffer (Promega), and 319 ul water. Five 
microliters of the restriction reaction was added to 5ul of diluted RCA product in 
a fresh 96-well PCR plate and incubated at 37°C for 2hours. The entire volume 
was mixed with 4ul gel loading buffer249 and a 7ul aliquot of this mixture was run 
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on a 1.2% agarose gel for 30 minutes at 85V. The gel was stained with ethidium 
bromide (0.01ug/ml) and visualized under UV light as previously described. 
For the sample to be accepted for sequencing, at least three regions of 
intensity should be visible on the gel. The chromosomal DNA from the bacterial 
host can be seen at the origin of the well, and the purified plasmid from the 
RCA reaction is observed as a distinct band at 3000bp. A third band represents 
the portion of the DP insert that was cut out of the plasmid during the restriction 
digest. For high-throughput purposes, if at least 88 of the 96 plasmids contained 
inserts, the entire plate was submitted for sequencing. Otherwise, additional 
clones were prepared as described in order to submit a full 96-well plate. 
The final round of difference products (DP3) from the first two reciprocal 
RDA experiments were cloned into the XL1-Blue MRF- Vector and grown under 
the selection of ampicillin, X-gal, and IPTG as described. The third RDA 
experiment was performed in the same manner as the first two. However, the 
ratio between blue and white colonies was vastly different. In the first two 
experiments, the number of blue and white cfu was fairly evenly distributed. In 
the third experiment, there were 17,750 white cfu and only 3500 blue cfu for the 
WC. This trend was repeated with the SR, in that 22,250 white cfu grew and 
only 6750 blue. Rather than indicating an extremely efficient transformation, 
restriction digest following RCA revealed that many of the white colonies picked 
did NOT contain an insert. It is possible that during the cloning step, the F-
episome can fall off. If that happens, the colony will remain white, even though 
there is no cDNA insert in the vector. Because so many of the white colonies 
81 
picked did not contain an insert, this appears to have happened in the third 
experiment. To reduce the number of these false positives, the Stratagene 
manual suggests a double antibiotic selection. Tetracycline selects specifically 
for the F- episome, so growing the colonies on media supplemented with both 
ampicillin and tetracycline, further selects for vectors containing inserts. Once 
double selection was implemented, misleading white colonies were no longer a 
problem. 
The Hubbard Center for Genome Studies (HCGS) at the University of New 
Hampshire performed the sequencing of differentially expressed RDA 
transcripts on a service basis using the CEQ 8000 Genetic Analysis Capillary 
System (Beckman). The M13 Reverse primer (5' GGAAACAGCTATGACCATG 
3') was selected to amplify the target inserts from the pBS vector. The results 
were provided in a digital file that included the individual sequences and quality 
scores in "fasta" format, along with the associated chromatograms. 
Sequence Analysis and Characterization of RDA Difference Products 
It is challenging to identify differentially expressed genes from an 
uncharacterized genome and to establish biological relevance of the significant 
players. When confronted with 384 raw sequences per RDA experiment, it is 
important to stay focused on the research objectives. Each individual base pair 
position is scored, and any nucleotide can be manually eliminated or substituted 
in order to produce a more refined query for subsequent identification steps. 
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This process can be subjective if strict criteria are not established, and it is easy 
to get distracted with sequence analysis for its own sake. Therefore, sequence 
trimming and curation was kept to a minimum, and the few steps that were 
taken are described in the following paragraphs. 
Raw Sequence 
The length of each sequence was recorded as the number of nucleotide 
bases. If no nucleotides were sequenced from a given clone (# bp = 0), the raw 
sequence was REJECTED. All remaining sequences were analyzed for vector 
contamination in step B. 
Vector Trimming 
The raw sequences were screened for vector contamination using the 
"VecTrim" program available through the National Center for Bioinformatics 
(NCBI). This is necessary because the target sequence amplified with the 
M13R primer will include the flanking vector sequences. Once the vector 
nucleotides were identified, the first and last base pair position of the target 
transcript was recorded, and the adjusted sequence size calculated. For 
example, if the raw sequence was 748 bp in length, and the "VecTrim" program 
identified two regions of vector nucleotides (nt 3-75; nt 273-677), the target 
transcript is represented from nt 76-272, and the adjusted length would be 
197bp. This truncated sequence is the "query" for step C. If the entire sequence 
was identified as vector (no insert), the sequence was REJECTED. 
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BLASTn 
The vector-trimmed sequences were queried against the NCBI non-
redundant nucleotide database (BLASTn) in order to identify them by inferred 
sequence homology to other species257. Subject matches were accepted as 
statistically significant if the Expect Value (E) was < e-10. Orthologous 
sequences that met this criterion were considered to be "Transcript Tag 
Orthologs" and were further annotated in step G. Queries that resulted in no 
subject match, or a subject match with an E of >e-10 were analyzed for 
sequence quality in step D. In practice, the sequence quality was evaluated 
while waiting for the BLASTn output screen. It may seem like the sequences 
should be evaluated for quality earlier in the analytical process, but in fact, the 
vector nucleotides tended to have higher quality scores than the target 
transcript. Analyzing the trimmed sequences prevented the acceptance of a 
sequence based on the vector region rather than the target. 
Sequence Quality 
The CEQ 8000 Genetic Analysis system provides a modified version of 
standard Phred quality scores in fasta format, called Call Scores (Beckman 
Coulter, A-1940A). Each base pair "call" in a sequence is given a confidence 
rating on a scale of 0-100. Call Scores above 90 are generally reserved for 
nucleotides that have been inserted, substituted, or otherwise manually edited 
(CEQ manual). The fasta files containing the quality Call Scores were easily 
viewed using the Microsoft Notepad program, but in order to view the Standard 
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Chromatogram Format (SCF) file associated with each sequence, a special 
viewer (Finch TV) was downloaded from Geospiza. Finch TV (Version 1.4.0 
©2004-2006) was developed with an NIH SBIR grant (R44HG02244-02) and is 
distributed freely from the company's website, 
http://www.geospiza.com/finchtv/. 
Evaluation of quality grids along with the chromatograms of validated 
sequences indicated that if "most" of the call scores were above 40, the 
corresponding peaks were clearly distinguished from each other. When the Call 
Score dipped below 40, the peaks began to have "shoulders" and the number of 
overlapping peaks slowly increased. These observations were too subjective to 
quantify. Therefore, in order to establish a consistently routine procedure, the 
following criteria were developed to accept or reject the quality of the query 
region of the sequence. If there were no Call Scores above 31, the entire 
sequence was REJECTED. If there were some (more than one) Call Scores 
above 37, the sequence was ACCEPTED. 
Although crude, these cut-off values served as usable guidelines for 
accepting or rejecting a sequence for subsequent analysis. Query sequences 
that were of acceptable quality but had no hit in the BLASTn database search 
were further characterized in step E. Although the decision was made to not 
work with any sequences of borderline quality for this project, the rejected 
sequences were saved for future manipulations. 
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TBLASTx 
There is a chance that transcript tags not identified using BLASTn can be 
identified using the tBLASTx search tool, also available through the NCBI 
website258. Because of the degeneracy of the genetic code, the amino acid 
sequence of a protein may be conserved even though the nucleotide sequence 
may have diverged to the point that it is no longer homologous to the ancestral 
sequence. BLASTn aligns nucleotides of the query with nucleotides of subjects 
in the database, but tBLASTx translates all six reading frames of the nucleotide 
sequences of both the query and the database entries to their amino acid 
sequence in order to identify potential orthologs. 
The E values of the tBLASTx output were more difficult to interpret than 
those of BLASTn because the queried sequences are one-third the size. The E 
decreases with sequence length, and if the same criteria used to accept 
BLASTn hits were used to accept tBLASTx hits, it would be possible to reject a 
potential match that may be biologically relevant. Therefore, the tBLASTx 
alignment results were scored from 0-3 based on the following criteria. One 
point was assigned for an E value of < e-10. One point was assigned if the 
percent identity was over 50%, and the alignment was at least 12 amino acids 
in length. One point was assigned if there was a six amino acid region that 
aligned with no gaps or substitutions. Alignments receiving a score of 2-3 were 
categorized as "Transcript Tag Orthologs" whereas queries that resulted with no 
match, or received an alignment score of 0-1 were labeled "Unidentified 
Transcript Tags", and further characterized in step F. Unidentified transcripts 
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represented query sequences of acceptable quality that were not identified in 
the NCBI database with either the BLASTn or the tBLASTx search tool. 
Unidentified Difference Products 
The unidentified transcripts from each RDA experiment were merged into 
one large fasta file for two types of batch analysis. The sequences were first 
uploaded to the HCGS BLAST Server and queried against the most recent 
version of the chicken genome {May, 2006 Version 2.2). Although no significant 
matches were expected because of the lack of introns in cDNA compared to 
genomic DNA, this step was done to determine if any of the pigeon transcripts 
did match to a specific chicken chromosome. The unidentified transcripts were 
then compared to one another for sequence homology using the Sequencher 
Software (Demo Version 4.7 Build 2946, ©1991-2006 Gene Codes 
Corporation). Assembly parameters were set for a minimum of 85% identity and 
a minimum overlap of 20 bases. Sequencher performed 8,382 comparisons and 
clustered the sequences into contigs and singletons. After categorizing the 
unidentified transcripts by this method, they were named and counted for 
statistical analysis as described (p93). Because the unidentified transcripts 
were in fact, differentially expressed, it was important to characterize them as 
completely as possible. Therefore, each sequence was translated into its six 
potential reading frames using the Expert Protein Analysis System (ExPASy) 
available at http.7Awww.expasy.org and maintained by the Swiss Institute of 
Bioinformatics259. The frame with the longest amino acid sequence that did not 
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include a stop codon (TAG, TAA, TGG) was selected as the most likely open 
reading frame for that nucleotide sequence. 
In a final attempt to characterize all transcripts as completely as possible, 
the contigs, singletons, and expressed sequence tags (ESTs) were BLASTed 
against the Tentative Consensus (TC) sequences in the Chicken Gene Index 
Database, currently maintained by the Dana Faber Cancer Institute 
(DFC1)260,261. The TC identification number was recorded for any sequence 
alignment that met the criterion of an E value of < e-10. Transcripts that did not 
have a TC number remained "unidentified". Transcripts with a TC number were 
analyzed for sequence homology to known genes. The tentative annotation 
assigned to each TC is scored as follows: 90-100% identity is considered a 
"homologue to", 70-90% identity is "similar to", and anything below 70% is 
"weakly similar to"260. For the purposes of this project, sequence similarity > 
80% was considered annotated. Fifteen transcripts that were "unidentified" in 
GenBank were identified using the DFCI Chicken Gene Indices and included in 
the overall analysis. 
Annotation of Difference Products 
Transcript orthologs identified using BLASTn, tBLASTx, and the Gene 
Indices were further analyzed in order to place the transcript tags into gene 
families or metabolic pathways that contribute to the susceptibility and/or 
resistance to atherosclerosis in the pigeon. A gene family is a loose, non-
binding classification that relates genes that share important characteristics to 
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each other. For example, genes can be grouped into families according to 
structure, size, function, expression patterns, location, etc. and can therefore be 
placed in multiple categories. For the purposes of this project, it was determined 
that that most informative way to organize the genetic transcripts would be by 
cellular function. Two distinct databases were used to annotate those 
transcripts with known protein products. Sequences that were not translated to 
a specific protein, such as those matching ESTs and other clones from the 
Chicken Genome Project were not annotated using either software package 
because there was not enough descriptive information available. 
The first software system used to annotate the RDA difference products 
was the Kyoto Encyclopedia of Genes & Genomes (KEGG) Database. This 
compilation of regulatory and metabolic pathways was first established in 1995 
as part of the Japanese Human Genome Program, and has been continually 
updated as new genomes are sequenced and experimental functional data 
becomes available worldwide262. Version 41.1, released February 1, 2007 was 
freely accessed at http://www.qenome.ip/keqg. Each molecular entry in KEGG 
has been assigned a unique identifier called the "KO" number and placed within 
a functional hierarchy based on gene orthology. 
The first level of the KEGG hierarchy provides the most basic description 
of biological function. KEGG Level One segregates entries into five major 
groups: Metabolism (01100), Genetic Information Processing (01200), 
Environmental Information Processing (01300), Cellular Processes (01400), 
and Human Diseases (01500). If a single molecule participates in more than 
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one pathway or functional group, each unique association was mapped so as 
not to limit the biological interpretation of its role. Enolase is an example of a 
protein that that fits into more than one KEGG Level One category. As an 
enzyme, enolase is part of the glycolytic pathway of carbohydrate metabolism. 
Enolase is also capable of translocation to the nucleus and acting as a 
transcription factor263. Using the KEGG system, enolase would be assigned 
both to the Metabolism Group (01100) and the Genetic Information Processing 
Group (01200) for Level One annotation. 
The five KEGG categories of Level One are further delineated in KEGG 
Level Two, where general pathways specific to each functional group are 
assigned another unique identifier. For example, Genetic Information 
Processing (01200) is divided into four sub-categories: Transcription (01210), 
Translation (01220), Replication & Repair (01240), and Folding, Sorting, & 
Degradation (01230). Metabolism (01100) is divided into carbohydrate 
metabolism (01110), energy metabolism (01120), lipid metabolism (01130), etc. 
Again, if a single molecule participates in more than one pathway, its unique KO 
number will cross reference to each appropriate match. 
KEGG Level Three divides the general pathways of Level Two into even 
more specific functions within that pathway. In the enolase example, 
carbohydrate metabolism (01110) is the Level Two designation, whereas 
glycolysis (00010) represents only one specific aspect of carbohydrate 
metabolism. Therefore, glycolysis is assigned a unique KO number at Level 
Three to distinguish it from other aspects of carbohydrate metabolism such as 
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the pentose phosphate shunt (00030). Up regulated transcripts from each 
pigeon breed were categorized by all three levels of the KEGG orthology 
system. Obviously, if an identified transcript was not represented by a KO, it 
was not included in the KEGG Results. 
In an attempt to look at the functional relationship between the 
differential transcripts from as many angles as possible, a second software 
package was used to annotate the RDA products. Pathway Studio is a 
commercially available package that contains "more than 100,000 events of 
regulation, interaction and modification between proteins, cell processes, and 
small molecules"264 and has an automated connection to PubMed. The 30-day 
trial version of Pathway Studio (Version 4.0; Ariadne Genomics, Inc. ©2002-
2006) was used to complement and extend the functional information obtained 
from KEGG. In addition to biological process and protein "groups", Pathway 
Studio also provides specifics on the cellular compartment where the functional 
protein is known to be active. Upregulated transcripts that were represented in 
the database were characterized by all three systems and reported in 
conjunction with the KEGG results in order to present the most complete profile 
of differential gene expression between the White Carneau and Show Racer 
Pigeon that can be determined at this time. 
Assignment of Pigeon Transcripts to the Chicken Physical Map 
The average avian genome is 1.43 Gbp, ranging from 0.97 Gbp in the 
common pheasant to 2.16 Gbp in the ostrich265. The typical avian karyotype 
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includes several pairs of macro-chromosomes, and numerous micro-
chromosomes266. The chicken has a haploid size of 39, whereas the pigeon 
haploid number is 38. Although the recombination rate of birds is three times 
that of mammals,267 most of these occurrences are on the same chromosome, 
rather than alleles crossing over to a different chromosome266. The chicken 
genome displays fewer evolutionary rearrangements than the mouse, and it is 
expected that genome organization and synteny are highly conserved between 
avian species181,268. 
In 2004, Derjusheva et al compared four species of birds using 
chromosome painting266 Chromosomes #1-10, Z, and 9 micro-chromosomes 
from Galliforme (chicken) were compared with the counterparts in 
Columbiforme (pigeon) and two Passerines (redwing and chaffinch). No more 
than two inter-chromosome rearrangements were observed in each species, 
and the authors concluded that all four species "have retained the chromosomal 
integrity of ancestral synteny". More recently, 8 macrosomes and 14 
microsomes of the chicken and the quail (coturnix japonica) were compared 
using fluorescent in-situ hybridization (FISH). All of the chicken clones selected 
hybridized to the appropriate quail chromosome, as 49 macrosome hybrids and 
20 microsome hybrids were observed269. 
Although the microsomes were difficult to distinguish from one another, 
the authors of the FISH study noted a high degree of stability between avian 
karyotypes, further supporting the conclusions reached in the chromosome 
painting study, that intra-chromosomal arrangements are very rare across 
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various species of birds. Because of the conserved synteny of the avian 
genome, transcripts identified in the pigeon were compared to their chicken 
counterparts and assigned to the corresponding chromosome. Not all of the 
chicken chromosomes have been mapped, but as of April 2007, 15,368 genes 
had been placed on chromosomes 1-28, W, Z, and within the mitochondria270. 
Statistical Analysis of Differential Expression 
The Chi Square Statistical Test for Similarity was used to demonstrate 
that the transcripts isolated using RDA were not simply a collection of random 
artifacts, but were in fact, differentially expressed. Chi Square is an appropriate 
test to analyze the distribution of categorical data, and has been shown to have 
the "best power and robustness" to detect significant changes in ESTs271 such 
as those generated by SAGE272 experiments. Therefore, once a dataset of 
differentially expressed (identified and unidentified) "Transcript Tags" was 
generated for each experiment, the results were analyzed in a pairwise 
contingency table to determine the significance of distribution within each 
individual experiment, and within the combined totals of all four experiments. 
The calculations were performed using the number of times a specific 
transcript was expressed (Express) compared to the number of times it was not 
(No Express). The hypothesis (null) was that the expression level of each 
transcript would be identical between breeds. Ideally the total number of 
occurrences (SUM = express + no express) would be the total number of 
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clones. However, sequences that were REJECTED during previous analytical 
steps were not included in the total. Therefore, the SUM is different for each 
experiment. Acceptable statistical significance of differential expression was set 
at p<0.05. All p-values were recorded in a Microsoft Excel Worksheet and 
sorted according to pigeon breed. 
Chi Square Analysis was also used to determine the significance of the 
distribution of genes and copy number variation across the individual 
chromosomes of the chicken genome. No statistics were performed at the 
pathway level, because there were multiple cases where the expression of a 
given pathway was not different between two breeds, but the specific genes 
expressed therein were different. 
Determination of False Positives 
Differentially expressed transcripts were considered to be false positives 
if the transcripts were expressed in both breeds at low copy number and/or 
were found to be up regulated in each breed in different experiments. A 
transcript was not a candidate gene for susceptibility/resistance to 
atherosclerosis if its expression was not consistent across the replicate 
experiments. False positives were not included in any of the analyses, because 




The raw sequence data from the four reciprocal RDA experiments are 
presented in Table 4 (p.96) along with the identification rate of the quality-
accepted, vector-trimmed sequences derived from BLAST analysis of difference 
products. 
A total of 1344 clones representing 672 difference products from each 
breed were sequenced and analyzed. Of the 880 transcripts that were 
identified, 165 represented unique (non-redundant) tags. Seventy-four of these 
unique transcripts were up regulated in the WC, and 63 were up regulated in 
the SR. Twenty-eight transcripts were found to be present in both breeds in 
varying copy number, and 18 of these were determined to be false positives. 
The compiled list of difference products isolated in the four reciprocal 
RDA experiments and the corresponding genes are presented in Table 5a 
(WC), Table 5b (SR) and Table 5c (WC & SR). Copy number and the statistical 
significance of each transcript as determined by Chi Square Analysis are also 
included in Tables 5a-5c (p.97-105), along with the identification of the RDA 
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Table 5a: Differentially Expressed Genes Exclusive to White Carneau 
Upregulated Transcript Ortholog Gene Replication Information 





Chi Square is Significant (p<0.05) 
Cleavage & Polyadenylation Specific Factor 
Enolase (alpha) 




Ribosomal Protein L27 (mitochondrial) 
Proteosome 26S ATPase Subunit 2 
Contig 1 
DiacylglycerolO-acetyltransferase 
Dachshund Homolog 1 
Ligatin 
Annexin 2 
Ribosomal Protein L32 
Transketolase 
Pro-alpha 2 Collagen Type 1 
BACCH261-138K4 


























































































Chi Square is Not Significant (p>0.05) 
Contig 5 
Lactate Dehydrogenase A 
Macrophage Erythroblast Attacher 




Eukaryotic Translation Initiation Factor 4E2 
Glucose Phosphate Isomerase 
HRAS Like Suppressor 
MGC75678 
Nardilysin 
Nuclear Hormone Receptor Activity 








































































Table 5a: (continued): 
Upregulated Transcript Ortholog Gene Replication Information 





Chi Square is Not Significant (p>0.05) 
Pectinesterase Inhibitor 
Phosphogluconate Dehydrogenase 
Reprolysin type disintegrin & metalloprotease 
Ribosomal Protein L7 
Ribosomal Protein L7a 
Ribosomal Protein S3 
RNA Binding Motif S1 
Small Nuctear RNA LSm3 
Transmembrane Protein 167 
Acetyl-coAAcetyltransferase/Thiolase 
Acyl-coA Synthetase 
Cadherin Related Neuronal Receptor 
Cartilage Associated Protein 
Chaperonin Protein theta 
Chaperonin Protein zeta 
Chromosome 10 Orf 58 
Clone 38f 16 
Clone BU37787 
Clone BU447803 
Collagen, alpha 2 Type 5 
Cyclin D2 
Cytokine like nuclear factor n-pac 
Dipeptidase M20 Family 
Eukaryotic Translation Elongation Factor 1A1 
Exocyst Complex Component 7 
Ezrin/Villin 
Fibronectin Type 3 
GABA A Receptor 
Heme-Oxygenase 1 
Hypothetical Protein 
Inhibitor of Kappa Light Polypeptide Enhancer in B cells 
KIAA1432 
Mannosidase, alpha Class 2B Member 2 
Marvel Domain Containing 2 
Myosin regulator light chain L20-B 
Periostin 
Plastin 3 
Ribosomal Protein L26 
Ribosomal Protein L53 (mitochondrial) 
Sec13L 
Secreted Modular Calcium Binding 
Small Inducible Cytokine E1 
Spleen Focus Forming Virus Sp1 Oncogene Activation 
Vimentin 
White Carneau Unidentified Singlet # 1 
White Carneau Unidentified Singlet # 2 
White Carneau Unidentified Singlet # 3 
White Carneau Unidentified Singlet # 4 
White Carneau Unidentified Singlet* 5 
White Carneau Unidentified Singlet # 6 
White Carneau Unidentified Singlet # 7 





































































































































































































































































Table 5b: Differentially Expressed Genes Exclusive to Show Racer 
Upreguiated Transcript Ortholog Gene Replication Information 





Chi Square is Significant (p<0.05) 
Cytochrome B 
Fibronectin Type 1 
Fibulin 5 
Contig 2 
Smooth Muscle Cell Myosin Heavy Chain 
Tropomyosin, alpha 
Alpha 2 Actin 
Myosin Light Chain Kinase/Telokin 
Proteosome 26S non-ATPase Subunit 
Coactosin 





























































GTP Binding Protein 
Mariner 1 Transposase Gene 
Proteosome 26S ATPase Subunit 4 




Histone Promoter Control Protein 1 
Sarcolipin 
Contig 3 
Actin Related Protein 10 
Actin Related Protein 3 















FK506 Binding Protein 9 
H+/K+ ATPase Subunit B 
Heat Shock Protein 40 
High Mobility Group 14 
High Mobility Group 2a 


























































































































































































Table 5b (continued): 
lUpregulated Transcript Ortholog Gene Replication Information 





Chi Square is Not Significant (p>0.05) 
Microsatellite 2G 




Ribonuclease/Angiogenin Inhibitor 1 
ribosomal DNA repeat 
RIKEN3110009E18 
RIKEN 6030443007 
Show Racer Unidentified Singlet # 1 
Show Racer Unidentified Singlet # 2 
Show Racer Unidentified Singlet # 3 
Show Racer Unidentified Singlet # 4 
Show Racer Unidentified Singlet # 5 
Show Racer Unidentified Singlet # 6 
Show Racer Unidentified Singlet # 7 
Show Racer Unidentified Singlet # 8 
Show Racer Unidentified Singlet # 9 
Show Racer Unidentified Singlet # 10 
Show Racer Unidentified Singlet #11 
Show Racer Unidentified Singlet #12 
Show Racer Unidentified Singlet #13 
Show Racer Unidentified Singlet # 14 
Show Racer Unidentified Singlet # 15 
Show Racer Unidentified Singlet #16 
Show Racer Unidentified Singlet* 17 
Show Racer Unidentified Singlet* 18 
Show Racer Unidentified Singlet # 19 
Show Racer Unidentified Singlet # 20 
Show Racer Unidentified Singlet # 21 
Show Racer Unidentified Singlet # 22 
SP1 Transcription Activator cofactor 
Spermidine/Spermine N1-acetyltransferase 
Squalene epoxidase 
Steroid Alpha Reductase 
Ubinuclein 
Ubiquinone/NADH Dehydrogenase 
Zinc Finger Protein 100 






































































































































































































































































Table 5c: Differentially Expressed Genes Found in WC and SR 
Upregulated Transcript Ortholog Gene Replication Information 
# Reps (4) Rep # ID 





Chi Square is Significant (p<0.05) 
Clone WAG-65N20 
Lumican/Keratan Sulfate PG 
Ribosomal Protein L3 
Chemokine Ligand 12 
NADHSubunit4 
Beta Actin 











































Chi Square is Not Significant (p>0.05) 
Cytochrome Oxidase II 
Eukaryotic Translation Initiation Factor 4A2 
Aldehyde Dehydrogenase Isoform E3 
Open Reading Frame 45 Chromosome 20 
SEC 61 Alpha Subunit 
Peroxiredoxin I 
Proteasome Maturation Protein 
Ribosomal Protein S8 
Solute Carrier 25 A5/A6 
Eukaryotic Translation Initiation Factor 4G2 
Matrix GLA Protein 
Ribosomal Protein S3A 
Lactate Dehydrogenase B 
NADH Subunit 1 
ATPase 6/8 subunits 
Fatty Acid Binding Protein 4 
Prohibitin 2 
Chaperonin Protein CCT5 
Eukaryotic Translation Initiation Factor 3S 
Nuclear Phosphoprotein 32 































































































































The most consistently differentially expressed transcript codes for 
cytochrome b (CYTB), which was exclusively up regulated in the SR in all four 
experimental repetitions (Table 5b). Cytochrome oxidase II (CON) was also 
found in all four experiments (Table 5c). However, it was expressed in both 
breeds, although in each case, relative copy number was greater in the SR. 
Chemokine Ligand 12 (CXCL12) and beta actin (ACTB) were up regulated in 
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the WC in three comparisons (Table 5c). In contrast, alpha actin (ACTA2) was 
up regulated in the SR in two of the comparisons (Table 5b). The fact that 
ACTB and CXCL12 were each found once in the SR illustrates the capacity of 
RDA to identify relative differences in copy numbers of the same transcript. A 
number of transcripts were found only in one copy, in one experiment, resulting 
in a non-significant contribution to the overall genetic difference between 
breeds. However, knowing that RDA can isolate rarely expressed transcripts, all 
difference products were analyzed in terms of their metabolic pathway and 
biological process. Of the 165 unique tags, 124 were entered into the KEGG 
metabolic hierarchy, and 84 were successfully placed within this system. The 
distribution of general biological functions across KEGG Level One is presented 
in Table 6. 
Table 6: General Biological Functions (KEGG Level 1) 
General Biological Functions 
KEGG Level 1 Category 
Metabolism 
Genetic Information Processing 







































































At this level of analysis, there are no obvious differences between WC 
and SR aortic SMC. The number of unique genes is not significantly different 
from each other, but there is no information regarding which genes are actively 
participating in the different levels of Biological Functions. In order to observe 
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the actual genetic differences at the cellular level, it is necessary to look at the 
specific types of metabolism in Level 2 of the KEGG system (Table 7). 
Table 7: Types of Metabolism (KEGG Level 2) 
Types of Metabolism (KEGG Level 2) 
Amino add metabolism 
Biosynthesis of Secondary Metabolites 
Carbohydrate Metabolism 
Cell adhesion molecules 
Cell Communication 
Cell Growth and death 
Cell Motility 




Folding, Sorting & Degradation 


















































































































































































































































Subtle differences between the two breeds begin to appear at KEGG 
Level 2. Glycan metabolism and peptidase activity appear to be increased in 
the WC, in addition to genes involved in translation. In contrast, only 2 genes in 
the SR contribute to translation, but the overall copy number is much higher (76 
in SR vs. 37 in WC). In the SR, energy metabolism is clearly up regulated, with 
these transcripts representing 13.4% of all tags placed versus 0.3% in the WC. 
In the WC, carbohydrate metabolism is up regulated, as 13.8% of the WC 
transcripts participated in this pathway in contrast to only 0.7% of SR tags. 
103 
There appears to be no difference in the number of genes involved in the 
immune system, cell communication, or signaling molecules and interaction 
between the two breeds. However, further analysis into the specific pathways of 
each of the types of metabolism reveal differences that are not apparent in the 
first two levels of the KEGG hierarchal system. Table 8 (p105-108) displays the 
individual genes that participate in each of the delineated pathways as 
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From Table 8, it becomes clear that although each breed expresses the 
same number of genes in Cell Communication and the Immune System, very 
different messages are being transcribed. For example, Adherens Junction and 
Tight Junction in the WC are represented by ACTB, a marker of the synthetic 
phenotype. The Focal Adhesion pathway in the SR is represented by ACTA2 and 
myosin light chain kinase (MYLK), both of which are commonly associated with 
the contractile phenotype. In contrast, Focal Adhesion in the WC was comprised 
of collagen (COL1A2, COL5A2), cyclin D2 (CCND2), and ACTB. Phenotypic 
modifications between breeds are also apparent in the Cell Motility and Signaling 
Molecules and Interaction categories. Ezrin (VIL2), ACTB, and spondin (SPON) 
are markers of a synthetic state in the WC cells, whereas actin related proteins 3 
& 10 (ACTR3, ACTR10), ACTA2, MYLK, and fibronectin type 1 (FN1) are 
evidence of a more contractile phenotype in the SR aortic cells. Proteoglycan 
synthesis is increased in the SR as evidenced by lumican (LUM), but 
glycosylation itself is up regulated in the WC - indicated by ribophorin 1 (RPN1). 
CXCL12 participates in both Signaling Molecules and Interaction and the 
Immune System. As an immune factor, CXCL12 is responsible for leukocyte 
transendothelial migration and it functions as a signal in Cytokine-Cytokine-
Receptor Interactions, both of which are up regulated in the WC. 
Ribosome biogenesis and protein translation is clearly up regulated in the 
SR, but closer inspection of the ribosomal proteins (RP) reveals that all of the 
expression in the SR is represented by RPL3, whereas in the WC, 8 unique 
ribosomal proteins are expressed, representing transcripts from both the large (L) 
109 
and small (S) subunits. Individual subunits of the 26S proteasome are also 
differentially expressed between the two breeds, with PSMC2 and PSMC3 
proteasome ATPase subunits present in the WC, whereas PSMC1 and PSMD1 
subunits were exclusive to the SR. 
Differences in energy metabolism observed earlier in the hierarchy are 
also seen in KEGG Level 3. Oxidative phosphorylation is up regulated in the SR, 
represented by CYTB, cytochrome oxidase I (COI), NADH subunit 4 (ND4), 
NADH dehydrogenase (NDUFA10), and H+/K+ ATPase subunit b (ATP4B). 
Glycolysis is up regulated in the WC, represented by enolase (EN01), glucose-
phosphate isomerase (GPI), and lactate dehydrogenase subunit A (LDHA). 
Carbohydrate metabolism is also over represented in the WC by the pentose 
phosphate shunt. Coupled with the increase in fatty acid biosynthesis and 
glycerol lipid metabolism observed in the WC, it appears that synthesis reactions 
are favored in the susceptible breed, whereas oxidation is favored by the 
resistant SR cells. 
In contrast to KEGG, which categorizes annotated genes in a hierarchal 
reference to each other, Pathway Studio employs three distinct lenses to group 
protein products: Functional Cell Compartment, Types of Metabolism, and 
Biological Process. One hundred twelve transcripts were placed in at least one of 
the three Pathway Studio annotation categories. In the Functional Cell 
Compartments category, the cell is divided into 13 distinct regions. The 
distribution of WC and SR transcripts across the cellular landscape is presented 
110 
in Table 9. The specific genes composing each functional cell compartment are 
listed individually in Table 10 (p112-114). 
Table 9: Functional Cell Compartment of WC and SR Differentially Expressed 
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Although the number of genes actively expressed in the mitochondria does not 
appear different between WC and SR (n= 4, n= 5 respectively), transcript number 
and individual gene identity reveal significant differences in oxidative 
phosphorylation. This metabolic difference was also revealed in the KEGG 
system, but due to the different placement schemes the percentages are slightly 
different. 
There were 12 different genetic products expressed in the extracellular 
compartment in the WC, and only 4 in the SR. However, copy number variation 
analysis between the two breeds indicates the polygenic contribution from the 
WC accounts for only 9.4% of overall expression, whereas one-third of the 
number of genes in the SR account for 25.6% of total expression. The opposite 
scenario is true in the nucleus, where 4.9% of the genes expressed in the WC 
constitute 11.7% of the overall expression. In contrast, 14.5% of the genes 
actively expressed in the SR compose only 3.9% of the total message. 
The types of differential metabolism generated by Pathway Studio (Table 
11, p116) are comparable to those generated by KEGG. Protease activity is up 
regulated in the WC, which corresponds to the increase in peptidases observed 
in KEGG. One major difference between the two annotation systems is that 
Pathway Studio categorizes the electron transport chain as a general 
"transporter" where KEGG specified oxidative phosphorylation as a distinct type 
of metabolism. Glycolysis, amino acid metabolism, and the enzymes of lipid 
biosynthesis are all encompassed by the umbrella "Metabolic Enzymes" in 
Pathway Studio. 
115 
Table 11: Types of Metabolism (Pathway Studio) 
Type of Metabolism 




































































































































































The individual genes composing each category are listed in Table 12 
(p117-118). From Table 12 it becomes obvious that the differences observed in 
the nucleus (Table 10) correlate with the specific transcription factors that differ 
between the two breeds. For example, dachshund homologue 1c (DACH1), 
EN01, inhibitor of kappa light polypeptide enhancer in B cells (IKBKAP), and 
spleen focus forming virus (SFFV) are regulating transcriptional events in the 
WC, whereas high mobility groups (HMG14, HMG2a) and zinc finger proteins 
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1 2 3 
Consistent with the gene expression profile reported for the extracellular 
component of each breed (Table 10, p112-114), the extracellular matrix 
metabolism is also quite different (Table 12, p117-118). Although 7 genes 
constituting a synthetic phenotype are up regulated in the WC, this represents 
only 5.1% of the total expression. In contrast, only 2 genes are expressed in the 
SR ECM, but their activity constitutes 21.6% of the overall metabolism, indicating 
a major difference between the two breeds. 
Perhaps the most informative of the Pathway Studio analyses is the 
breakdown of the actual biological processes in the cell. Table 13 (p. 120-123) 
presents the distribution of involved genes and copy number variation as a 
percentage of the total cellular process. The contribution of specific genes to 
each category is listed in Table 14 (p. 124-127). Cell adhesion appears to be up 
regulated in the WC, with the expression of COL1A2, COL5A2, SPON and 
periostin (POSTN) reflective of a synthetic phenotype. In contrast, Cytoskeletel 
Organization is up regulated in the SR, where MYLK, SMC myosin heavy chain 
(MYH11), and ACTA2 comprise a contractile phenotype. Corresponding to the 
greater ATP needs of a contractile cell, oxidative phosphorylation is also up 
regulated in the SR. In the WC, glycolysis was again up regulated, revealing a 
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There were more ribosomal proteins located within the KEGG database 
(n=9) than were found in Pathway Studio (n=7). However, those that were 
identified in each annotation system were placed in the same manner. Genes 
involved in the biological process of Protein Biosynthesis were identical to those 
representing Ribosome Biosynthesis (Table 14, p122). In the KEGG hierarchy 
the same list of genes representing general levels of Translation were the same 
as those representing the specific pathway of Ribosomes (Table 8, p105). 
Pigeon Transcripts that had an orthologous gene in the chicken were 
mapped against the chicken genome. Not all of the chicken chromosomes have 
been resolved, but as of April 2007, 15,368 genes had been placed on 
chromosomes 1-28, W, Z, and those within the mitochondria268. Figure 3 (p129) 
and Figure 4 (p130) compare the total number of genes that have been placed 
on each chicken chromosome to the corresponding genes differentially 
expressed by each pigeon breed. 
Although incomplete, the chicken genome provides a null expectation for 
pigeon gene expression. If the expression differences between breeds were truly 
random, it would be expected that the number of genes expressed per 
chromosome would be proportional to chromosome size. Table 15 (p131) 
presents the Chi Square analysis of the WC compared to the chicken, the SR 
compared to the chicken, and the WC compared to the SR. A p-value < 0.05 
indicates that the number of genes expressed on a given chromosome is 
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In general, the number of genes expressed was, in fact, proportional to the 
expected number of genes per chromosome. However, it is clear from Figure 3 
(p129) that significant differences exist at Chromosome #7 (Gg7) between the 
chicken and the SR pigeon (p =0.0008), and Chromosome 12 (Gg12) between 
131 
the chicken and the WC (0.0000). Figure 4 (p130) shows that although he 
increased copy number observed on Gg7 in the SR is also significant (p=0.0314) 
when compared directly to the WC, this is not the case with Gg12. Although 
increased expression of genes located on Gg12 in the WC is still observed when 
compared to the SR, the trend is not significant (p=0.0757). 
In addition to looking at the relationship between the number of pigeon 
genes expressed per chromosome, the copy number variation between 
chromosomes was also analyzed. The chicken was not used as a null 
expectation, because the expression levels in the chicken were not measured. 
Therefore, the WC and SR were compared only to each other. Figure 5 (p133) 
presents the differential expression of transcripts observed between the WC 
(n=346) and SR (n= 350) cultured aortic cells, and the statistics are reported in 











































































































































































































































































































































Highly significant (p=0.0000) differences in transcript numbers per chromosome 
between breeds are observed at Gg7, Gg12, Gg18, Gg21, and the mitochondria. 
The mitochondrial difference was not evident in the previous chromosome 
analyses because the number of genes differentially expressed was not 
134 
statistically significant. In contrast, Figure 5 (p133) clearly demonstrates the up 
regulation of mitochondrial activity in the SR, which is consistent with the 
annotation results demonstrating elevated expression of oxidative 
phosphorylation relative to the WC. Other chromosomes (Gg1, Gg3, Gg6, Gg26, 
and GgZ) also demonstrate significant differences in gene expression patterns, 
and will be considered in the final analysis. 
As stated previously, transcripts that were successfully identified in the 
NCBI or DFGI Databases, but were not associated with a known protein product 
were not annotated. However, they were examined to determine the most likely 
reading frame and corresponding amino acid sequence. Table 17 (p136) 
presents the amino acid sequences for 22 of the transcripts matching the WAG 
65N20 clone, the most highly expressed differential transcript in the WC. From 
Table 17, it appears that the consensus sequence for the WAG-65N20 clone is: 
>SLTTIFTNVS GKPYEDAESV SEHSTIVRAK SSCRSQHHNM SQRLCFLGLA 
LCNVAVSHNTLPLRLPDVAA//. This peptide consists of 70 amino acids, with an 
estimated molecular weight of 7580Da and an isoelectric point of 7.78. It does 
not have a match in any of the current databases, so its cellular function remains 
unknown at this time. Table 18 (p137) presents the most likely amino acid 
sequence for all of the remaining clones that were identified using the databases, 
but did not have an annotation product. 
135 




































































































































































m9GLf lN iX3IOiaKlFRnra/ \F I«NM^ 
aTTF7N^(W>*H>ie9^SBiSTlVF^ 
CPFBUn-WK/CU<H. 
aTT1FT^O<P*H?e^SBHSI l \^S3C^^ 
a^PSCEvO/GFFBLhFHyK/CLHH. 
S L T i n ^ G K P T O e ^ S B H S m ^ S S C ^ ^ 
RYRCFFN RIHSFHSWPIRTIPI IKBW+WOCSffJ SNB+RtWKSIU^SRPRSMVRCNSRr 
SLTTlFTNK£(K=fmaeS/SBH=rtlVF^SS^^ LRRFCXM 
a.TTTFTN^O<RBD6E^a-EIlVFmS8CR3CHtW3a^U^ I W V M M 
SLTT1FlTSM=GKPYe>!e9/SBH5F\^ ^ LHRHXCLS 
aT11CT^Q<P»H>€S^SBH5m\/IWSSC^^ 
SLTTinS^G<Pim<e^SBHSm/R^SSCK^^ 
axnnN^a<p*a}€gDs&e! i \m<s8CRscH^ 
a s n n > ^ a < P f H ? e y s B « n \ « ^ 5 S < F e c H ^ 
SUOTH^G<PIH>^SB-6TIVIWSSI«SCH^ 
aTTlFM/SGKP*e>m/SBHSri\/FWSaCR^^ 
3JT in^G«=<H>^SBHSn \m<SSCR9^^ 
aTTinrM"Q<RH>e^SBeilVR^SaCFSCHtW3CRCRJa^ 
aJTlFTN3SQ4=VB>se^SBH3AI\^SSCR3>f^ 
SLTT\HN^GKPf l>m/Sm5l lMW^ 
H3FRraAOCHRJ<iCK^^^^c^mJ^PEL\M^ 
From Table 18, it can be observed that some of the nucleic acid sequences that 
matched multiple BAC clones represent the same peptide fragment when 
translated. The regions that matched BAC CH261-3201, -93G5, -71A6, and -
15P9 begin with >REVLLPYST LVRPHLEYCV//. There is variation in the codon 
usage within the larger peptide, explaining why they matched different genomic 
clones. However, if these sequences had been clustered and reported as one 
match, the transcript itself would have been significant by Chi Square analysis. 
The functional pathway of this transcript is not known, but, because some version 
136 
of this transcript was isolated in multiple experiments, it appears to be important 
in the overall expression profile of the SR. 
Table 18: Predicted Amino Acid Sequences of Un-Annotated Clones 


















































































































































































































































































































H H W 3 P F SFW2P(H3S K S I K O T ^ AUJ<SRrf^ 
RE\AJJ^YSftL\miE»WCfiMPCfi<KDRBIE«/OT 
RCm*AK('IW3BCfflX»RU:S«*ERTRGN 
FGPSSAOGOP BCTO'LSyPT/iMvaKJ<U<TlPIVPSai01,<rW*ME GEEMITOWTOJQ 
RB/Um5ALVRPH£*a/C!FWF!Faa 
RGOJMAKril«H>HX»RU&»IX)R'TRGN 
R E V U R ^ L / W l B W C F V W W D R a i H W R A T K M W ^ 
QGDUartWriMGBOeiGAFlSSWWERTOGN 
\«*SPW<^IWIM1^ f l + ^ M 1 ^ 






QCAGRSCHKPVBRIHAA.SE GDrasNwuMExwra-itTcacnn WEYDSSSTA VRTSUFF 
OCPSG«KWSR!HWJSEGiraSNWlFaB<^^ 







GCFTFPWrtF R.VKSNSPEP AQPUNFTEEH SCRQNFM. C Y A U M W C E 
CXFWF*WPtfStGPB>AO?UfTmGGU}<IRJLCYM3MPfCE 
KV\PrPI<WI^BW^alSHRILIVCMTSIJSAYFR^H«CS 
P/3=SUUKAYIOHFPI*rtMmWClPCTDM3UDFai WRTO«ffiCL VYR3«SMXWL 
R « N a P K R a Y K D F K y T F C X l i M ^ S W B S P N n S P W L P Q G S A T P G P ^ ^ 
KM{SI3^\JH^Km\imHXymWFOfm<i/DtHHi 
T M Y B A Y C N l W M I X E N m E K n K U I F A C l G 
DP^nSWiMSPVPLVnAERGYACVSIERGPR 
ARTSUXsNIS n5TPCM«3 G S + F I C Y O / 
KEFBMWEE RPKELOm. ERKStBGDMnWhMOCC KJSKLfaS'TOSRKBNGFMJREQPLSD 







RB/UJ^>5AL\mi£rcv (BWWaraRBiH* iU«AT™^ 
im»MHKfii«H>m»RLRWf*ERTFiGN 
niOT\^REEPGSttJBGTH^YIYKi^NR/IPCmLan<^^ 













VhMJCSELG B/CGS/ESSDVPFMAPASSR QCGLSPRSP U T C T O W F S I H J C E S V K ^ T A L J ^ M F S B / H 
0CU : l lF I«AU3mOT^WrO5ERC^PRDa^^ 
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Seventy transcripts were not identified in either database. Cluster analysis 
revealed 35 unique sequences; 11 of which were up regulated in the WC, and 24 
that were up regulated in the SR. The most likely open reading frames (ORF) for 
each of these unidentified, but differentially expressed transcript tags were 
determined and are presented in Table 19a and 19b. 





































































Predicted Amino Acid Sequences of Unidentified White Carneau Transcripts 
CWSCNHGCD KCCSLSLLLP AWFTRNPAS GCLSTSVADG LENSSRLPPK QNHQ 
CSCARRFSQT AOACAYGTTC FNGLASVGKH VWVSWELDKVS FKHYWKIffiS LARAPACAGNERLSSLSQG 
VTOAAVLAGF SQYSRYlXMWSKlSMGWiQ RANTGGAGSSINvSSQRTTG KQKQSPVHSS PRPAAGNETD SUHFPRAL 
SCSSQGGREVLQVLSLIAlNBSaGMMVFCSVFSCRESGPFPGSSDSLWHJQI^ 
SAWAAIRPHQAY 




CALYKAWLRE HOTASKHLKL LLNSFKPGLN PWPW 
D L V L T S R I L A R S R B r a V l r C > S F m . T F a R r ^ ^ 
CDYKKLTPRL KNKTNDIGMD S.CNSPPPR GPWAKB<LRN SQRPYSNTGR XSRGGARVTQ IRPLLG 
KNPAVWFDRD SSTGMUHKS RIKTCLDSTR ARALERPLL KAQAGCQTPWCSIYCrawrTKPKDASLVDL NSYGMMHNLV AVMSLNVF 
VPQU.QWSVVAW<PTOSYL SULRLSLLL ALKALQSTSR SSGYKYGE 






































































































































Predicted Amino Acid Sequences of Unidentified Show Racer Transcripts 
TKAVLMSHEK HPYGFEQSDC PALNCLPFLM NQANHCKMFL 
CRAVTLLKPI RMFLMVHKNC FGLEQFNQLKIPMAKFFNPP 
KTTTQSNSPH KPLPQTAGNC CFPQLGTRVW GSYLLPPKLM ANSWRYLDFS LFFFSPRQTI FFSNITFNLT PHVH 
FGLQWDLCGR SYMNLLTCHS VAHQNHCGLE CKTYICFFSN GFEIAKRLNG SSLL 
FGLQWDLCGR SYMNLLTCHS VAHQNHCGLE CKTYICFFSN GFEIAKRLNG SSLL 
FAHSGTESAP QVDTTSLTVP KRTSDCHSPR RAALHASDKF KPSPVGNNNE SC 
AVSRRICMGG GLSPLPRKLV QETQNNPRLF YASARLNKSE QSCSSTLLGV SGLGHEYLCPMSSLFAPYVP YSLLQS 
KMELFSSGCN RLMTFIVFCP VTTRDSQTVT PRAFELHQQL EFAG 
IGTSLCLSCP GQREGPDIPA YCSSSKLMEE GTRLSVQSLI PSPACLSSGN SRPSGFLNIGIVQGVTAMLL SCMLCSYEHL PLCDSS 
PNTISLIVDL SRCLGRTKNR TNIYPEISSE PQIIFI 
CVRLLLTLQH PALHHLSPSP ATQNRHDLNS LLSPAEEGAVARSSLCSHVL FSVL 
MQVLAMUQD NTHLFTFWQL NLRTCPVHYP WLHAGLLCLF HGMFLES 
ASPSSLSCPC HYPPALHSPG WCPCPAAVSL RKNRTRICFA VKIAGAPVPF WWGCQGSDRLLPFCVCPC LK 
YHVCICSELG EMCGSVESSD VPPHWPASSR GICGLSPRSP LFTQITCHRK FSLFLCESVSGATALRVWFS EVH 
QATENCFLLWIQPQSPASHS LLSCLFRVRT TLFTYEDSNE CKLPINPKAV PSNFPPHSQPVPCPSMDQAA RKAGAFPLSS NLELLLLTEN NSCFSPSQ 
KECVLLCKDR HYLQGRKPCC AWGGDFALQV PTLVPERFIE SLSTLPAADR FTPPDLTPEPEGRFWINCQI RPGSRIDTFT HTKGRVY 
FWATLHACSV RPRNVIVQLS YPTAMYCDNL KLENHILYHL VNTKVWENKQ YLAHVLLRVPNKLQ 
KKLGFFSVPV LISLLTLHYP PDGPHCLIKW WLSTSSLFLQ FYNVTKLEEN TYLLSSRMVFCSTLUKLGF WTLPEMT 
NGTQFPVSCD LSFAATDLKC EPLKEIKEPR CIYPCSTIRY HCDSFTSEAG VLAAKACSAA RFNTRWIGA S 
VSYVFRLSAF NLHYVRPSLL LLSLSTGHPT TDQLLHKLLF TGVQKPTVSK SS 
MCHORDVSQS KSTRFTYRWF LNPSEOKLVQ QLVSGGMAGG QRQQKQAWSH IV 
EHGAASEASP PGHSHAVSKI SACITRQSIL QYQAIQAMFQ WLLQDYAKVK VGSYCPVFCSLYC 
DVGDDFSSRL FPAPCSSVPS PAGLAARHQI GDYQPPAESS P 
SSAAASPQPS RYSGVFPLSF LFIFFPQQKC VDILQLDFLQ AYVSVPSVPG MRKVTPHSPIWPFKLKGSNT LPLLHHLGQR QGFIP 
YIHEIKFLYL GIFFCKKRMF QIYRFCGWSK APQNAVLSAS LLSHVPSSRQ GDVRTTETLL LKDKSILSSN RFITVQLVLR DELELHFSKN TVFPCSSVW 
GGLTGRHXAY GXDXXTIGAF KADTKRDLXS HDVSNGNGFX LKERTSVTKV EXTVGDNHGPPPQLGGVKYR G 
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Finally, because the reproducibility of RDA has not been reported in the 
literature, experimental replications 3 & 4 were subsequently analyzed as a data 
subset because these two RDA experiments were conducted on the same pools 
of cells. Two plates of clones (n=192) were analyzed in RDA #3 (Plate A, B), and 
only 1 plate (Plate A) was analyzed in RDA #4 (n=96). The number of transcripts 
that were duplicated and different between the experiments was counted. 
Transcripts that were differentially expressed between replicates were further 
categorized as to whether the transcript was missed or was additive within the 
comparison. In order to determine how much information is gained by performing 
additional RDA experiments versus characterizing more clones per individual 
RDA experiment, three types of comparisons were made and are reported in 
Table 20 (p140). 
The first comparison reflects the plate-to-plate variation that randomly 
occurs within a single experiment (RDA #3). From Table 20, it appears that 
approximately 7.3% of the observed variation between plate A and plate B can 
be explained by the random nature of colony picking. This means that for any 
given set of 96 clones, one clone will match another clone in the data set 92.8% 
of the time. Of the total variance, 4.1% represented genes that were missed in 
the second plate, compared to 3.2% of the genes that were new. The second 
comparison examined the variation between two given plates resulting from 
separate RDA experiments. An experimental average of 10.2% variance was 
observed between RDA #3 and RDA #4. Because 7.3% can be explained by 
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random picking, at least 2.9% of the variation between the two plates can be 
explained by the difference in the RDA replicate itself. 
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The third comparison looks at the combined data obtained from two plates 
representing one experiment (n=192) to the data obtained from either plate alone 
(n=96). By analyzing 192 clones from an individual experiment rather than 96, 




Biological Relevance of Results to Atheroqenesis 
Determination of Candidate Genes Contributing to Pigeon Atherosclerosis 
Multiple perspectives were used to prioritize the contribution of 
differentially expressed genes to atherosclerotic susceptibility and/or resistance 
in the pigeon. In the first analysis, individual genes were divided into four tiers of 
candidacy based on copy number variation and reproducibility as presented in 
Table 5a-5c (p97). In order to qualify for placement in the first tier, genetic 
transcripts needed to be differentially expressed in at least two experiments, 
and be present in high enough copy number to be statistically significant by Chi 
Square Analysis (p < 0.05). For the second tier of candidacy, one of two criteria 
needed to be met. First, transcripts needed to be differentially expressed in at 
least two experiments, as in Tier 1, but not present in high enough copy to be 
statistically significant by Chi Square Analysis (p >0.05). Second, transcripts 
were differentially expressed in only one experiment, but were present at high 
enough levels to be statistically significant by Chi Square Analysis (p < 0.05). 
Although each criterion reflects a different perspective, they were coupled in the 
same tier to avoid the temptation of placing emphasis of copy number over 
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biological reproducibility, and vice versa. In Tier 3, transcripts were differentially 
expressed in one experiment, the copy number was >1, yet it was not high 
enough to be statistically significant by Chi Square Analysis (p >0.05). Tier 4 
consisted of genes that were isolated one time in one experiment, and were not 
considered to be major candidates from this perspective. The top candidate 
genes represented in the first three tiers are presented in Table 21. 
Table 21: Candidate Genes Determined by Copy Number and Reproducibility 
White Carneau (Susceptible) 
Gene Protein Product 
Show Racer (Resistant) 
Gene Protein Product 





































cleavage & polyadenlyation specific factor 2 
chemokine ligand 12 
dachshund homolog 1c 
diacylglycerol O-acetyltransferase 
alpha enolase 
ribosomal protein L27, mitochondrial 
ligatin 
N-acetyltransferase 13 
proteasome, ATPase subunit 2 
retinol binding protein 
ribosomal protein L32 
ribophorin 1 




collagen, alpha 2 type 1 
unknown 
eukaryotic translation initiation factor 4E 
glucose phosphate isomerase 
HRAS like suppressor 
macrophage erythrocyte attacher 
nucleoside diphosphate kinase 
proteasome, ATPase subunit 3 
ribosomal protein L7 
ribosomal protein L7a 
sec 61 protein, alpha subunit 
transketolase 












cytochrome oxidase subunit 1 
cytochrome b 
fibronectin type 1 
lumican 
myosin light chain kinase 
NADH subunit 4 
ribosomal protein L3 
alpha tropomyosin 
unresolved 












SMC myosin heavy chain 
proteasome, ATPase subunit 4 
proteasome, non ATPase subunit 
GTP binding protein 
sec 61, gamma subunit 
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Table 21 (continued) 
White Cameau (Susceptible) 
Gene 
p

















Show Racer (Resistant) 
Gene 
Tier 3 Candidate Genes 
reprolysin type disintegrin & metalloprotease 
aldehyde dehydrogenase isoform E3 
unknown 
decorin 
lactate dehydrogenase subunit A 
small nuclear RNA LSm3 
unknown 
nardilysin 
nuclear receptor hormone 
pectinesterase inhibitor 
phosphoglucodehydrogenase 
proteasome, ATPase subunit 3 
RNA binding motif S1 























histone promoter control 1 
unknown 
mariner 1 transposase 
sarcolipin 
In the second analysis, differentially expressed genes were prioritized 
according to their physical loci. This analytical step was performed because if 
differentially expressed genes are clustered together on a single chromosome, 
they are more likely to be inherited together and possibly respond to a common 
transcription factor. Individual chromosomes containing significantly more 
transcriptionally active genes than the corresponding chromosome in the 
opposite breed were identified using Chi Square Analysis. The graphic results 
of these comparisons were presented in Figure 3, 4, and 5 (p129,130,133) 
and formed the basis for the tiered ranking system presented in Table 22 
(p145). In order to be included in Tier 1, differentially expressed genes must 
reside on a chromosome that was determined to be "up regulated" in all three 
statistical comparisons. Tier 2 is comprised of genetic transcripts residing on 
chromosomes that were "up regulated" in two of the three comparisons. In 
addition, mitochondrial genes were included in Tier 2 because at least one-third 
143 
of them were differentially expressed. This difference was not apparent until the 
third comparison because of the small number of genes coded by the 
mitochondria (n=13). Finally, differentially expressed genes were placed in Tier 
3 if the chromosomes on which they reside were "up regulated" in one of the 
three comparisons, and was not W or Z. 
Sex-determinant chromosomes were not considered as candidate genes 
for atherosclerosis for two reasons. First, breeding studies have indicated that 
disease susceptibility in the WC pigeon is inherited as an autosomal trait, and 
there is no difference between males and females, only between WC and SR. 
Second, the number of genes expressed on the W and Z chromosomes is 
dependent on the gender of the embryos used to culture the aortic cells. This 
information is usually recorded for in-vivo experiments, as once the birds are six 
weeks of age, gender can be determined during autopsy. However, it is not 
known how many males (ZZ) and females (ZW) are represented in the cell 
culture pools used for RDA. Therefore, any conclusion regarding the impact of 
either chromosome on phenotype is inappropriate. In the future, it is 
recommended that a blood sample be taken from each embryo sacrificed for 
cell culture in order to determine the gender273 and the expected number of 
alleles per biological pool. 
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Table 22: Candidate Genes Determined by Chromosomal Position 
Gg Gene Protein Product 
White Carneau (Susceptible) 
Gene Protein Product 
Show Racer (Resistant) 




collagen, alpha 2 type 5 
RNA binding motif S1 




















coatomer protein complex gamma 
U6 small nuclear RNA LSm3 
ribosomal protein L32 
ribophorin 1 
Sec 61 alpha subunit 
Sec13L 
transketolase 









f>, - , . , . ,;•, Tier 3 Candidat 
enolase, alpha 
phosphoglucodehydrogenase 
retinol binding protein 7 
exocyst complex component 7 
mitochondrial RPL27 
nucleoside diphosphate kinase 
eukaryotic translation initiation factor 








cleavage & polyadenylation factor 2 
lactate dehydrogenase subunit A 
spondin 
proteasome, ATPase subunit 3 
spleen focus forming virus 
ALDH9A1 
NARD1 










actin related protein 3 
activin/TGFB receptor 1 
fibronectin type 1 
unknown 
myosin light chain kinase 
NADH dehydrogenase 
unknown 






cytochrome oxidase I 












alpha 2 actin 
proteasome regulatory subunit 
unknown 
unknown 
actin related protein 10 
unknown 
unknown 
histone promoter complex 1 




From Table 22, chromosomes C7, C12, and the mitochondria occupy the top 
two tiers. This suggests that the genes expressed at these loci are potentially 
involved in the atherosclerotic phenotype, and should be considered in the final 
analysis regardless of copy number. The transcripts expressed from Gg1 and 
Gg3 were placed in Tier 3 - however, the total number of genes residing at 
these loci was too extensive to record in Table 22. Therefore, a complete list of 
all the genes that were physically placed on theoretical chromosomes is 
presented in Appendix D (Table D.31). 
Finally, KEGG and Pathway Studio were used to annotate the identified 
transcripts. As stated in the Methods, Chi Square analysis was not performed at 
the pathway level. This is because there are obvious differences in gene 
expression within a pathway between the two breeds that would not be 
detected. For example, Table 7 (p103) reveals no difference between the WC 
and SR in Signaling Molecules & Interaction. In the WC, 6.8% of the 
differentially expressed genes represented this category, and 7.3% of total 
transcripts. In the SR, 8.6% of genes fit, representing 8.1 % of total transcript 
number. This comparison is not statistically significant. However, when the 
individual genes within Signaling Molecules & Interaction are examined, it 
becomes evident that very different signals are being sent out from developing 
WC and SR aortic smooth muscle cells. 
Five general themes of differentially expressed pathways were 
consistently observed between the WC and SR aortic cells and are presented in 
Table 23 (p147). These themes will be subsequently discussed in terms of their 
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potential contribution to atherosclerotic susceptibility and resistance in the 
pigeon. Briefly, dramatic differences were observed in energy metabolism, 
phenotypic markers, protein metabolism & modification, the immune response, 
and in the types of signals, transcription factors, and receptors expressed. The 
subcategories in each column of Table 23 represent the KEGG and Pathway 
Studio groups that contributed to each major theme. 
Table 23: Five Major Themes as Determined by KEGG and Pathway Studio 
BiergyMstabolism 
Qyxrd Lipid (Vfetabdism 
Glycols 
Qcc&i\eRT6ptrr>lation 
Pentose Phosphate St i r t 
TCAcyde 
Phenotype Markets 
Cell ach3si ore 
Cell matrix amissions 
CeBnrotilily 



















Hflnli 1 nil 
Mstaocusm 










Aaie phase response 
Aiigsn presenting 
BceH receptor petftm/ 
LaKcc^etrareerdcthslialrrigration 
Toll receptor partway 
-
A scoring system was developed in order to compile one list of candidate 
genes derived from all three levels of analysis. To accomplish this objective, a 
genetic transcript was assigned one point for each contribution to one of the five 
thematic pathways listed in Table 23. For the candidate genes that were ranked 
according a system of tiers (Table 21, 22), points were distributed as follows: 
Tier 1= 3 pts, Tier 2 = 2 pts, Tier 3 = 1 pt, and Tier 4 = 0 pts. Although 
imperfect, categorizing the 165 unique and differentially expressed genes 
according to these criteria provided a comprehensive framework for prioritizing 
the contribution of candidate genes to the susceptible or resistant phenotype in 
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pigeons. Table 24 (p149) presents the top candidate genes in descending 
order of score, excluding transcripts that scored less than 3 points. 
There are 22 difference products that scored at least 5 points, indicating 
their relevance in at least two of the analytical perspectives described. The "top 
22" candidate genes represented each of the five pathways: phenotype marker 
(n=6), energy metabolism (n=6), signaling molecules (n=9), protein metabolism 
(n=7) and the immune response (n=2). The genes involved in protein 
metabolism were evenly divided between those active in the 26S proteasome 
(n=3) and the ribosomal proteins (n=3). Since 22 genes represent 30 distinct 
pathway functions, it is clear that some of the candidates have multiple 
functions. These genes are of special interest because they represent a 
potential link between the pathways, and thus are a potential mechanism to 
connect seemingly divergent events in atherogenesis. 
This select group includes MYLK, which is a marker of the contractile 
phenotype, a signaling molecule, and, as a kinase, plays a role in protein 
modification in the SR. Myosin light chain kinase was placed on Gg7, which 
displayed a significant increase in both the number of genes and in the copy 
number expressed when compared against the WC and the chicken. In 
addition, MYLK was important in its own right, as it was isolated in two 
experiments, and in high enough copy number to be considered significant by 
Chi Square Analysis. Beta actin, in the WC, is a synthetic phenotypic marker 
and a signaling molecule, but its third role is in the immune system. The 
presence of COL5A2 also marks a synthetic phenotype in the WC, and, 
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myosin light chain kinase 

































































chemokine ligand 12 
alpha enolase 
lumican 
ribosomal protein L32 
ribophorin 1 
transketolase 
cytochrome oxidase subunit 1 
cytochrome B 
NADH subunit 4 
alpha actin 
collagen, alpha 2 type 5 
dachshund homolog 1c 
diacylglycerol O-acetyltransferase 
ribosomal protein L27, mitochondrial 
ligatin 
N-acetyltransferase 13 
proteosome, ATPase subunit 2 
ribosomal protein L3 
Sec 61 alpha subunit 
actin related protein 3 
activin/TGFB receptor 1 
annexin II 
collagen, alpha 2 type 1 
decorin 
eukaryotic translation initiation factor 4E 
glucose phosphate isomerase 
unknown 
SMC myosin heavy chain 
NADH dehydrogenase 
proteosome, non ATPase subunit 
GTP binding protein 
RNA binding motif S1 
retinol binding protein 
TNFa induced protein 8 
alpha tropomyosin 
zinc finger protein 100 
reprolysin type disintiqrin & metalloproteas 
calnexin 
C3a anaphylatox receptor 
cyclin 
coatomer protien complex gamma 
coactosin 
cleavage & polyadenlyation specific factor 
fibulin 5 
fibronectin type 3 
HRAS like suppressor 
inhib. Kappa light polypeptide enhancer 
small nuclear RNA LSm3 
macrophage erythrocyte attacher 
nardilysin 
nucleoside diphosphate kinase 
nuclear receptor hormone 
phosphglucodehydrogenase 
proteosome, ATPase subunit 4 
unknown 
ribosomal protien L7 
ribosomal protien L7a 
ribosomal protein S3 
Sec13L 
sec 61, gamma subunit 
spondin 1 











































































































































































































































































































































































































































































































































like ACTB and MYLK, can function as a signaling molecule. This particular 
collagen isoform is also located on the same chromosome as MYLK (Gg7). 
Enolase is a glycolytic enzyme that normally functions in the cytoplasm as part 
of glycolysis. However, a shortened transcript codes for tau-crystallin enolase, 
which has been reported to translocate to the nucleus and act as a transcription 
factor263,264. Finally, the chemokine ligand CXCL12, also known as stromal 
derived factor 1 (SDF1), plays a major role in the immune system by interacting 
with many types of cytokines, but also has other signaling functions, many of 
which are not yet understood. 
The Five Major Themes Associated with Atheroqenesis in the Pigeon 
Many of the differentially expressed genes identified in this set of 
experiments correlate with biochemical pathways and morphological events 
previously documented in the pigeon. Differences in proteoglycan metabolism, 
myofilament organization, mitochondrial function, and ATP usage patterns 
reported in the literature were observed at the genetic level in the current study. 
In addition, this is the first study to report an immune response in the 
spontaneous (non-induced) model. The immune factors expressed by the WC 
precede actual foam cell formation, and the SR cells grown under parallel 
conditions do not express these same factors. 
Theme One: Energy Metabolism. The most striking difference observed 
between the WC and SR was energy metabolism. The SR cells clearly relied on 
oxidative phosphorylation, whereas the WC cells generated most of their ATP 
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from glycolysis and the pentose phosphate shunt, bypassing the mitochondrial 
reactions altogether. This finding corroborates previous studies that 
demonstrated mitochondrial abnormalities145,184, increased glycolysis173 and 
decreased oxidative phosphorylation170 in the WC relative to the SR. Hajjar and 
Smith168 showed that WC pigeons lacked the necessary regulation of NADH 
transhydrogenation. Inappropriate amounts of NADH in the cell would impact 
the NADPH/NADH ratio, which, among other cellular events, regulates the 
synthesis of triacylglycerols (TAG) and fatty acids. Because of this, the authors 
suggested that a defect in transhydrogenation could explain the enhanced lipid 
biosynthesis in the WC. 
In the current study, WC aortic cells expressed diacylglycerol transferase 
(DGAT2), a metabolic enzyme that facilitates the final step in TAG synthesis. In 
further concordance with Hajjar & Smith, both NDUFA10 and ND4 were up 
regulated in SR, suggesting that the SR smooth muscle cells have maintained 
their ability to regulate NADH transhydrogenation. Also, up regulated in the SR, 
were CTYB and COI, providing evidence that deficiency of these protein 
components of the electron transport chain may be involved in the 
mitochondrial dysfunction observed in the WC. 
The primary function of a mature SMC is contraction, so by necessity this 
cell type requires more ATP than its non-contractile muscle counterparts. To 
accomplish this, energy production in muscle cells is compartmentalized in 
order to optimize ATP delivery to the cellular ATPases274 . Weiss et al. 
observed that ATP generated by oxidative phosphorylation was used for 
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myofibril contraction, whereas glycolysis-produced ATP is used by the 
membrane and transport ATPase complexes274. If this division of labor also 
occurs in the pigeon, insufficient oxidative phosphorylation could account for the 
lack of contractile elements identified in the WC. The WC aortic cell may try to 
compensate by up regulating glycolysis, but this pathway does not produce 
nearly enough ATP for contraction. In that case, excess ATP could be re-
directed into storage, first in triacylglycerols as suggested by DGAT2 
expression in the WC, and later in cholesterol esters, as the literature reports. 
The excess ATP could be used to drive untimely phosphorylation reactions, 
leading to various abnormalities in cell signaling and enzyme activation states. 
The precise reason as to why glycolysis is up regulated in the WC is not 
clear from these studies. It could be a compensatory measure or a response to 
a marginally aerobic cell. In either case, the dual effects of one of the glycolytic 
enzymes identified, enolase, has already been discussed. Glucose phosphate 
isomerase (GPI) and lactate dehydrogenase A (LDHA), were also identified in 
the WC, and play a role in cell signaling. An important distinction to note is that 
the enzymes that participate in oxidative phosphorylation do not signal. The 
function of the electron transport chain (ETC) is to produce ATP, which in a 
SMC, is believed to specifically target contraction. One observation that 
supports the idea that the ATP produced by the ETC is coupled to contraction is 
that in the SR cell, along with the increased expression of ETC enzymes was 
the concurrent up regulation of many phenotypic markers denoting a contractile 
cell. 
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Theme Two: Phenotvpic Modification. Synthetic and contractile 
phenotypes are on opposite ends of a continuum, yet cells can exhibit both 
features at the same time50. This occurs during vascular development, which is 
considered the "maturation" phase52. The phenotype can also switch if the adult 
tissue is injured, and the vessels need to be repaired. Under these conditions a 
contractile cell will start expressing synthetic transcripts again67. In reality, the 
phenotype of a SMC population seems to be the net result of the expression 
ratio of synthetic to contractile elements. 
The aortic cells compared in this study were harvested on day 7, which is 
just prior to actual foam cell development in the WC. At the same time, the 
resistant SR SMC are moving from the "Maturation Phase" to the "Contractile 
Phase" as described by Owens et al52. This smooth transition is not occurring in 
susceptible cells because the WC are losing their myofilament structure145, and 
do not fully reach the contractile phase. This initial disorganization of the 
cytoskeleton in the WC has been reported to occur prior to foam cell 
development in the WC275 and cell proliferation in culture276. Studies in mice 
have demonstrated that a dramatic reduction in ACTA2, alpha tropomyosin 
(TPM1), smooth muscle myosin heavy chain (MYH11), and calponin45 
accompanies foam cell formation. 
Among the many contractile markers found in the SR, MYLK was the 
most consistently expressed and scored the most points in the compiled 
ranking system. Telokin, a specialized protein within the MYLK gene, was also 
identified. Telokin stabilizes un-phosphorylated myosin filaments so the kinase 
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domain of the protein can perform its function. It is also believed to play a role in 
SMC relaxation and calcium sensitivity61. Telokin is highly specific to SMC, but 
is not used as a phenotypic marker because of its low expression levels in the 
aorta and coronary arteries. The fact that telokin was isolated in the SR aortic 
cells using RDA demonstrates the sensitivity of the method. 
The enzymatic action of MYLK is to phosphorylate myosin regulatory 
light chain (MYRN)277. One copy of MYRN was found in the WC, but it must be 
phosphorylated in order to then phosphorylate the myosin heavy chain 
(MYH11). MYH11 performs the actual mechanics of contraction, and is calcium 
and calmodulin dependent264. The status of MYH11 phosphorylation during the 
early stages of SMC differentiation has been investigated. Despite the marked 
presence of myosin phosphatase (MP) in the SMC, the myosin itself was 
heavily phosphorylated278. When the action of MYLK was inhibited, even 
partially, the differentiation process was slowed, or even arrested. The authors 
were not sure if the inhibitors blocked MYLK itself, or if it blocked the calcium 
release. 
If MYLK were either deficient or inefficient in the WC, ATP generated 
from oxidative phosphorylation would be unable to support muscle contraction. 
In response to the decreased energetic needs of the cell, the electron transport 
chain would down regulate to basal levels, making it appear to be up regulated 
in the SR. The prolonged lack of contraction may cause (by default) a 
phenotypic switch, turning on synthetic transcripts and halting differentiation. 
The SR appears to proceed through the maturation phase into differentiation, 
154 
evidenced by the presence of both beta and alpha actin. Two copies of ACTB 
and 7 copies of ACTA2 suggest that the SR cells were harvested during their 
phenotypic transition. However, at the same stage of development, the WC only 
expresses ACTB, evidence that differentiation is not moving forward smoothly. 
Differences in the alpha/beta actin ratio during lesion formation have also been 
observed in chickens. It was determined that there was more alpha actin in the 
aortic SMC tissue than in the developing plaque from the same group of 
birds279. 
Alpha actin is a major constituent of the contractile apparatus, and the 
concentration of ACTA2 and TPM1 in SMC is twice that of skeletal muscles277. 
Unlike ACTB, ACTA2 does not have a double role in cell signaling. Perhaps as 
the expression of ACTA2 decreases, the parallel increase in ACTB expression 
signals that the cell is losing contractility. This idea is supported by RDA 
experiments conducted in 1-3 day old pigeons280 where ACTA2 and FBLN5 
were identified in the WC, suggesting that differentiation is initiated, but then 
stops. It is possible that the reason ACTB has evolved a secondary immune 
function is to communicate the presence of a non-muscle phenotype in a 
muscle cell. 
A second characteristic of a synthetic cell type is the development of an 
extensive extracellular matrix. The ECM is an integrated structure of 
proteoglycans and collagen fibrils, and the distribution of these molecules and 
the ligands they bind are believed to determine the integrity of the matrix in the 
face of metalloproteases and immune assault. The small, leucine rich 
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proteoglycan, lumican (a keratin sulfate GAG), was found to be significantly up 
regulated in the SR, whereas in the WC, decorin, alpha collagen type 1 
(COL1A2), and collagen type 5 (COL5A2) were dominant proteins in the ECM. 
Pro alpha collagen, elastin, and gamma actin have been identified in the WC 
aorta in vivo 281, along with an increase in chondroitin 6 sulfate (C6S). Increases 
in COL1A2 and ACTB have also been observed in apoE null mice282. Enzymes 
related to C6S were not identified in the current study and the finding of lumican 
instead, and in the SR, was a surprise. Lumican has been reported to be 
present in advanced human plaques, and is believed to contribute to the matrix 
degradation and collagen fibrillogeneis that was also observed in the coronary 
artery104,283. However, lumican was one of eight proteins that were down 
regulated in response to mechanically induced injury284. The authors provided 
no rationale for the loss of lumican expression in damaged cells, as it was not 
their research target, and possibly because it could not be explained in the light 
of conventional wisdom, which states that lumican is associated with an a 
increase in atherosclerosis, not vice versa. 
One of the advantages of conducting a discovery-based versus a 
hypothesis-driven experiment is exemplified by the unexpected identification of 
lumican as a differentially expressed gene. This is the first study to report the 
presence of lumican in either pigeon breed, and the increased expression of 
keratin sulfate in the resistant SR. Most proteoglycan research described for the 
pigeon has focused on chondroitin sulfate (C6S) in the WC, as it is observed in 
susceptible regions of the WC aorta as early as six weeks of age. The SR is 
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commonly used as a control for these studies, as the accumulation of C6S is 
unique to the WC aorta. However, as genetic transcripts specific for C6S 
proteoglycans were not identified in this study, the accumulation of C6S in the 
WC could be a consequence of lumican not being expressed. It is possible that 
lumican confers resistance to the SR by a mechanism that has not yet been 
described. 
Support for the protective nature of lumican comes from the cancer field, 
where studies have shown that lumican decreased tumor growth and the 
invasion of melanoma cells. In addition, lumican appeared to increase the 
apoptosis of malignant cells, causing the authors to suggest that lumican might 
be "considered an anti-tumor factor from the ECM"285. Lumican is also known to 
bind collagen, thus regulating the interfibrillar spacing264. In this capacity, 
lumican is thought to regulate cell growth and circumference. 
As "rounding of the cell" is one of the degenerative events seen in the 
WC145,184, perhaps the appropriate conformation for the SMC is not possible 
without the framework provided by lumican. Lumican deficient mice are 
characterized by a very loose connective tissue and collagen structure that 
parallels Ehlers-Danlos syndrome in humans286. Finally, recent studies in the 
field of arthritis have shown that in a cell containing multiple proteoglycans, one 
of the metalloproteases, MMP-13, preferentially cleaved fibromodulin and 
biglycan rather than lumican287. This suggests that the presence of lumican in 
the ECM of the SR aortic cells may cause them to be more resistant to cellular 
proteases. This type of protection would prevent the matrix from binding and 
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retaining circulating lipoproteins and cytokines82. This possibility is further 
supported by the fact that both proteases and chemokine ligands were up 
regulated in the WC cells. 
In addition to the differences reported for MYLK, lumican, and the actin 
isomers, many other phenotypic markers were differentially expressed between 
the two breeds. In the WC, synthetic proteins such as plastin, periostin, 
vimentin, spondin, ezrin, and fibronectin type 3 were identified. In the SR, actin 
related proteins 3 & 10; coactosin, fibronectin type 1, and fibulin 5 were 
expressed. Interestingly, FBLN5 null mice have displayed exaggerated 
vascular remodeling accompanied by a thickened intima, revealing a potential 
role of FBLN5 as an inhibitor of VSMC proliferation and migration288. The ability 
of FBLN5 to suppress tumor growth has also been observed289, and, unlike 
FBLN1, it is down regulated in most cancer cells290 . In humans, aberrant 
versions of FBLN5 have been found to actually contribute to tumor 
development. Finally, as a secretory protein, FBLN5 is believed to mediate cell-
cell and cell-matrix interactions. The overall distribution of phenotypic markers 
in this study clearly demonstrates that the WC and SR cells are not following 
the same pattern of SMC maturation and differentiation. 
Theme Three: Immune Response. The immune response has not been 
reported as a factor in the spontaneous pigeon model of atherogenesis. 
Macrophage cells and leukocytes are well documented in the cholesterol-fed 
pigeon model, where activation is assumed to occur in response to the 
unnatural diet. In one of these studies, Denholm & Lewis isolated a monocyte 
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chemoattractant produced by the WC in vivo prior to foam cell development159, 
but did not clarify what cell type was expressing the signal. The current study 
demonstrates that SMC can, and do, signal for an immune response. 
Mouse aortic SMC have been observed to become "macrophage-like". 
The authors termed this phenomena "Transdifferentiation", and suggested that 
the inflammatory changes observed in vivo "may not be a simple consequence 
of cholesterol accumulation"45. As there were no major differences in the genes 
controlling cholesterol metabolism between the cell types of the two pigeons, it 
appears that something other than lipid accumulation is also signaling the 
immune system in the WC pigeon. 
Chemokine ligand 12 (CXCL12) was highly expressed in the WC aortic 
cells, yet no receptors were identified. This finding suggests that the cell types 
that express receptors for, and normally respond to, CXCL12 were not present 
in the culture system. Further investigation is required in vivo to fully 
characterize this ligand-receptor partnership. Microarray analysis of 1-3 day old 
WC and SR aortic tissue revealed the increased expression of one type of 
chemokine receptor in the WC, CXCR4291. In a recent description of 23 
chemokines and 14 receptors confirmed to function in the chicken, CXCR4 was 
identified as the putative receptor for CXCL12292. A non-specific chemokine 
receptor has been identified in advanced human lesions, along with Tumor 
necrosis factor alpha induced protein 2 (TNFalP2)104. 
Although expression of TNFa itself was not detected, traces of its activity 
were present in the WC. The non-specific responder TNFalP8 was up 
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regulated, and is reported to have anti-apoptosis activity264. The ADAMS family 
of matrix proteases is also induced by TNFa82, and ADAMSTS15 was isolated 
from the WC cells. In addition, CXCL12 is known to respond to TNFa, along 
with lipopolysaccharide and interleukin-1, neither of which was identified. 
Recent proteomic studies293 have also detected a TNFa induced protein in the 
WC pigeon. 
The immune response in the WC cells was also represented by 
macrophage erythrocyte attacher protein (MAEA), spleen focus forming virus 
(SFFV), inhibitor of kappa polypeptide enhancer in B cells (IKBKAP), ezrin, 
ACTB, and glucose phosphate isomerase (GPI). Two proteins were found to be 
associated with the inflammatory response: the anaphylatox receptor (C3AR1) 
in the SR, and a small inducible cytokine (SCYE1) in the WC. The catalyst for 
the immune response in the WC is not apparent from these experiments, nor is 
the relationship between the responders. One possibility is that the presence of 
ACTB in a non-contractile cell may be considered foreign, eliciting a response. 
However, other differences in signaling are simultaneously observed between 
the WC and the SR, so THE causative signal remains elusive. 
Theme Four: Signaling. Receptors, and Transcription Factors. Cytokine 
binding and other cellular events induce a myriad of signaling cascades. Of 
special interest in the WC are the "signal transducers and activators of 
transcription" (STAT). One member of the STAT family, STAT4, may play a 
role in VSMC proliferation and has recently been demonstrated to be up 
regulated in cholesterol fed WC pigeons in vivo 294. In the current study, the 
160 
STAT signaling pathway was represented in WC aortic cells by cyclin D2 
(CCND2). The cyclins regulate the mitotic cell cycle, and CCND2 is expressed 
as the cell moves into its replication phase63 . In a recent genome wide 
association (GWA) study, two types of cyclin dependent kinases (CDK) were 
found to be an independent predictor of coronary artery disease (CAD) in 
humans295. 
The GWA consortium screened 17,000 individuals with 500,000 markers 
of seven human diseases. Within the susceptible loci, both CDKs were 
differentially expressed between those individuals with CAD and the 
experimentally matched controls. This was the first study to implicate cyclins in 
heart disease, a risk factor not currently considered during routine screening 
tests. The fact that CCND2 was up regulated in the susceptible WC aortic cells 
is very exciting in light of this new discovery, as both of the CDKs identified in 
humans are regulated by CCND2262, and can be studied in the spontaneous 
pigeon model. 
The transforming growth factor beta (TGFB) signaling pathway was also 
differentially expressed between the WC and SR. Decorin and spondin were 
isolated in the WC, whereas activin (ACVR1) and Sp1 were expressed in the 
SR. Sp1 is a transcription factor necessary for SMC differentiation, and may be 
responsible for successful differentiation in resistant aortic cells. Since decorin 
and spondin are synthetic proteins, and also respond to TGFB, it appears that 
TGFB may be involved in the phenotypic differences observed between the WC 
and SR. It was recently demonstrated by Wagner et al. that TGFB reduced 
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growth in SR cells (decreased proliferation), but increased growth in WC cells 
from the comparable site in the celiac region296. 
TGFB has historically been accused of a pro-atherogenic role because of 
its ability to promote fibrosis and inhibit endothelial regeneration297. More 
recent studies have shown that TFGB limits atherosclerosis by modulating a 
number of processes, including lipid accumulation and the inflammatory 
response. At this point, the mechanism by which TGFB contributes to 
atherosclerosis remains to be clarified, as there are widely varying dose-
dependent effects even within the same experimental system. Activin is a type 
1 TGFB receptor, and was expressed in the SR aortic cells. Although many 
transcripts that are induced by TGFB were identified this study, including fibulin 
5, and periostin, the specific ligand for activin in the SR was not determined. 
A different receptor, ligatin, was up regulated in the WC. Ligatin has 
been shown to bind glycoproteins to the cell surface298 in a calcium dependent 
manner299, possibly protecting itself from trypsin digest. It also retains 
phosphorylated sugars, allowing hydrolases to bind and degrade the glycosyl 
groups from core glycoproteins as needed. Hisotochemical studies have 
reported a "fuzzy ring" around WC aortic cells prior to foam cell development, 
but this phenomenon has not been investigated300. Ligatin receptor is able to 
embed in the hydrophobic cell membrane because it contains a domain that 
binds covalently to palmitate301. This association with palmitate suggests a 
mechanistic link with one of the traditional risk factors, saturated fat. Palmitate 
is the 16-carbon saturated fat most commonly handled by the body, as it is 
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prevalent in the American diet and is the point that de novo fatty acid synthesis 
stops. Either of these scenarios would ensure ample palmitate in the cell 
membrane, allowing more ligatin receptors to embed, thus increasing the 
retention of extracellular glycoproteins In addition, ligatin also functions as a 
transcription factor, suggesting a direct connection between membrane 
composition and gene expression. 
It was very interesting to look at the types of transcription factors that 
were identified. Subjectively, the SR seemed to express what might be 
considered "normal" transcription factors (TF) such as the high mobility group 
proteins (HMG14, HMG2a), and zinc finger proteins (ZFP-100, ZFP-183). HMG-
14 specifically facilitates gene transcription by maintaining the chromatin in an 
accessible conformation. In contrast, the transcription factors isolated from the 
WC did not seem "normal". 
Abnormal transcription in the WC is best exemplified by SFFV. In the 
current study SFFV was identified in one experiment, ranking it rather low as a 
candidate gene for susceptibility. However, it has also been shown to be 
expressed in the 1-3 day old WC in vivo 291. Many studies in chickens have 
looked at the effects of Herpes, Mareks disease, and Chlamydia on 
atherosclerosis, but these have not been found to play a causative role in 
pigeon atherogenesis. Yet, the identification of SFFV in the WC keeps the virus 
theories alive, because the initiating genetic factor for WC susceptibility is not 
evident. 
163 
In addition to SFFV, tau-crystailine enolase, an isomer of EN01 that 
acts like a transcription factor was also active in the WC aortic cells. ENOt, 
along with GPI, and LDHA have demonstrated transcription activity263, and all of 
these enzymes were up regulated in the WC. It may not have been so 
surprising that these glycolytic enzymes were expressed at such high levels, 
but coupled with the fact that these WC cells exhibited no oxidative 
phosphorylation, the communication between glycolysis and the nucleus seems 
excessive. LDHA and EN01 were two of the substrates first identified for the 
oncogene tyrosine kinase v-src, a compound highly investigated for 
pharmaceutical purposes in cancer263. It would be interesting to know if 
individuals undergoing this type of chemotherapy demonstrate a decreased risk 
for atherosclerosis. LDHA can bind to single-stranded DNA (ssDNA) and 
destabilize the helix. NADH has been shown to inhibit the binding of LDHA to 
ssDNA. However, given the lack of regulation of the NADPH/NADH ratio in the 
WC168, LDHA could be a de-stabilizing factor in the susceptible breed. This 
idea is supported by the fact that LDHA was exclusive to the WC; whereas both 
WC and SR expressed LDHB. 
Finally, the over-expression of EN01 and LDHA was coupled with GPI in 
the WC cells. GPI is one of the enzymes secreted by cancerous cells to 
promote proliferation, but the mechanism of this response is not completely 
clear168. However, all of these glycolytic enzymes were up regulated in the WC 
aortic cells, and their dual role as transcription factors may be relevant in the 
susceptible phenotype. Inappropriate activation of transcription can have 
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innumerable effects. If, as is in the case of v-src, a glycolytic enzyme such as 
enolase is capable of turning on an oncogene: one of two things could happen: 
The oncogene can in turn activate many genes in multiple signaling pathways 
to achieve the simultaneous overproduction of growth factors and associated 
proteins. Or, the activated oncogene can overproduce just one co-activator that 
coordinately controls expression of all necessary genes for a malignant cell to 
outstrip its peers in growth209. Both of these scenarios may help to explain why 
so many genes were found to be differentially expressed between the two 
breeds, when susceptibility to atherosclerosis in the pigeon is caused by a 
single gene. 
In addition to oncogenes, nuclear lipid second messengers also effect 
cell proliferation by activating many different genes302. A non-specific nuclear 
hormone receptor (NHR) was identified in the WC, as was the increased 
expression of retinol binding protein (RBP). Retinoic acid is required for many 
types of NHR activation, and these results may suggest coordinate regulation 
by a single genetic response element or promoter that impacts downstream 
gene expression. 
Theme Five: Protein Modification & Metabolism. Ribosomal proteins are 
often considered to be false positives in RDA experiments because they are 
expressed in such high copy number compared to other cellular products. In the 
current study, 3 out of 18 false positives were transcribed for the small subunit 
(S). However, the differential expression of many other ribosomal genes in the 
pigeon aortic cells was evident in multiple analyses, and appears to be of 
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significance in this model. Ultrastructural examination of WC aortic cells 
harvested between 6-8 days indicates a loss of ribosomes145. It is possible that 
the WC is attempting to compensate for ribosomal degradation by increased 
synthesis. It is suspect that so many transcripts of RPL3 were isolated in the 
SR, especially since they all came from the same biological pool of birds. It 
could be an example of PCR preferential amplification, or it could be a true 
reflection of increased ribosome and protein synthesis in the SR. However, the 
excessive expression of RPL3 in the SR cannot be explained by the current 
data, and the difference in distribution of ribosomal proteins between the WC 
and SR aortic cells will need to be further investigated before a conclusion can 
be reached. 
Protein catabolism was up regulated in the WC in both the expression of 
proteasome enzymes, and in the expression of non-specific proteases. 
Proteasomes are distributed throughout eukaryotic cells at a high concentration 
and cleave peptides in an ATP/ubiquitin dependent manner264. The 26S 
proteasome degrades cytoplasmic and nuclear proteins303 that are not targeted 
to the lysosome. One of the 26S ATPase subunits, (PSMC2) has been 
identified in advanced human atherosclerotic plaques102. This subunit was also 
up regulated in the WC aortic cells, along with PSMC3. In contrast, PSMC1, 
and PSMD1, the non-ATPase regulatory subunit, were up regulated in the SR. 
It was interesting that the proteasome maturation protein (POMP) was 
determined to be a false positive in these experiments, as it seems that different 
proteasome activities are occurring between the two breeds. This discrepancy 
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is possibly explained by the presence of ribophorin 1 (RPN1) in the WC, which 
directly connects the rough endoplasmic reticulum (RER) to the 26S 
proteasome base286, and may be responsible for determining the types of 
proteins that will be degraded. 
Ribophorin is believed to perform a regulatory function in the ER, by 
tagging improperly folded proteins for degradation by the proteasome. RPN1 is 
one of many subunits of the oligosaccharide transferase (OST) complex304 and 
functions to mediate the transfer of "high mannose oligosaccharides from a 
dolichol carrier to suitable (asparagine) acceptor sites in nascent chains"305. 
The OST is closely associated with the ER translocon (SEC61) for secretion 
from the ER. The SEC61 complex is the major site for the integration of both 
single spanning and transmembrane proteins306. As with the ATPase subunits 
of the proteasome, the SEC61 subunits were also differentially expressed 
between breeds. SEC61a was present in each breed, but up regulated in the 
WC, whereas SEC61G was exclusive to the SR. However, the distinct function 
of each of the SEC61 subunits is not yet understood. Recent experiments have 
isolated RPN1 as part of the lysosomal membrane protein fraction. Therefore, 
its glycosyl transferase activity is not restricted to the ER307 and it is possible 
that RPN1 also targets proteins to for degradation by the lysosomes, although 
this remains to seen. 
Although protein glycosylation was clearly up regulated in the WC, and 
one de-glycosylase enzyme was also found, the major proteoglycan identified in 
either cell type was lumican in the SR. Although this specific finding was 
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unexpected, similar observations have been made in WC pigeons at all ages 
over six months. In one of these experiments, Edwards & Wagner308 
demonstrated less proteoglycan production, but more proteoglycan degradation 
in the WC than the SR. The authors proposed that the increase of C6S 
observed in susceptible pigeons may be a result of longer chain length and/or 
increased hydrolysis, rather than increased synthesis of a core protein such as 
versican or aggrecah. The glycosylation of native proteins and the subsequent 
degradation of non-relevant glycoproteins is a very intriguing pathway to 
investigate in the spontaneous pigeon model, especially in light of the varying 
resistance of proteoglycans to proteases, and the striking differences observed 
within the proteasome complex itself. 
Finally, the degradation of the ECM by metalloproteases (MMPs) has 
been well documented in the literature, mostly in terms of plaque stability 
because of the signaling relationship between MMPs and the immune system. 
Although investigating an entirely different stage of the disease in this study, 
proteases were identified in the susceptible aortic cells, suggesting that the 
degradation begins very early in the pathogenesis. A Disintegrin And 
Metalloprotease Thrombospondin (ADAMSTS15), nardilysin (NARD1), and a 
non-specific dipeptidase (CNDP2) were all up regulated in the WC cells. 
Nardilysin seems to be able to increase cell migration and proliferation by 
binding to heparin bound growth factors309. However, peptidases did not 
represent the dominant pathway in the WC, and as ECM degradation had not 
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yet occurred, proteolysis is not believed to be a primary or initiative factor in 
atherosclerotic susceptibility in the pigeon. 
The five major biological themes identified in the RDA experiments 
represent intermediate phenotypes214 or sub-phenotypes46 that are common to 
many types of disease. For example, some of the genetic transcripts identified 
in the WC cells susceptible to atherosclerosis were understood only in terms of 
their effects in cancer or arthritis. It may seem counterintuitive that so many 
genes were differentially expressed in a monogenic phenotype. But the 
development of atherosclerosis is gradual, with many cellular changes 
occurring simultaneously, all of which depend on the transcription of DNA and 
processing instructions. Overall, there were very few transcripts identified in this 
study that were capable of cross-talk between the pathways, and these 
interactions are a logical place to begin integrating the diverse theories of 
atherogenesis into one coherent story. 
Genetic transcripts representing oxidative phosphorylation and 
contractility were significantly up regulated in the SR cells. In contrast, the 
synthetic phenotype was indicated in the WC, as well as increased glycolysis. 
Energy metabolism is tightly coupled to muscle contraction in aortic cells. 
Therefore, a genetic defect in this partnership might determine susceptibility 
and/or resistance to atherqsclerosis in the pigeon. It is not clear from the RDA 
results whether myosin light chain kinase (MYLK) cannot perform its role in 
contraction in WC cells because it does not have the energy, or it is 
dysfunctional. The transport of ATP between the mitochondria and the 
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contractile apparatus of the cell does not appear be implicated in pathogenesis 
because the expression of one type of transporter, SCL25A5, was not 
differentially expressed between the two breeds, and no others were identified. 
Hypotheses of Human Atheroqenesis Supported by Pigeon RDA Results 
As most of the more common theories of human atherogenesis were 
described in detail in the Literature Review, the background will not be repeated 
here. The hypothesis of phenotypic modification received the most supporting 
evidence in this study. The resistant SR cells were clearly expressing the 
normal contractile phenotype of a SMC, whereas the WC cells were in the 
synthetic phase. It remains unclear if contractility does not develop in WC 
because of inefficient ATP production, a dysfunction in MYLK, or a deficiency of 
lumican. Regardless, the arrested differentiation observed in the WC aortic 
cells is one of the first events in pathogenesis. 
The presence of active proteases in the WC provides a plausible 
mechanism to support the response to retention hypothesis. Lumican has been 
shown to be more resistant to MMP13 degradation. Without the protection of 
lumican, the matrix between WC cells is vulnerable to degradation, rendering 
more hydroxyl groups available to bind lipid and inflammatory factors, leading to 
a destructive cycle. The response to retention hypothesis is also supported by 
the expression of ligatin and ribophorin in the WC. Ligatin is a cell membrane 
receptor that actually binds glycoproteins to the cell surface, providing an 
additional mechanism for retention. Ribophorin glycosylates proteins using a 
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dolichol carrier, and if these by-products accumulate in the cell, they can 
aggregate and provide clusters of binding sites for infiltrating LDL or aberrant 
signaling molecules. 
The hypothesis of mitochondrial dysfunction was also supported in this 
study. The fact that the WC displays no oxidative phosphorylation, and an over 
reliance on glycolysis makes this hypothesis appealing. It seems fairly clear that 
the ATP generated in the mitochondria is effectively coupled to muscle 
contraction in the SR, and not in the WC. Cytochrome b is strongly implicated 
as a resistance factor, but it cannot be deleted or completely disabled in the 
WC, or the birds would not survive to reproduce and transmit the susceptible 
allele. However, if not enough CYTB was produced, or the complex did not 
transport electrons efficiently, the WC may not be able to make enough ATP to 
meet the high energy needs of muscle contraction. Unable to perform its fully 
differentiated function, the WC SMC may slowly revert to a more synthetic and 
less differentiated phenotype. However, this scenario would also take place if 
MYLK were deficient, so it remains unclear whether phenotypic modification 
causes mitochondrial dysfunction, or vice versa. 
The response to injury hypothesis was not directly supported or refuted 
in this study, as injurious perturbation was not a controlled variable in these 
RDA experiments. The inflammatory response was not invoked, but the WC 
cells were clearly attempting to signal the immune system with CXCL12, ACTB, 
and IKBKAP. However, it is not clear what the immune system was being asked 
to respond to. Experiments need to be designed to directly explore the immune 
171 
response to phenotypic change in the SMC, and be conducted in a non-induced 
model of atherogenesis to remove ambiguity. 
Finally, although lipid metabolism was slightly elevated in the WC with 
the expression of DGAT2, there was no direct evidence that the substrate used 
for triacylglycerol synthesis was delivered by infiltration. Therefore the Lipid 
Infiltration Hypothesis was not supported by this study. In fact, given the lack of 
TCA enzymes and electron transporters in the WC, it is more likely that the 
anabolic substrate for TAG synthesis was derived from incomplete beta-
oxidation, forcing fatty acids into synthesis and storage. 
The Chicken as a Comparative Genomics Resource for the Pigeon 
Despite the vast difference in genome size, the human genome is closer 
to that of the chicken than of the mouse268. Therefore, comparative avian 
genomics are likely to provide valuable insight into gene regulation, splicing 
mechanisms, and other types of functional divergence relevant to human 
disease. The recent publication of the Gallus gallus genome contributed greatly 
to the 93% identification rate of sequenced clones generated in the current 
study. 
One hundred forty five of the 167 unique genetic transcripts isolated in 
the pigeon were orthologous to the chicken. The categorical exception was that 
the mitochondrial genes expressed in the pigeon were more closely related to 
birds such as the oriental stork, greater flamingo, and turkey vulture. In fact, the 
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SR transcript of CYTB matched over 100 other avian species before aligning to 
the chicken. The ND4 gene (NADH subunit 4) was used to analyze the 
phylogenic relationship between the pigeon, chicken, and various other birds 
that were matched during the BLAST analyses. Table 25 lists the avian species 
selected and their nucteotide-coding region of the ND4 gene within tiie 
complete mitochondrial genome (GenBank). 






















CLUSTALW was used to align the six nucleotide sequences from 
GenBank with five different ND4 transcript tags isolated from the Show Racer in 
the current experiments. The resultant Phylogram is depicted in Figure 6 (p174) 
From Figure 6, it can be seen that the chicken is most closely related to 
the quail, as are the turkey vulture and oystercatcher. The SR transcripts are 
obviously related to each other, although not congenic, and are in fact, more 
homologous to the zebra finch than the chicken. This corresponds with a 
phylogenic tree generated using 12S/16S rRNA and reported by Van Tuinenn 
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produced by Pimentel-Smith et al311 using a proteoglycan gene, the chicken 
was very closely related to the guinea fowl, quail, and turkey, demonstrating 
approximately 97% homology at the nucleotide level. In contrast, the pigeon 
and chicken shared only 30% homology. 
These phylogenic comparisons reveal that despite the observed synteny 
within avian species, there is still a good deal of nucleotide diversity at the level 
of the individual genes. From the results of the current study, it would appear 
that the majority of this diversity is mitochondrial, as 147 out of 165 transcripts 
were identified using the chicken, and none represented this organelle. 
Mitochondrial comparisons between the pigeon and the chicken are therefore 
not appropriate, as limited homology is expected. However, based on the 
NADH4 transcripts characterized from the SR pigeon, the zebra finch will help 
bridge this gap. The zebra finch genome project is well underway at the Arnold 
lab at UCLA and, with continual annotation updates to the chicken genome, will 
provide an invaluable resource for further pigeon studies that remain dependent 
on comparative avian genomics. 
- Taeniopygiaguttata 
_r-136SRPaD03 







Limitations to Data Interpretation 
Inherent Limitations of RDA 
Differentially expressed RNA transcripts will only be captured using the 
described method if the cDNA product contains at least two internal Dpn II 
restriction sites. Therefore, although finding a transcript is evidence that the 
gene is active, the reverse is not true271. Lack of identification does not mean 
the gene is not present; it could be that a biologically relevant and differentially 
expressed transcript was isolated in the RNA extraction, but did not have an 
amplifiable restriction fragment. This is expected to be the case in 
approximately 10-15% of mammalian genes312. Until the restriction profile is 
known for the avian counterparts, it can be assumed that only 85-90% of the 
target genes will be identified using RDA in the pigeon. One way to increase the 
number of cDNA transcripts in the final difference products is to repeat the 
experiment with a different four-cutter enzyme. In addition, if the same 
restriction site is included in the primers used to generate cDNA as is used to 
generate amplicons; the potential to capture amplifiable fragments increases. 
The number of difference products isolated does not directly correlate to 
the original copy number of the RNA transcript. This is because the number of 
Dpn II sites and the efficiency of each restriction step determine the final 
number of fragments produced. In some cases, such as SMC myosin heavy 
chain, multiple restriction fragments, representing distinct regions of the original 
transcript were isolated. This can be confusing because it is not clear whether 
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the sequence tags came from one full-length transcript of myosin heavy chain, 
or from multiple copies of myosin heavy chain that happened to be randomly 
picked. In contrast, only one fragment was isolated from ribophorin, yet this one 
fragment was picked 16 times. To avoid over emphasizing the influence of one 
gene, restraint is required when analyzing copy number variation with Chi 
Square Analysis. It is possible that differences in copy number are a result of 
preferential amplification of select transcripts during PCR230. It is also possible 
that observed variation in copy number reflects general differences in RNA 
stability, transcription, and translation levels of diverse proteins unrelated to the 
disease. On the other hand, the number of transcripts identified might be a true 
reflection of the atherosclerotic susceptible/resistant phenotype in the pigeon. 
Finally, the fact that a gene is present in low copy number does not 
mean it is less important than a gene present at high copy levels. One of the 
advantages of RDA is the ability to capture rare cellular messages. It is possible 
that one genetic transcript could be responsible for eliciting a multitude of 
responses in other genes and on other chromosomes. In addition, the Chi 
Square statistical test fails to recognize real biological differences when the 
sample number is less than five271. For these reasons, although copy number 
was recorded, and was an important aspect of the analyses, it was not the only 
perspective used to determine genetic differences between the WC and SR. 
176 
Experimentally Introduced Limitations 
Although every effort was made to keep the parameters consistent 
throughout all of the RDA experiments, the availability of cell culture material 
and the changes made in antibiotic selection could impact repeatability. Table 
26 presents the experimental variables potentially impacting gene expression in 
the WC and SR aortic cells. 
Table 26: Cell Culture and RDA Experimental Parameters 
Cell Culture Parameters 
RNA Extraction Exp# 
Number of Embryos 
Days Grown 





Horse Serum Lot 
1%Ethanol Present? 
RDA Parameters 
Driver Yield (ug) 
DP1 Hybridization Time (hrs) 
DP1 Yield (ug) 
DP2 Hybridization Time (hrs) 
DP2 Yield (ug) 
DP3 Hybridization Time (hrs) 
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It is critical that the two cell populations be grown under identical 
conditions and harvested at similar densities313. This is because the number of 
cells will impact the number of alleles expressed at any given moment in time. 
However, in vivo, the WC aorta is hypocellular compared to the SR, having a 
larger lumen281,296. For this reason, it seemed more important to harvest the 
cells at similar points in development, so RNA was extracted just as the cells 
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formed a monolayer. Typically this monolayer forms in seven days, but in the 
WC cells used for RDA #1, 8 days were required. 
Tissue samples should also be as closely matched as possible, and 
when experiments require the processing of cells grown in vitro, it is best to split 
a single culture for selected treatment to generate the driver and tester, rather 
than using separate cultures313. Our lab routinely follows this guideline when 
investigating different stages or enzyme effects within one breed. However, by 
necessity, WC and SR cultures are prepared at separate times so their 
phenotypes remain distinct. It is clear from Table 26 that none of the cultured 
cells used for the RDA comparisons were perfectly matched. RDA Experiment 
#2 appears to be the best matched in terms of the relative growth of the cells 
and the dates the media reagents were made, but the impact of this on the 
gene expression not known. 
Although changing environmental conditions may have impacted the overall 
gene expression profile, there were some transcripts, such as cytochrome B, 
cytochrome oxidase II, and LDHB that were consistently isolated in all four RDA 
experiments. Because atherosclerosis in pigeons is an autosomal recessive 
trait, it was assumed that variations in gene expression between experiments 
were a result of the different environments, rather being a function of the 
pathology itself. 
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Reproducibility & Efficacy of RDA for Identifying Differentially Expressed 
Genes in the Pigeon 
One technical replicate (Table 20, p138) was performed in order to guide 
the direction of future experiments. For a proper statistical comparison to be 
made, the same number of clones from each experiment should have been 
sequenced and characterized. However, determining the reproducibility of the 
RDA method was not one of the primary research objectives. From the few 
comparisons that were made, it appears that approximately 2.9% more genes 
were identified by doing a technical replicate, which is similar to what was 
gained by doubling the number of clones analyzed in one experiment (2.5%). 
Therefore, there is no advantage to performing technical replicates from the 
same biological sample. In fact, one author has stated that generating excess 
technical information is "akin to studying the difference in heights of the two 
sexes by repeatedly measuring one man and one woman"314. Resources would 
be better spent either maximizing what can be learned from one individual 
experiment by picking more colonies, performing biological repetitions, or 




Genes representing several biochemical pathways were distinctly 
different between the aortic cells from susceptible (WC) and resistant (SR) 
pigeons. These differences include: 
1. Cells from the susceptible aortas express genes controlling a 
synthetic phenotype while those from resistant aortas produce a 
contractile phenotype. 
2. Susceptible aortic cells derive their energy from glycolysis and the 
pentose phosphate shunt in contrast to resistant aortic cells, 
which rely on oxidative phosphorylation. This indicates that the 
beta-oxidation of lipids is limited in the WC, while lipid synthesis is 
enhanced. 
3. Resistant aortic cells appear to be more effective at organizing 
and maintaining an intact extracellular matrix and internal 
cytoskeleton, whereas susceptible cells do not develop a 
supportive structural foundation. 
4. In general, proteasome degradation is enhanced in susceptible 
cells while protein synthesis predominates in the resistant aortic 
cells. There are also dramatic differences between the individual 
ribosomes being used by each cell type for protein translation. 
5. Although the synthesis of core proteoglycans was increased in the 
resistant cells, protein glycosylation itself predominated in the 
susceptible cells. In addition, the susceptible cells expressed a 
unique glycoprotein receptor/transcription factor. 
6. Consistent with the above generalizations, genes expressed by 
susceptible cells in the nucleus and endoplasmic reticulum are 
different than those of resistant cells. This suggests that there are 
cellular differences at the level of transcription and translation. 
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These conclusions support the atherogenic hypotheses of phenotypic 
modification and mitochondrial dysfunction of smooth muscle cells, and, to a 
lesser degree, the response to retention hypothesis as contributing factors in 
pigeon atherosclerosis. A causative role of inflammation was not supported by 
these experimental results. However, this is the first study to observe an 
immune response in a non-induced, non-hyperlipidemic model of 
atherosclerosis, and further studies are needed to determine the cellular 
triggers that are eliciting the immune response. The current results do suggest 
that the decreasing ratio of alpha/beta actin that precedes foam cell 
development in the WC may be enough to signal an immune response. 
Because oxidative phosphorylation is so tightly coupled to smooth 
muscle cell contraction, and the time scale of in-vitro cell growth is so 
compressed, it is not obvious whether insufficient ATP synthesis is preventing 
the WC aortic cell from performing its contractile function, causing differentiation 
to slow down; or, if the lack of functional contractile elements are causing the 
mitochondrial synthesis of ATP to down-regulate. In order to determine the 
causative sequence of events, parallel RDA experiments are being conducted 
on the celiac bifurcation in one-day and six-week old pigeons of each breed. 
The pending results of these experiments should facilitate the placement of 
differentially expressed genes in a chronological context during atherogenesis. 
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APPENDIX A: ANIMAL RESEARCH DOCUMENTATION 
UNH Animal Care and Usage Committee Approval #050601 
This study involved the use of pigeon aortic cells prepared by the 
Dissertation director. No individual approval was required because I did not 
participate in either the care of the pigeons or the acquisition of pigeon tissue 
used for cell culture (communication with Julie Simpson, Manager, Research 
Conduct & Compliance Services, Office of Sponsored Research). 
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APPENDIX B: SELECTED PROTOCOLS 
Table B.27 SLOWCOOL (Adapter Ligation Protocol) 
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APPENDIX D: ANNOTATION TABLES 
Table D.31 Distribution of Differentially Expressed Pigeon Genes by Chicken 
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